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Abstract 
Bone morphogenetic protein (BMP) signalling is essential for correct lung 
morphogenesis. The pathway controls branching morphogenesis in the nascent lung 
and is also involved in the establishment of correct epithelial cell distribution 
throughout the airways. In the adult lung, BMP signalling is reactivated during 
airway injury and inflammation and there is evidence of aberrant signalling in lung 
cancer and in chronic lung diseases such as asthma and fibrosis. However, little is 
known about the role of BMP signalling in healthy adult airways. Furthermore the 
effect of incorrect BMP pathway expression during epithelial repair and 
inflammatory and malignant lung diseases remains elusive. The aims of this project 
were to characterise BMP pathway expression in the descending airways of large 
animal models and to investigate the role of BMP signalling during adult airway 
homeostasis, recovery and disease.  
To investigate the role of BMP signalling in malignant lung disease we used a 
heterogeneous lung cancer cell line DLKP. We explored the effect of the BMP 
pathway on epithelial-to-mesenchymal (EMT) progression and phenotypic 
plasticity between the tumour subpopulations. BMP-4 treatment induced 
mesenchymal-like projections in the DLKP-SQ clones and significant 
morphological changes in the DLKP-M clones towards the stem-cell like colonies 
of DLKP-I populations. Elevated N-cadherin and Vimentin protein expression was 
also evident in the clones following BMP-4 treatment. By stably transfecting an E-
cadherin gene in these E-cadherin-null cells we demonstrated the distinct 
phenotypic differences between these tumour subpopulations. 
  
 
ix 
 
 
Healthy porcine and rhesus macaque lungs were used to characterise BMP pathway 
expression throughout the airways. Active BMP signalling was present in the 
descending airway epithelium and a gradient in pathway activation along the 
proximal-distal axis of the lungs was observed [1].  Using a primary porcine 
tracheal in vitro explant model the BMP signalling gradient was investigated further 
and it was found that by modulating BMP signalling, using exogenous BMP-4 
stimulation, the epithelial phenotype of the porcine tracheal cells was altered.  
Finally, to assess the role of BMP signalling during airway inflammation and repair 
an established non-human primate model of allergic airway disease was used.  A 
reduction in pSMAD1/5/8 expression was present in the epithelium of asthmatic 
monkeys compared to healthy controls. In addition, following a period of six 
months in filtered air to facilitate airway repair, there was a significant increase in 
Proliferating Cell Nuclear Antigen (PCNA), BMP Receptor 1a (BMPRIa) and 
pSMAD1/5/8 throughout the asthmatic airways. Taken together, these data suggest 
that not only is the developmental pathway re-activated during inflammatory 
airway disease but that basal BMP pathway expression is important for maintaining 
healthy airways.  
Overall these data highlight the presence and importance of BMP signalling 
gradients in healthy adult airways and further implicate BMP signalling in the 
pathogenesis of inflammatory and malignant airway diseases. 
 
[1] T.M Lynn, E.L Molloy, J.C Masterson, S.F. Glynn, R.W. Costello, M.V. 
Avdalovic, E.S Schelegle, L.A. Miller, D.M Hyde, S O’Dea. ‘SMAD signalling in 
descending airways of healthy versus asthmatic rhesus macaques highlights a 
relationship between inflammation and BMPs’. AJRCMB, In Press. 
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1 Chapter 1 
Introduction 
1.1 The respiratory system: development, health and disease 
The lungs are responsible for oxygenation of the blood and the removal of 
respiratory waste products from the body. On average, an adult human breathes 
4,000 litres of air per day (Naclerio 2012). Air is inhaled through the nasal and 
mouth cavities where it is warmed and filtered before reaching the trachea and 
descending bronchi. Two main stem bronchi descend into the right and left lobes 
where the airways become progressively narrower and terminate in alveolar 
structures surrounded by a dense network of capillaries. Here, the oxygen in the air 
traverses the alveolar wall and is taken up by the red blood cells for transport around 
the body. Conversely, carbon dioxide and water vapour leave the blood and are 
exhaled out of the lungs. As a result of this, the lungs are constantly exposed to 
inhaled pathogens and disease-causing agents that exist in our atmosphere. The 
airway epithelium lining the lungs is a primary point of contact for these infectious 
agents and thus the lung plays an important barrier function for protection against 
infection and disease. The formation of this complex organ during embyonic 
development occurs in a specific pattern which is tightly controlled by growth 
factors, morphogens and signalling molecules (Warburton et al. 2000). 
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1.1.1  Lung morphogenesis 
Originating from the endoderm, the primary lung buds develop as they invaginate 
from the laryngo-tracheal groove into the splanchnic mesenchyme (Spooner and 
Wessells 1970). The four stages of lung development are known as the 
pseudoglandular, canalicular, saccular and alveolar stages (Figure 1.0.1). 
Pseudoglandular development begins at embryonic day 9.5 (E9.5) in the mouse and 
week 7-17 in humans (Ten Have-Opbroek 1991). This stage 
 
 
 
  
Figure 1.0.1 Lung bud development and morphogenesis 
The development of the lung buds occurs in four main stages, beginning 
at embryonic week 4. Modified from (Kajekar 2007). 
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involves multiple branchings of the buds coupled with elongation and subdivision 
of the cells lining the buds. This allows the fundamental broncho-pulmonary tree to 
be formed. The canalicular phase follows from E16.5-17.5 in mice, week 17-26 in 
humans and involves extension of the broncho-pulmonary tree. The saccular stage 
occurs from E17.5 to postnatal in mice and week 27-36 in humans. During this 
stage, terminal sacs form on the bronchioles and the capillary network develops.  
The final stage of development is called the alveolar stage where the gas exchange 
function of the lungs is established. This occurs from post-natal day 4-28 in mice 
and from week 36 of foetal development to 36 months post-natal in humans 
(Alejandre-Alcázar et al. 2007; Hogan 1996; Sun et al. 2008).  
1.1.2 Proximal-distal axis 
The homeobox sequence NKX2.1 is expressed in the foregut endoderm-derived 
epithelial cells and is an early instructor of lung epithelial cell fate (Minoo et al. 
1999; Morrisey et al. 2013). Subsequent lineage differentiation is tightly controlled 
by transcription factors, growth factors and signalling molecules. Proximal 
epithelial cells are under the control of the transcription factor SOX-2 whereas 
distal epithelial cells are instructed by SOX-9, GATA-6, ID-2 (Gontan et al. 2008; 
Que et al. 2009; Rawlins et al. 2009; Yang et al. 2002, 2014). 
 Growth factors originating from the endoderm or the underlying mesoderm are 
involved in complex signalling cascades to control epithelial cell differentiation 
along the proximal-distal axis and direct extension of the developing lung buds into 
the surrounding mesoderm (Morrisey et al. 2013). A broad range of signalling 
molecule families are involved in this process including Wnt- β-catenin, BMP, 
FGF, Notch, EGF and others (Cardoso 2001; Morrisey, E., Hogan 2010). The 
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complex communication between these growth factor families ultimately leads to 
the formation of the Epithelial-Mesenchymal-Trophic Unit (EMTU) (Figure 1.0.2). 
The EMTU is made up of opposing layers of epithelial and mesenchymal cells 
encompassing a network of basement membrane, fibroblasts, nerves and 
endothelial cells (Evans et al. 1999). The role of various growth factors and 
morphogens in lung development is explored further in section 1.2.3. 
 
 
 
  
Figure 1.0.2 The Epithelial-Mesenchymal trophic unit (EMTU) 
The fibroblast sheath consists of an epithelial cell layer and an 
mesenchymal cell layer with the basement membrane existing in the  
middle and joining the two (Evans et al. 1999) 
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1.1.3 Phenotypes of the epithelial cells lining the proximal-distal 
axis 
Epithelial cells along the proximal-distal axis have different functions. The trachea 
and bronchi are lined with ciliated and secretory cells in the form of a 
pseudostratified epithelium to facilitate the mucociliary escalator and the clearance 
of inhaled pathogens. The tall columnar cells possess cilia to trap invading 
pathogens. Secretory cells such as goblet cells are interspersed with the ciliated cells 
(Figure 1.0.3). Goblet cells produce high molecular weight glycoproteins that 
facilitate pathogen trapping by the fluid on the surface of the epithelium (Chang, 
Shih, and Wu 2008). In human lungs goblet cells are present in the tracheobronchial 
airways and become less frequent in the smaller, distal airways where non-ciliated 
secretory club cells prevail. This is very different to mouse and small rodent 
airways, where club cells are the only secretory cell present in the airways (Chang 
et al. 2008; Plopper et al. 1983).  
Basal cells facilitate attachment of ciliated and non-ciliated columnar cells to the 
basement membrane. They possess hemidesmosomes that anchor them to the 
basement membrane (Breeze and Wheeldon 1977). Basal cells are found at a higher 
frequency in the upper airways. In addition to their anchorage function, lineage-
tracing experiments have demonstrated that basal cells can self-renew and 
transdifferentiate to give rise to ciliated, goblet and club cells following injury 
(Boers, Ambergen, and Thunnissen 1998; Hong et al. 2004; Rock et al. 2009). 
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Figure 1.0.3 Epithelial cell types that exist along the proximal distal axis 
Descending epithelial cell types along the trachea, bronchi and alveolar regions of 
the lung. Stem cell niches are circles and numbers 1-3. Diagram adapted from both 
(Chang et al. 2008; Kajekar 2007) 
Trachea and conducting airways 
Alveoli 
Club 
cell 
Variant 
Club cell 
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In the conducting airways and descending into the distal bronchioles, goblet cells 
and club cells function largely to protect the epithelium from invading pathogens. 
Club cells produce cytochrome p450 enzymes to detoxifying any harmful 
substances present in the lungs and they are also an established population of 
ciliated cell progenitors in the airways (Baron et al. 1988; Plopper et al. 1992).   
At the terminal end of the bronchioles, a single layer of airway epithelial cells 
(AEC) type I and II line the alveolar sacs. These cells facilitate the bi-directional 
movement of gases between the airways and the blood (Chang et al. 2008). AEC I 
and II express low levels of EpCAM and AEC II are capable of self-renewal and 
differentiation to type I cells and express SFTPC (Barkauskas et al. 2013; Krieken 
and Litvinov 2003). 
As well as the differentiated epithelial cells capable of self-renewal and 
transdifferentiation that exist in the respiratory tract, different regions along the 
airways contain progenitor cells capable of differentiation to restore epithelial 
integrity following injury. These regions are circle in black in Figure 1.0.3.  In the 
submucosal gland, bromodeoxyuridine (BrdU) label-retaining cells remained in the 
subepithelial layer following weekly intratracheal detergent or SO2 inhalation 
(Borthwick et al. 2001). By denuding tracheal airways of surface epithelial cells 
and carrying out xenograft transplantation, it was found that the stem cells residing 
in these SMGs had the ability to migrate and regenerate the surface airway 
epithelium. Pulmonary neuroendocrine cells (PNECs) and neuroepithelial bodies 
(NEBs) have also been shown as a reservoir for progenitor cells in the lung. NEBs 
are associated with club cell accumulation following epithelial injury (Hong et al. 
2001; Reynolds et al. 2000). In the bronchoalveolar duct junction (BADJ), a 
progenitor population known as the bronchioalveloar stem cell (BASC) reside. 
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These cells can self-renew and are multipotent, maintaining club and AEC 
populations and mutations in these BASC result in adenocarcinoma formation (Kim 
et al. 2005). Finally, in the alveolar region a SFTPC- progenitor exists which is 
capable of differentiating into both SFTPC+ AEC I and AECII  following 
bleomycin airway injury (Chapman et al. 2011).  
1.1.4 The Lung epithelium  
Airway epithelial cells are dependent on correct cell-cell contact between adjacent 
cell populations and anchorage to the basement membrane zone (BMZ) at the 
EMTU. The characteristics that define an epithelial cell include the ability of cells 
to grow as a continuous sheet, the polarised nature of the cells displaying 
distinctions between apical, lateral and basal regions and the immobile nature of the 
cells in the structure (Savagner 2007). Actin is responsible for establishing 
epithelial cell polarity (Angst et al, 2001). Various types of cell junctions exist 
between neighbouring epithelial cells (Figure 1.0.4). Tight junctions or zona 
occludens (ZO) exist in the apical region of epithelial cells and consist of at least 
three transmembrane proteins including occuldin, claudin, cytoplasmic adaptors 
and junctional adhesion molecules (Matter and Balda 2003). Claudin-1 is an 
example of a transmembrane protein which interacts in a homodimeric fashion to 
form the tight junction. The interaction of these proteins results in a tight seal 
forming between adjacent epithelial cells and the generation of a selectively 
permeable junction (Balda and Matter 2000; Jefferson, Leung, and Liem 2004). TJs 
interact with the actin cytoskeleton using adaptor molecules (Fanning et al. 1998). 
ZO-1, also known as Tight-junction-1, and afadin are an examples of such adaptor 
protein molecules that link intercellular homodimers to the cytoskeleton. CD2AP 
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is an intracellular scaffolding protein also believed to link tight junctions to the 
cytoskeleton (Matter and Balda 2003). 
The second type of interepithelial junction is the cell adherens junction (ADJ).  
Cadherin homodimers form between adjacent epithelial cells in a calcium 
dependent interaction. Epithelial (E-), Neuronal (N-), Placental (P-) and Cadherin-
12 are the four classic cadherin proteins involved in ADJ formation.  These cadherin 
complexes are linked to the internal actin cytoskeleton by adaptor molecules such 
as γ-, β-,α-catenin, vinculin and p120 (Angst et al. 2001). β-catenin is involved in 
both regulation of the cell cycle via the Wnt signaling pathway and cell adhesion. 
When localised at the membrane, β-catenin protein interacts with the cadherin 
proteins and helps to stabilise the complex (Figure 1.0.5) (Angst et al. 2001) 
Thirdly, desmosomal junctions are formed by interactions with desmocollins and 
desmogleins and the intermediate cell filaments. Desmocollin and desmoglein are 
cadherin proteins. Following homodimer formation the complex interacts with 
intermediate filaments in the cytoplasm via desmoplakin plakoglobin or 
plakophilin. This complex is depicted in Figure 1.0.5.  
Gap junctions are the fourth type of epithelial junction. These junctions connect the 
cytoplasm of adjacent epithelial cells through a hydrophilic channel made up of 
connexons. Gap junctions facilitate the movement of small molecules and ions from 
one cell to the next and they can exist as homotypic, heterotypic or heteromeric 
complexes (Goodenough and Paul 2009). 
Finally, hemidesmosomes are the junctions responsible for cell-matrix interactions 
and the anchorage of epithelial cells to the BMZ. As previously mentioned, basal 
cells possess hemidesmosome junctions. Keratins, the intermediate filaments in the 
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epithelial cells are linked to laminins in the ECM via α6 β4-integrins interacting with 
cellular plectin, bulbous pemphigoid (BP) BP180 and possibly BP230 (Borradori 
and Sonnenberg 1999). Although not depicted in figure 1.0.4, focal adhesions exist 
on the basal surface of epithelial cells to anchor the cell to the BMZ. These junctions 
link the actin cytoskeleton to the ECM via interactions with integrin and docking 
adaptor molecules  such as  talin, paxillin and filamin (Van Tam et al. 2012; 
Wozniak et al. 2004). 
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Figure 1.0.4 The epithelial cell junctions 
Representative image of the interepithelial junctions. Tight junctions and 
adherens junctions are connected to the actin cytoskeleton. Desmosomes are 
linked to the intermediate filaments via desmoplakin. Adapted from (Matter and 
Balda 2003) 
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Figure 1.0.5 Adherens junctions and desmosomal junction 
  
Classical cadherin mediated cell adhesion between cadherins possess five 
repeated extracellular domains. (A) Homodimeric cadherin junctions, in 
yellow, form in the interepithelial space linking the internal actin 
cytoplasmic networks between adjacent epithelial cells. This occurs via 
interactions with β-catenin (β),α-catenin (α) and vinculin (V). Neural (N-
), Epithelial (E-), Placental   (P-) are the three main types of classical 
cadherin proteins. (B) Desmosomal junctions use the desmosomal 
cadherins desmoglein and desmocollin in yellow.  Interactions with the 
intermediate filaments (IF) occur via desmosomal plaques plakoglobin 
(PG), plakophilin (PP) and desmoplakin (DP). Adapted from (Angst et al. 
2001) 
A     B 
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1.1.5 Lung injury and repair 
Due to the respiratory function of the lungs, the airway epithelium is constantly 
exposed to smoke, allergens, bacteria, viruses, noxious gases and infectious agents 
that exist in our atmosphere. However, the fact that the lungs usually maintain their 
function under these conditions is a testament to the highly effective barrier 
activities and immune response of the lung epithelium. A principle function of the 
epithelium is the formation of a mucociliary layer which provides a physical barrier 
against invading pathogens. This tightly-knit seal is formed by the various cell 
junctions and adherens junctions which exist between the epithelial cells, as 
explained in section 1.3.  The epithelium produces a diverse range of secretory 
products which contribute to the mucociliary escalator of the lungs. In addition, the 
production of nitric oxide and arachidonic acid further help to fight infection and 
maintain airway homeostasis (Crosby and Waters 2010; Knight and Holgate 2003).  
However, damage to the epithelium can arise following severe or prolonged 
exposure to harmful agents. Multicellular damage to the epithelium causes a 
cascade of events which, in the case of normal repair processes, will lead to the 
physical restitution of the denuded BMZ and the recruitment of immune cells to 
eradicate the invading pathogen responsible for the damage (Erjefalt et al. 1997a). 
The repair of the epithelium is the primary goal of the damage response as any 
breech in this protective layer can result in widespread infection and detrimental 
effects to the respiratory system and indeed, the organism.  
Physical damage to the epithelium has been shown to induce a mechanical response 
in the cells. As the epithelium is a relatively immobile structure, loss of surface 
tension in the injured region triggers a stress response (Bilek, Dee, and Gaver 2003; 
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Ghadiali and Gaver 2008). The cells at the edge of the wound lose contact inhibition 
of locomotion and become leaky resulting in the passive movement of small 
extracellular molecules in these cells (Jacinto, Martinez-Arias, and Martin 2001). 
These events may trigger the downstream signalling cascades involved in epithelial 
repair. Extensive actin cytoskeleton rearrangements occurs following physical 
stress of an intact epithelium. This was shown by pulling an intact epithelium in 
vitro  (Martin and Lewis 1992). The sequence of events involved in repairing the 
damaged epithelium are outlined in Figure 1.0.6 A. 
Exposure of the BMZ following an injury activates residing macrophages which in 
turn recruit additional immune cells to the damaged site. The secretion of 
inflammatory cytokines, matrix metalloproteases and growth factors such as FGF, 
EGF, BMP and TGF from both immune cells and cells of the activated EMTU 
promotes the sealing of the epithelial layer and the eradication of pathogens (Crosby 
and Waters 2010). Fibronectin and collagen are produced by the underlying 
fibroblasts in response to the influx of growth factors such as TGF- β to repair the 
epithelial basement layer. Many in vivo epithelial restitution experiments have 
demonstrated that cell migration. rather than cell proliferation, is the primary event 
which occurs during restoration of the damaged epithelial region (Erjefalt et al. 
1997b; Joanne C. Masterson et al. 2011; Zahm et al. 1997).  As outlined in Figure 
1.0.6  B, cells bordering the wounded region downregulate epithelial cell markers 
to assume a migratory phenotype and migrate onto the exposed BMZ. Resident lung 
progenitors undergo squamous cell metaplasia followed by migration and 
proliferation to restore epithelial integrity.  
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Figure 1.0.6 The sequence of events and signalling molecules involved in 
epithelial restitution 
B 
(A) Following epithelial damage, immune cells are recruited to the site and 
cause increased immune cell recruitment and the secretion of growth factors. 
ECM is deposited on the exposed BMZ and epithelial cell spreading, migration, 
proliferation and differentiation occur to restore the damaged region.  
(B) Secretory molecules including peptides, mucins, proteases, cytokines and 
growth factors are secreted by epithelial, endothelial and fibroblast cells as well 
as infiltrating immune cells to induce and control the restoration events. 
Modified from (Crosby and Waters 2010; Puchelle et al. 2006) 
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Tightly controlled differentiation events occur following proliferation to reinstate 
epithelial function (Crosby and Waters 2010; Puchelle 2000; Puchelle et al. 2006; 
Warburton et al. 2008; Woolley and Martin 2000; Zahm, Chevillard, and Puchelle 
1991). Experiments using adult human nasal epithelial xenografts on denuded 
tracheae in nude mice showed that while exposed BMZ were partially covered by 
a poorly differented epithelial layer after only three days post-implantation, it took 
up to five weeks for the establishment of a fully functional differentiated, 
pseudostratified epithelial barrier (Dupuit et al. 2000). This highlights the level of 
control and regulation required for correct epithelial cell repair. 
The regulation and subsequent cessation of the reparatory processes is controlled 
by cells of the EMTU and infiltrating inflammatory cells. For example, eosinophils 
help mediate the inflammatory process by producing anti-inflammatory cytokines 
IL-4 and IL-13 (Ahdieh, Vandenbos, and Youakim 2001).  If this process is not 
correctly regulated and the reparatory events are prolonged, a chronic inflammatory 
environment will manifest in the airways. Extensive ECM deposition, abnormal 
epithelial cell migration, uncontrolled cell proliferation and unregulated growth 
factor and cytokines release ultimately contributes to a disease phenotype in the 
lungs. Asthma, COPD, IPF, cancer and acute lung injury are disorders of the 
airways which present with pathophysiologies resembling different aspects of 
incorrect epithelial repair. 
1.1.6 Lung Cancer 
Lung cancer is the leading cause of cancer-related deaths in the USA. According to 
the American Cancer Society, it is forecast that about 221,200 new cases of lung 
cancer will be diagnosed in 2015 and that approximately 158,040 deaths will be 
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attributed to lung cancer. Tobacco smoke is the main risk factor for developing lung 
cancer and at least 80% of lung cancers are linked to smoking. Genetic inheritance, 
air pollution, radon and asbestos are also believed to elevate the risk of developing 
lung cancer (Challem 1997; Ger et al. 1992).  
The two main types of lung cancer are small cell lung cancer (SCLC) and non-small 
cell lung cancer (NSCLC). SCLC is subdivided into the highly invasive small cell 
carcinoma (SCC) and combined small cell carcinoma (c-SCC). SCC is often termed 
“oat-cell carcinoma” as the cancer cells are small and flat with little cytoplasm and 
big nuclei. SCC forms metastatic sites very quickly and are thought to originate 
from PNECs (Jackman and Johnson 2005; Stovold et al. 2012, 2013).  c-SCC is 
characterised by the presence of SCC alongside another non small cell-derived 
malignant tissue such as adenocarcinoma or large cell carcinomas (Wagner et al. 
2009).  
NSCLC is the most dominate form of lung cancer and 80-85% of all lung cancer 
cases fall into this category. The three main types of NSCLC include squamous cell 
carcinoma originating from epithelial cells, adencocarcinomas from secretory cells 
and large cell carcinomas such as large cell neuroendocrine carcinomas – which is 
similar to SCC (D’Addario et al. 2010). Surgical resection is the main treatment for 
NSCLC from stages I through to IIIA whereas combined chemotherapy and 
radiation are prescribed later stage NSCLC and for SCLC patients. Drugs such as 
the platinum based- cisplatin and etoposide are commonly used in 
chemotherapeutic treatment plans. In addition, recent advances in targeted therapy 
have seen drugs such as denosumab, a monoclonal antibody against receptor 
activated NFKB and crizotinib, a ROS1 and anaplastic lymphoma kinase (ALK) 
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inhibitor, being approved by the FDA for treatment of specific lung cancer subtypes 
(Scagliotti et al. 2012; Timm and Kolesar 2013).  
Within a tumour a number of different cell subpopulations exist. As outlined in 
(Hanahan and Weinberg 2000), the cancer cells adopt specific properties in order 
to survive and thrive as a neoplastic legion. These include the ability to generate 
distant metastatic sites for increased tumour invasion, evade apoptosis and growth 
inhibitory signals, (3) develop sustained angiogenic potential, act as a source of 
autocrine growth factor signals and develop the capabilities of limitless replicative 
processes. While this list is not exhaustive and not all tumours acquire every 
characteristic, these six fundamental processes are central for cancer survival and 
tumour progression.  
Tumour heterogeneity defines the differences in genotype and phenotype that exist 
between cancer cells in a single tumour (intra-tumour heterogeneity). These 
variations can also occur between different tumour sites in the body and similar 
tumour types occurring in different people (inter-tumour heterogeneity) (Burrell et 
al. 2013). Intra-tumour heterogeneity has been described as a branched evolutionary 
model enabling increased cancer cell survival following adoption of the six 
fundamental cancer cell properties. Heterogeneity can be introduced into the 
tumour population by genetic or non-genetic means. Genomic instability can 
introduce somatic point mutations leading to impaired DNA repair processes. This 
causes replication errors and alters chromosomal numbers which propagate 
between tumour subpopulations. Epigenetics play a role in non-genetic-induced 
tumour heterogeneity via silencing of tumour suppressor genes. Additionally, the 
tumour microenvironment affects cancer cell phenotype and different signals 
determine altered cell fate. Tumour heterogeneity is also introduced by dynamic 
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phenotypic switching events between the different cancer subpopulations (Ferrao 
et al. 2015; Marusyk, Almendro, and Polyak 2012). 
In normal non-neoplastic tissues a hierarchy exists whereby a stem cell gives rise 
to committed progenitor cells which in turn produce lineage-restricted fully 
differentiated cells (Figure 1.0.7). Progenitor cells are capable of de-differentiating 
into stem cell in certain conditions. The field of directed de-differentiation of 
committed lung epithelial cells has received much attention recently and re-
programming experiments have highlighted the potential use of committed cells in 
lung regeneration (Huang et al. 2014; Tata et al. 2013).  
 
 
 
 
 
 
 
 
In neoplastic tissues, similar differentiation hierarchies exist. Stem cell and non-
stem cell populations exist in the tumour and interconversion between the two 
occurs more frequently (Figure 1.0.7) (Marusyk et al. 2012). 
Both SCLC and NSCLC actively form metastatic foci, particularly the more 
invasive SCLC (Jackman and Johnson 2005). One of the central dogmas regarding 
Figure 1.0.7 Differentiation hierarchies in normal and cancer cells 
(Marusyk et al. 2012) 
Introduction 
  
 
21 
 
tumour progression and metastasis formation is the clonal selection theory. This 
theory is centred on the existence of a cancer stem cell in the body of a tumour that 
is capable of undergoing metastasis to establish a new tumour at a distant site 
(Talmadge 2007). Subsequent differentiation and expansion of the metastatic 
population leads to the formation of complex heterogenous tumours at these new 
sites (Fidler 2003; McMorrow et al. 1988).  Furthermore, karyotypic analysis of 
multiple metastatic sites originating from a primary tumour have revealed 
individual phenotypes specific to each metastatic site. This suggests that primary 
tumours can possess numerous clonal stem cell subpopulations capable of 
establishing new neoplastic legions each with different characteristics and 
properties (Talmadge et al. 1984).  
Another dogma regarding the development of metastatic foci is the process of 
phenotypic switching. This phenomenon allows non-invasive benign tumour cells 
to adopt a more migratory and mesenchymal phenotype. These cells are then 
capable of detaching from the primary tumour to facilitate the formation of novel 
tumour sites at a different location in the body (Jonathan M. Lee et al. 2006; Li et 
al. 2015). Phenotypic switching can be driven by environmental stresses, growth 
factor signalling and transcriptional reprogramming and causes an epithelial-to-
mesenchymal transition (EMT) in the cells (Ferrao et al. 2015; Kemper et al. 2014). 
Recently, a zebrafish-melanoma xenograft model was used to illustrate that 
metastatic foci can also form due to collective cooperation between intrinsically 
invasive cells and benign non-invasive cells (Chapman et al. 2014). In addition, 
different types of cancer cells favour metastasis formation in specific locations in 
the body and tend to repeatedly migrate to these regions. Thus, it is believed that 
the microenvironment plays an important role in establishing novel metastatic sites. 
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This is termed the “seed and soil” hypothesis (Fidler 2003). EMT is explored further 
in section 1.3.  
1.1.7 Inflammatory lung disease 
Asthma is an inflammatory airway disease characterised by broncho-constriction, 
wheezing and shortness of breath. According to the American Academy of Allergy 
Asthma and Inflammation (AAAAI), the incidence of asthma in US population has 
risen from 1 in 14 in 2001 to 1 in every 12 in 2009 (Center for Disease Control and 
Prevention 2011). Atopy, allergens, environmental pollutants and genetic 
inheritance are all risk factors for asthma (Knight and Holgate 2003; Saetta and 
Turato 2001).  
At a structural level the EMTU of an asthmatic patient is both more susceptible to 
damage compared to a healthy individual and experiences impaired repair 
responses following injury (Knight and Holgate 2003). The EMTU is the central 
unit undergoing remodelling during asthma. Changes to the EMTU include mucus 
cell hyperplasia and metaplasia causing excessive mucus production, basement 
membrane thickening, ECM deposition, narrowing of the airway lumen, elevated 
smooth muscle mass, increased fibroblast proliferation and myofibroblast 
activation (Figure 1.0.8). All of these changes are mediated through abnormal 
growth factor signalling, inflammatory mediators, chemokines, cytokines and 
secretory products such as matrix metalloproteases (Bai and Knight 2005; Davies 
2009; Saetta and Turato 2001). 
At a cellular level, inflammation in asthma is mediated via the Th-2 response 
involving eosinophils, basophils and mast cells. Eosinophils exert their function via 
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secretion of inflammatory cytokines, eosinophil derived cationic proteins and 
growth factors such as TGF-B to promote collagen deposition (Gleich and 
Adolphson 1993a; Gundel, Letts, and Gleich 1991; Humbles et al. 2004). 
Differential eosinophilic infiltration has been reported throughout the airways in 
both the upper large airways and the smaller bronchioles (Carroll, Cooke, and 
James 1997). However, due to the mucus cell metaplasia and establishment of the 
Th-2 response that occurred in the absence of eosinophils in a mouse GATA-1 
double knockout, additional inflammatory cells are believed to play a significant 
role in asthma pathology (Humbles et al. 2004). There is evidence that neutrophils 
are also involved in asthma and the once accepted paradigm segregating COPD and 
asthma based on neutrophil versus eosinophil infiltration is blurring. Different 
asthmatic endotypes are now accepted including allergic bronchopulmonary 
mycosis and neutrophilic asthma (Lötvall et al. 2011; Walford and Doherty 2014).  
A novel study from Harvard School of Public Health, has highlighted the role of 
jamming and unjamming in an experimental model of asthma using human 
bronchial epithelial cells (Park et al. 2015). Cell movements in healthy cultures are 
minimal and each cell is tightly compacted with its immediate neighbours. 
However, in a model of bronchospasm, cell movement changes drastically and cells 
move in fluid-like swirling patterns. Interestingly, using a vortex model and shape 
indexing, this jamming and unjamming has been attributed to changes in epithelial 
cell shape as opposed to the expression of cell adhesion molecules. This study 
contributes to our knowledge about the biological processes involves in the tissue 
remodelling in asthma and adds a new mechanical dimension to the etiology of 
asthma’s disease phenotype.  
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Figure 1.0.8 The asthma phenotype 
(A) The changes in the asthmatic airway compared to healthy airways. Image 
obtained from NHLBI GOV http://www.nhlbi.nih.gov/health/health-
topics/topics/asthma (B) The structural and cellular changes that occur in 
asthmatic airways include epithelial damage, BMZ thickening via 
subepithelial fibrosis, smooth muscle hyperplasia, excessive mucus 
production and inflammatory infiltration (Leonardi et al. 2013) 
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1.1.8 The DLKP cell line 
The DLKP human cell line was established from a lymph node metastasis of a 
primary lung tumour, described as a “poorly differentiated squamous carcinoma”. 
When grown in culture the DLKP parental population was observed to contain 
morphologically heterogenous sub-populations. The DLKP line was sub-cloned 
and three distinct clonal populations DLKP-SQ (squamous phenotype), DLKP-M 
(mesenchymal phenotype) and DLKP-I (intermediate) were established (Figure 
1.0.9) (Law et al., 1992; Mcbride et al, 1998). This was achieved by serial dilutions 
to isolate individual cell colonies. DLKP-SQ cells grow as relatively small, 
squamous, cuboidal cells and form compact colonies in culture. The colonies 
display a “cobblestone”-like appearance with bright distinct boundaries between 
each individual cell.  DLKP-SQ account for approximately 70% of the original 
parental population. DLKP-I cells are smaller than DLKP-SQ and account for 
approximately 25% of the parental population. DLKP-I cells also grow as colonies 
but no individual cell boundaries are evident between the cells. A bright outer 
boundary is present around the colony. DLKP-M cells are the largest of the three 
DLKP clones and represent approximately 5% of the parental population. DLKP-
M cells possess extended cytoplasmic projections and do not grown in colonies. 
Instead, DLKP-M cells appear mesenchymal and mobile (Mcbride et al. 1998) 
When grown in culture, spontaneous interconversion events have been observed 
between DLKP-I clones and both DLKP-SQ and DLKP-M. No conversion between 
DLKP-SQ and DLKP-M cells was evident and thus DLKP-I cells were deemed as 
a potential intermediate and stem-cell like population capable of switching 
phenotype between the two clones.   
Introduction 
  
 
26 
 
  
DLKP-SQ DLKP-M 
DLKP-I 
DLKP mixed parental population  
Figure 1.0.9 DLKP lung cancer cell line 
DLKP parental populations contained DLKP-SQ, DLKP-I and DLKP-M clones 
which are morphological distinct and interconvert in culture.  
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1.2  Bone Morphogenetic Signalling 
Bone morphogenetic proteins (BMPs) are a conserved family of signalling 
molecules that were first described by Prof. Martin Urist in the 1960s. He 
documented the osteoinductive capabilities of BMPs in the muscle pouches of 
rabbits (Urist 1965). Since then, BMPs have been referred to as “body 
morphogenetic proteins” based on their involvement with many different organs, 
structures and signalling cascades in the body (Wagner et al. 2010).  
Decapentaplegic (Dpp) is the BMP homolog expressed in Drosphila embryo and is 
vital for the correct dorsal-ventral patterning of limbs and organs (Ferguson and 
Anderson 1992). In zebrafish and Xenopus, BMP signalling is responsible for 
directing ectodermal and mesodermal tissue to the correct cell fate, in a 
concentration dependent manner (O’Connor et al. 2006; Wilson et al. 1997; Zhang, 
Lander, and Nie 2007). In mice, knockout models have highlighted the vital 
function of BMP signalling in the formation of bones, endoderm patterning of the 
liver, lungs, gut and pancreas as well as ectoderm-derived organ development such 
as the brain and the skin (Monteiro et al. 2008; Wang et al. 1990). This essential 
developmental role is conserved in humans and many diseases are attributed to 
incorrect BMP signalling events including neurological and ophthalmic diseases, 
pulmonary aerterial hypertension (PAH), fibrodysplasia ossificans progressiva 
(FOP), osteoarthritis (OA), juvenile polyposis (JP) and cancers of the lung and 
colorectum (Figure 1.0.10) (Wang et al. 2014).  
The signals involved in the BMP pathway and the molecules responsible for 
regulating pathway expression are discussed in this section. In addition, the role of 
BMP signalling in cancer and inflammatory diseases is highlighted.  
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Figure 1.0.10 Human diseases associated with aberrant BMP signalling 
Mutations in BMP receptors, SMAD signalling components and BMP ligands are 
associated with numerous diseases in the human body  (Wang et al. 2014) 
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1.2.1 BMP signal transduction 
BMPs are members of the transforming growth factor (TGF) superfamily of 
signalling proteins. Other family members include the activin/inhibins, Mullerian 
inhibiting hormones (MIH), TGF β and growth and differentiation factors (GDFs) 
(Kingsley 1994). To date, more than twenty BMP family members have been 
identified and these are subdivided to four groups based on amino acid sequence 
similarity. BMP-2 and BMP-4 are the best studied family members. These proteins 
have 83% homology and are grouped together (Wozney 1989). BMP-7 is known as 
osteogenic protein-1 (OP-1) and together with BMP-5, -6, -8 forms a second group 
known as the osteogenic protein group. Thirdly, BMP-9 and -10 are classed 
together while GDF-5, -6 and -7 form the final group (Miyazono, Kamiya, and 
Morikawa 2010).  
BMP ligands bind to type I and type II receptors on the cell membrane of BMP-
responsive cells. Both types of receptor possess a relatively short extracellular 
domain, a single transmembrane spanning domain and an intracellular cytoplasmic 
domain which contains a serine/threonine kinase domain (Miyazono et al. 2010). 
Type I receptors include BMPRIa/Alk-3, BMPRIb/Alk-6, ActR-I/Alk-2 and Alk-1 
which is specific to endothelial cells. Type II receptors possess a constitutively 
active kinase domain and include BMPRII, ActR-IIa/ACVRIIa and ActR-
IIb/ACVRIIb. BMP ligands bind weakly to type I receptors in the absence of type 
II receptors while type II receptors positively enhance the binding of ligands 
(Koenig et al. 1994; Rosenzweig et al. 1995). While some overlap does exist, 
generally BMPRIa and BMPRIb are involved in BMP-2, BMP-4 and BMP-7 
signalling while BMP-6 preferentially binds to Alk-2 and BMPRIb (ten Dijke et al. 
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1994). Co-receptors, such as the repulsive guidance molecule family (RGM) 
members RGM-b and RGM-c, commonly known as Dragon and hemojuevelin, 
respectively, can amplify signalling of certain BMP ligands (Babitt et al. 2006; 
Nohe et al. 2002; Samad et al. 2005; Xia et al. 2010).  
A variety of SMAD-dependent and SMAD-independent pathways can be activated 
following ligand-induced receptor activation. In canonical BMP signalling, three 
groups of SMAD proteins have been described based on their role in pathway 
activation:  receptor-regulated SMAD-1, -2, -3, -5, - 8 (RSMADs); common 
mediator SMAD 4 (co-SMAD) and inhibitory SMAD-6, -7 (iSMADs). BMPs and 
MIH activate SMAD-1, -5, and/or -8 signalling while TGFβ ligands activate 
SMAD-2 and -3 via Alk-2, -4, -5 and -7 receptors (Miyazono, Maeda, and Imamura 
2005).  
R-SMADs contain highly conserved N- and C-terminal domains known as Mothers 
against decapentaplegic (Mad) homology (MH)-1 and MH-2 (Figure 1.0.11). A 
variable linker region joins these two domains. This linker region contains motifs 
that can be phosphorylated by mitogen-activated protein kinases (MAPK) and 
glycogen synthase kinase (GSK) as part of the non-canonical BMP pathway 
(Massague 2003).  The linker also contain a Proline-Proline-x-Tyrosine (PPXY) 
motif. This PY motif is involved in interactions with proteins containing two 
conserved tryptophan residues spaced 20-22 amino acids apart (WW) such as the 
SMAD-ubiquitin regulatory factors (Smurfs).  
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Figure 1.0.11 SMAD molecules and the BMP signalling cascade 
Depiction of R-SMADs, coSMAD and iSMAD molecules including MH-1 
and MH-2 domains with SSXS motifs. Circle represent motif that can be 
phosphorylated by MAP kinases. Square represent PY motifs (Miyazono et 
al. 2010) (B) Non canonical (left) and canonical (right) BMP signalling 
cascade. BMP ligand-mediated activation of membrane bound receptors 
causes downstream activation of R-SMAD and subsequent association with 
coSMAD for nuclear translocation. 
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The MH-2 domain is present in all SMAD proteins however, in RSMADs, a 
conserved phosphorylatable Ser-Ser-X-Ser (SSXS) motif is present at the C-
terminal end. This motif is involved in canonical BMP signalling. co-SMAD4 
proteins contain a MH-1 domain but iSMADs do not (Miyazono et al. 2010). The 
MH-2 domain is responsible for receptor interaction whereas MH-1 facilitates 
nuclear translocation and interaction with DNA and DNA-binding proteins (Shi et 
al. 1998; Yamashita et al. 1996). 
BMP ligands bind to the extracellular domain of the constituently active type II 
receptor at the cell membrane and cause trans-phosphorylation of the type I 
receptor. This results in phosphorylation of the SSXS motif at the C-terminal end 
of R-SMADs (Huse and Chen 1999). Phosphorylated RSMADs (pSMAD) undergo 
a conformation change which releases the complex from the receptor. This allows 
pSMAD to form complexes with SMAD4 via the MH-2 domains and translocate to 
the nucleus. Both R-SMADs and co-SMAD4 contain signals to facilitate trafficking 
to and from the nucleus via its nuclear localisation signal (NLS) (Zhan Xiao, Latek, 
and Lodish 2003; Xiao et al. 2001). The NLS motif is recognised by importin which 
signals directly to nucleoporins to facilitate the passage of the complex across the 
nuclear envelope and into the nucleus (Görlich and Kutay 1999; Zhan. Xiao, Latek, 
and Lodish 2003). Interestingly, SMAD proteins can enter the nucleus 
independently of importins, by directly interacting with nucleoporins via their 
conserved MH2 domain (Xu et al. 2003).  Here, they modulate BMP-specific gene 
transcription by directly binding to SMAD- and BMP-responsive elements and 
recruiting transcriptional repressors/co-repressors/activators or activating DNA 
binding proteins (Figure 1.0.11). (Hayashi et al. 2007; Heldin, Miyazono, and ten 
Dijke 1997; Ogata et al. 1993; Shi and Massagué 2003; J. Yang et al. 2013; Ying 
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et al. 2003). BMP signalling affects transcription via interaction with Runx family 
which regulate bone formation and Inhibitors of differentiation (Id) genes which 
are involved in cell differentiation and proliferation events (Nakahiro et al. 2010; 
Phimphilai et al. 2006; Zaidi et al. 2002).  
Non-canonical BMP signalling occurs via MAPK, GSK and Akt/Protein kinase B 
pathways (Gallea et al. 2001). In Xenopus tissue, BMP type I and II receptors 
activated the mitogen-activated protein kinase (MAPK) pathway through TAK-1 
and its activator TAB-1 via X-IAP. In C2C12 cells, BMP2 has been shown to 
activate the small Rho-GTPase Cdc42 mediator and PI3K signalling during cell 
migration and actin cytoskeletal rearrangement (Gamell et al. 2008; Zhang 2009).  
In human umbilical vein endothelial cells, BMP-4 stimulation induced 
phosphorylation of ERK 1/2 in a dose- and time-dependent manner and capillary 
sprout formation was dependent on BMP-4 induced ERK pathway activation 
(Figure 1.0.11) (Zhou et al. 2007) 
1.2.2 BMP pathway regulation 
BMP signalling is tightly controlled both extra- and intracellularly (Figure 1.0.11). 
Outside the cell, several extracellular proteins act as ligand traps to prevent receptor 
activation. These include α2-HS-glycoprotein (Ahsg), BMP binding endothelial 
cell precursor-derived regulator (BMPER), Connective Tissue Growth Factor 
(CTGF), dorsomorphin and members of the secreted protein families Gremlin, 
Noggin, Chordin and DAN/Cerberus (Moser et al. 2003; Rittenberg et al. 2005), 
(Moser et al. 2003; Rittenberg et al. 2005). Ligands are also sequestered outside the 
cells by soluble forms of type I receptor extracellular domains (Natsume et al. 
1997). At the cell membrane, BAMBI acts as a pseudoreceptor as it lacks an internal 
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serine-threonine kinase domain  (Onichtchouk et al. 1999). By forming dimers with 
Type I receptors it prevents the formation of functional receptor complexes thus 
preventing ligand activation of downstream signalling (Onichtchouk et al. 1999).  
Inside the cell, iSMADs are important for negatively regulating the SMAD-
dependent pathway. SMAD-6 preferentially inhibits BMP-mediated signalling 
while SMAD-7 inhibits with both BMP and TGFβ pathways. iSMADs physically 
compete with R-SMAD complexes at the activated type I receptor, preventing co-
SMAD complex formation and interrupting gene transcription (Heldin et al. 1997). 
iSMADs also act as cofactors for the targeted ubiquitin-mediated degradation of 
type I BMP receptors and R-SMADs by recruiting Smurf-1. Smurf-1 is an E3 
protein ubiquitin ligase which induces proteosomal degradation of Type 1 BMP 
receptors (Murakami et al. 2010). SMAD-7 also binds to Smurf-2  to mediate 
proteosomal digestion of TGF- β receptor complexes (Kavsak et al. 2000; 
Murakami et al. 2003; Tajima et al. 2003). Lefty, another intracellular antagonist of 
BMP signalling, inhibits phosphorylation RSMADs and subsequent nuclear 
translocation of the coSMAD complex (Ulloa and Tabibzadeh 2001).  
SMAD8b is a splice variant of the R-SMAD, SMAD-8. SMAD8b lacks the SXSS 
motif in its MH2 domain and this renders the protein incapable of propagating 
downstream signal activation following ligand activation. Therefore, SMAD8b acts 
as a dominant negative regulator of BMP signalling (Nishita, Ueno, and Shibuya 
1999).  Using a PCR array, Nishita et al., examined coexpression of SMAD8 and 
SMAD8b mRNA in human tissues and demonstrated SMAD8b expression in 
placenta, kidney, heart and brain tissue. The results also highlighted that the balance 
between SMAD8 and SMAD8b may tissue-specific. 
Introduction 
  
 
35 
 
Following nuclear translocation of the R-SMAD-coSMAD4 complex, 
transcriptional co-repressors including c-Ski, SnoN and Evi-1 are activated (Luo et 
al. 1999; Moustakas, Souchelnytskyi, and Heldin 2001). These molecules recruit 
histone deactelyases to downregulate target genes. In addition, c-Ski, SnoN 
compete with SMAD-4 and Evi-1 binds to SMAD-2,-3-1 to repress TGF-B and 
BMP signalling. Fussel-15 and Fussel-18 have also been shown to inhibit 
intracellular BMP by binding to coSMAD-4 and preventing RSMAD complex 
formation (Arndt et al. 2007; Fischer et al. 2012). 
1.2.3 BMP signalling and lung development  
During lung development, the processes of branching and epithelial cell 
differentiation are controlled by complex signalling molecule cascades. The Notch 
family of signalling molecules are involved in regulating basal and ciliated cell 
expansion in the airways (Rock et al. 2013; Tsao et al. 2009). Wnt is a key 
orchestrator of proximal-distal lung patterning and induces expression of other 
signalling molecules from the endoderm and underlying mesoderm (Cohen et al. 
2007). Wnt represses proximal epithelial differentiation and promotes distal 
epithelial differentiation via regulation of other growth factors such as FGF and 
BMP-4 in the distal branching regions of the developing lungs (Shu et al. 2005). 
FGF-10 is present in the mesenchyme and acts as a chemoattractant for directional 
growth of distal endoderm-derived lung buds (Park et al. 1998). Targeted ablation 
of FGF-10 in developing mouse lungs using a dominant negative FGFR2 under the 
control of SP-c promoter resulted in the complete loss of alveolar cell populations 
in the distal epithelium and an abundance of secretory columnar epithelial cells 
(Peters et al. 1994).  
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 BMP-4 is strongly expressed at the distal tips of the developing lung bud and 
weakly expressed in proximal regions. Three main functions of BMP signalling 
have been highlighted in the developing lungs. Firstly, using various gain and loss 
of function systems in mice, BMP-4 has been shown to direct distal epithelial cell 
differentiation and repress the proximal epithelial cell programme (Bellusci et al. 
1996; Hyatt, Shangguan, and Shannon 2002; Lu et al. 2001; Weaver et al. 1999). 
Secondly, loss of BMP-4 using a floxed SP-C promoter-driven system during 
mouse lung patterning resulted in malformed, terminal cystic-like sacs at the lung 
tips. This highlighted the role of BMP-4 in orchestrating correct branching 
morphogenesis (Bellusci et al. 1996). Thirdly, deletion of BMPRIa using a SFTPC-
Cre transgene caused reduced epithelial cell expansion and high levels of epithelial 
cell apoptosis. This demonstrated that BMP signalling is a positive regulator of 
proliferation in the developing lung (Eblaghie et al. 2006).  
Studies of mouse lungs in the late saccular and alveolar developmental stages 
indicated that BMP signalling remains active in the airways up to, and potentially 
after post natal day 28.  High levels of BMP receptors, R-SMADs and pSMAD 1/58 
were detected in whole cell protein extracted from 28 day old mouse lungs.  SMAD- 
1 and 4 localisation also modulated as development progressed with reduced 
institial staining and increased epithelial expression (Alejandre-Alcázar et al. 2007). 
During late lung development, BMPRII, Alk-3 and Alk-6 also become localised to 
the epithelium of large airways and their previous expression in alveolar septae is 
greatly depleted (Alejandre-Alcázar et al. 2007). The role of BMP signalling in 
adult healthy lungs remained largely unexplored. 
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1.2.4 BMP signalling and cancer 
BMP ligands and receptors are overexpressed in numerous cancer tissues including 
BMP-2 in lung, BMP-7 in breast, BMP-2 and BMP-4 in ovarian, BMP-6, BMPRIa 
and BMPRIb in prostate and BMPRIa in colorectal tumours (Feeley et al. 2005; 
Hardwick et al. 2008; Karhu and Kuukasja 2006; Langenfeld et al. 2003; McLean 
and Buckanovich 2013; Yuen et al. 2008). In NSCLC tumours resected from human 
patients, 98% expressed higher levels of BMP-2 ligand compared to normal lung 
tissue. Similarly, 100% of the 15 NSCLC samples expressed abnormal levels of 
BMP-6 ligand (Langenfeld et al. 2005). In bone metastasis from primary colorectal 
tumours, BMP-6 was highly overexpressed compared to both normal prostate tissue 
and primary tumours (Ye and Park 2009).  
 In terms of defining the definite role of BMP signalling in cancer, studies show 
that the BMP effect appears to be both spatially and temporally-regulated. Juvenile 
polyposis (JP) is an autosomal dominant disorder that predisposes patients to 
developing colorectal and gastric cancer. BMPRIa and SMAD-4 mutations cause 
approximately 50% of JP cases.  This suggested that the loss of BMP signalling 
contributes to cancer formation and that a basal level of BMP signalling is required 
for health  (Howe et al. 2004). Following a review of the literature Harwick et al. 
(2008) suggested a dual role for BMP signalling. In hamartomas, which are benign 
tumours in the body, the loss of BMP signalling initiates carcinogenesis. In 
adenocarcinomas the loss of BMP signalling contributes to the progression of the 
tumours to carcinomas in patients with sporadic  colorectal cancer (Hardwick et al. 
2008; Kodach et al. 2008). In both cases however, decreased BMP signalling was 
correlated to worsened prognosis. 
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Conversely, elevated BMP signalling has been linked to increased tumour 
invasiveness and reduced patients survival rates. In breast cancer, poorly 
differentiated oestrogen-receptor positive tumours expressed high levels of 
BMPRIb. The elevated receptor expression level was correlated to high tumour 
grade, cancer cell proliferation, tumour plasticity and overall, a poor patient 
prognosis (Helms et al. 2005).  In gastric cancer cell lines AGS and SNU-638, 
BMP-2 signalling induced elevated invasiveness, motility and MMP-9 expression 
via the non-canonical BMP pathway. Furthermore, following analysis of 178 
gastric tumour biopsies, BMP-2 was associated with poor patient outcome and 
increased metastasis formation (Kang et al. 2011). In NSCLC, high serum levels of 
BMP-2 was also associated with decreased patient survival (Fei et al. 2013). While 
a comprehensive analysis of the downstream signalling cascades stimulated by 
abberant BMP signalling has not been fully elucidated, Id genes may be responsible 
for the increased tumourigenic properties seen in some cases of excessive  BMP 
signal activation (Ruzinova and Benezra 2003; Sikder et al. 2003) 
Taking the two opposing effects of aberrant BMP signalling in different cancer 
types, it would appear that a basal level of BMP signal activation is required to 
maintain homeostatic conditions in the body. When the correct basal level of BMP 
signalling is lost, tumours formation can occur as seen in JP. Conversely, when 
BMP signalling is overactive, tumour formation can occur as seen in gastric and 
breast cancers. Although no definitive role for aberrant BMP signalling in cancer 
has been globally assigned, clinicians are warned against treating patients with 
BMP due to the growing number of studies suggesting associations with tumour 
initiation, progression and metastasis formation. (Thawani et al. 2010).  
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1.2.5 BMP signalling and inflammation 
Inflammation is a normal physiological process which facilitates correct repair in 
the body following injury. Inflammatory mediators infiltrate the site of infection or 
damage and release cytokines, chemokines and stimulate growth factor release by 
the resident cells. These events culminate in tissue repair and restoration of 
homeostatic conditions. However, in chronic inflammatory states, the tissues 
become damaged due to prolonged exposure to inflammatory mediators and their 
effector molecules. The reactivation of developmental pathways during 
inflammation is a common phenomenon and further perpetuates the inflammatory 
phenotype (Beers and Morrisey 2011; Helbing et al. 2013). As BMP signalling is 
important in developmental processes it is believed that this signalling pathway is 
reactivated during injury and repair. The role of BMP signalling and inflammation 
has received growing attention in the past number of years and BMPs have been 
implicated in the inflammatory processes in a wide range of tissues.  
A recent study investigating the role of BMPs in stomach inflammation has 
highlighted an anti-inflammatory role for BMP signalling. Mice overexpressing the 
BMP inhibitor noggin controlled by a BMP-responsive element displayed elevated 
H. pylori-induced inflammation and epithelial cell proliferation. Stomach dysplasia 
was evident alongside elevated expression of STAT3. In addition, BMP-2,-4 and -
7 treatment of canine gastric epithelial cells inhibited both baseline and TNF-α 
stimulated Il-8 production (Takabayashi et al. 2014). This anti-inflammatory role is 
supported by evidence that BMP-7 treatment reduces inflammation in rats exposed 
to 2, 4, 6-trinitrobenzene sulfonic acid – a known experimental inducer of colitis. 
BMP-7 treatment reduced the expression of pro-inflammatory cytokines IL-6 and 
Introduction 
  
 
40 
 
TNF-β and fibrotic deposition mediated by TGF-β signalling (Maric et al. 2003, 
2012).  
In kidney formation, BMP signalling via BMP-7 specifically, facilitates correct 
epithelial cells differentiation and BMP-7 expression is present in podocytes, distal 
tubules and collecting duct to maintain correct kidney function in adults. Loss of 
BMP-7 expression occurs in early onset kidney fibrosis which indicates an 
important protective role for BMP signalling against fibrogenic renal diseases (Mitu 
and Hirschberg 2008; Simon et al. 2013). Furthermore, BMP-7 treatment of 
proximal tubule epithelial cells reduced basal and TNF-α induced pro-inflammatory 
cytokine (IL-6, IL-1β) release. Again, these results support an anti-inflammatory 
role for BMP signalling and particularly BMP-7 (Gould et al. 2002). These results 
also highlight potential a divergent role between different BMP ligands. BMP-7 
may be involved in the anti-inflammatory response and act as a negative regulator 
of fibrogenic events (Maric et al. 2003). Conversely, BMP-2,-4 and-6 have been 
shown to contribute to pro-inflammatory, fibrotic events in the skin and joints 
(Kaiser et al. 1998; Lories and Luyten 2009; Stelnicki et al. 1998). 
In lung injury and inflammation, BMP signalling is reactivated. Four studies have 
examined the expression of BMP signalling during allergic airway inflammation. 
Rosendahl et al., reported that BMP signal activation occured following ovalbumin 
(OVA)-induced airway injury in mice. Immunohistochemistry of healthy 
unchallenged mouse lungs did not reveal pSMAD 1/5 activation in the bronchial 
epithelium however, some alveolar and sub-epithelial fibroblast cells expressed 
pSMAD 1/5. Alk-2, BMPRIa and BMPRIb were expressed in the epithelium of 
healthy mouse airways. High expression levels of BMP-2, BMP-5 and moderate 
BMP-4,-6 and -7 expression were also found in the healthy airways, by western 
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blot. These results indicate that homeostatic BMP signalling is present in healthy 
airways. 
 Immunohistochemical staining of inflamed bronchial epithelial cells and scattered 
alveolar cells following OVA challenge revealed higher levels of pSMAD 1/5. In 
addition, BMPRIa, BMPRIb and Alk2 receptor expression were elevated in the 
injured airways in conjunction with increased BMP-2, -4 and -6 expression 
(Rosendahl et al. 2002). Interestingly, BMP-7 and BMP-5 expression were 
decreased following OVA challenge. These results suggest a divergent role for 
BMP ligands during inflammation similar to cancer.  
The second study was carried out by Kariyawasam et al., and investigated BMP 
signalling in healthy and mild asthmatic human patients before and after allergen 
challenge (Kariyawasam et al. 2008). Normal non-allergic individuals expressed 
BMP ligands BMP-2, -4 and -7 and BMP receptors Alk-2, BMPRIa, BMPRIb and 
BMPRII on epithelial airway cells. While no difference in ligand expression was 
present in asthmatic patients, a significant decrease in Alk-2, BMPRIb and BMPRII 
was reported compared to normal-non allergic individuals. Immunohistochemical 
staining revealed that 40% of the healthy airway epithelial cells expressed pSMAD 
1/5 compared to 3.8% in the asthmatic airways. This difference could be attributed 
to the reduced membrane-bound receptor expression. Alternatively, a different 
BMP ligand may be differentially expressed between healthy and asthmatic 
airways.  
Asthmatic airways displayed marked upregulation of Alk-2 and BMPRIb at day 1 
and day 7 post-allergen challenge. No change in BMP-2 or BMP-4 expression 
occurred whereas BMP-7 protein expression increased significantly in the epithelial 
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cells 7 days after allergen challenge. Furthermore, BMP-7 staining of inflammatory 
cell phenotypes revealed that eosinophils are the main source of this ligand in the 
allergen challenged airways. BMP-7 was shown to co-localize with Major Basic 
Protein (MBP) + eosinophils. Given these results, the authors concluded that BMP 
signalling is present in homeostatic airways and reduced in the inflammatory airway 
disease asthma. BMP signalling is reactivated in the airways following induced 
airway injury and the authors hypothesised a protective, anti-inflammatory function 
of BMP signalling attributed to BMP-7 expression (Kariyawasam et al. 2008).  
Thirdly, Sountoulidis et al., examined BMP signalling expression during branching 
morphogenesis and lung formation using a GFP tagged BRE allele in C57/bl mice. 
Moreover, they examined the expression of the fluorescent tag in airway epithelial 
cells following naphthalene and bleomycin injury in adult mouse lungs. The study 
highlighted the role of BMP signalling in the distal lung bud tips during branching 
morphogenesis and subsequent pathway activation in airway and alveolar epithelial 
cells during late stage development. Following epithelial cell injury using 
naphthalene, which depletes club cell populations in the airways, the eGFP reporter 
was localised to NEBs and regions of the terminal bronchioles where airway 
epithelial cell progenitors reside. Following bleomycin injury, BRE-driven eGFP 
expression occurred in SpC+ cuboidal epithelial cells, a progenitor population 
capable of self-renewal and differentiation into both AEC I and AEC II. Overall, 
the authors concluded that BMP pathway activation maintains undifferentiated 
progenitor cell states in the developing airways to prevent premature exhaustion of 
the epithelial cell pool prior to the completion of lung development. Moreover, the 
authors speculated that BMP signalling activation following injury is involved in 
reparatory event in the airways (Sountoulidis et al. 2012). 
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Finally, a recent study in LPS treated BMP-4 +/- mutant mouse lungs indicated that 
BMP-4 plays a protective role against inflammation and bacterial infection. Mutant 
mice displayed more severe lung inflammation following LPS or P. aeruginosa 
challenge. In addition, following siRNA knockdown of BMP-4 in human airway 
epithelial cells, higher levels of Il-8 were produced following LPS and TNF α 
stimulation indicating an anti-inflammatory function of BMP signalling mediated 
by BMP-4 expression. Conversely, BMP-4 +/+ mutant mice displayed incorrect 
reparatory processes and reduced lung function which could be attributed to 
increased airway remodelling and airway epithelial cell migration (Li et al. 2014). 
This study married the positive and negative aspects of BMP signalling during 
inflammation whereby BMP pathway activation could act as an anti-inflammatory 
mediator while also disrupting normal epithelial repair.  
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1.3  Epithelial to Mesenchymal Transition 
Epithelial to mesenchymal transition (T) is a biological process where epithelial 
cells undergo phenotypic changes to lose their polarised shape and many of their 
epithelial characteristics, detach from the basement membrane and become 
migratory, mesenchymal cells (Kalluri and Weinberg 2009). EMT is involved in 
organogenesis, wound healing and tumour progression. The types of EMT, 
characteristics of a cell undergoing EMT, growth factors responsible for initiating 
the process and its involvement in phenotypic switching will be discussed here.  
1.3.1 Types of EMT 
EMT is involved in different biological processes and three distinct subtypes of the 
EMT process have been assigned (Figure 1.0.12). The structural differences and 
cellular complexities involved in each type have yet to be elucidated however each 
EMT type is functionally distinct (Kalluri and Weinberg 2009). 
Type 1 EMT occurs during embryonic development. In the very early stages of 
implantation, EMT takes place in the trophoectodermal cells of the parietal 
endoderm to allow for correct penetration of the endometrium and attachment of 
the placenta. This facilitates the essential nutrient and gas exchange function of the 
placenta to occur and development of the embryo to proceed (Acloque et al. 2009; 
Aplin et al. 1998). Type 1 EMT also occurs during gastrulation and leads to the 
characterisation of the three germ layers, ectoderm, mesoderm and endoderm, 
Ectodermal cells at the edge of the developing epiblast, undergo EMT and migrate 
from the edge of the primitive streak. Internalisation of the migrating cells generates 
mesoderm which gives rise to cardiac cells, hematopoetic cells, the urogenital  
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Figure 1.0.12 Different types of EMT 
Type I EMT is involved in embryonic development and cell patterning events. 
Type 2 EMT facilitates wound repair and is linked to fibrosis due to prolonged 
inflammation, Type 3 EMT causes tumour cell metastasis formation and 
invasion of cancer cells into the blood to migrate to new sites. Modified from 
(Acloque et al. 2009; Kalluri and Weinberg 2009) 
 
Type 1  Type 2  Type 3  
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tract, bones, skeletal muscle and tendons. Subsequent MET of these internalised 
epiblast cells generates the digestive tract and epithelial lining of the organs. The 
external ectodermal cells remain in their epithelial cell state and are involved in 
neural crest EMT and the generation of cells of the nervous system, skeletal and 
cartilage precursors of the head and the epidermis (Acloque et al. 2009; Shannon 
and Hyatt 2004). Type 1 EMT is not involved in fibrosis or the invasion of cells to 
other regions of the body.  
Type 2 EMT is involved in wound healing and tissue repair. Unlike type 1 EMT, 
this normal reparatory process involves the recruitment of fibrogenic cells and 
inflammatory mediators. If inflammation doesn’t cease once its reparatory function 
is complete or if the primary insult is not attenuated, this type of EMT can be 
sustained in the cells which results in organ fibrosis and severe organ damage. Type 
2 EMT occurs mainly in normal restitution events of the lung, liver, kidney and 
intestine and thus, is also linked to the onset of fibrosis in these organs (Acloque et 
al. 2009). Both endothelial and epithelial cells can undergo EMT in these organs 
(Kalluri and Weinberg 2009; Jonathan M Lee et al. 2006) 
Type 3 EMT relates to cancer cell progression and metastasis formation. The 
dissemination of epithelial cancer cells from the primary tumour and migration to 
distant metastatic foci requires distinct changes in cell phenotype. EMT is involved 
in this process. EMT in the tumour cells facilitates tumour cell detachment, 
intravasation and migration in the circulatory system and the establishment of a 
nascent tumour site at a distant location in the body. This process is believed to 
involve a mesenchymal-to-epithelial (MET) process where the mesenchymal cells 
revert to their epithelial phenotype to promote tumour establishment in the new 
location (Kalluri and Weinberg 2009).  
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1.3.2 Characteristics of EMT 
During EMT extensive changes in epithelial cell phenotype occur which lead to the 
adoption of mesenchymal cell features and increased cell invasiveness (Figure 
1.0.13). Mesenchymal cells lack cell polarity, have a spindle-shaped extended 
morphology, are capable of migrating and do not express the typical epithelial cell 
adherens and junctional complexes (Hay 2005). Instead of apical-basal regions in 
the epithelial cells, mesenchymal cell have ventral-dorsal organisation with a 
leading edge morphology and extending filopodia to allow movement. Compared 
to the rigid quasi-immobility of the epithelial sheet, mesenchymal cells can migrate 
individually and are capable of resisting anoikis.  
A hallmark of EMT is the disassembly of the E-cadherin mediated cell adherens 
junction. Tight junction and desmosomal protein expression is also altered during 
EMT. The loss of E-cadherin can occur through genetic and non-genetic 
mechanisms. Transcriptional downregulation of E-cadherin gene occurs via the 
induction of transcription factors Snail, Slug, Twist, SIP/Zeb and E47. These 
molecules bind to the E-cadherin promoter and repress transcriptional activity 
(Bryant and Stow 2004). Post-transcriptional downregulation by dysadherin 
disrupts the E-cadherin complex and promotes EMT progression (Ino et al. 2002; 
Nam, Hirohashi, and Wakefield 2007). Post-translational mechanisms of E-
cadherin downregulation to induce EMT have also been described. Tyrosine 
phosphorylation of γ- and β-catenin by receptor tyrosine kinases (RTK) causes 
dissociation of the complex and induction of EMT. Phosphorylated catenins are 
flagged for proteosomal degradation and this prevents them from forming junction 
adhesion complexes. Ligand-mediated receptor activation of EGFR and HGFR 
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have been implicated in this process (Bremnes et al. 2002; Shiozaki et al. 1995). 
Epigenetic silencing of the E-cadherin gene via hypermethylation of CpG islands 
in the E-cadherin reporter has also been reported in many invasive cancer tumours 
such as the larynx, bladder and colorectum (Azarschab et al. 2003; Kanazawa et al. 
2002; Nojima et al. 2001). Finally, enzymatic cleavage of the E-cadherin by MMPs, 
stromelysin-1, calpain, presenilin, ADAM-10 and ADAM-15 all introduce 
instability in the cell adherens junction and ultimately result in loosened 
intracellular junctions and the induction of EMT (Huguenin et al. 2008; Krampert 
et al. 2004; Maretzky et al. 2005; Rios-Doria et al. 2003). 
Mesenchymal cells express different cell markers and intracellular molecules to 
account for the altered expression of desmosomal and tight junction proteins and 
the loss of E-cadherin (Chidgey and Dawson 2007; Kyuno et al. 2014). Proteins 
lost during EMT include E-cadherin as described, ZO-1, occuldin and demoplakin. 
Membrane bound N-cadherin and integrin α4β6 and intracellular fibroblast-specific 
protein 1 (FSP1), fibronectin, vimentin and α-SMA are commonly upregulated by 
mesenchymal cells (Jonathan M Lee et al. 2006).  N-cadherin provides much 
weaker cell adhesion between cells and in vitro force measurements in the mouse 
sarcoma cell line S180  revealed that a significantly higher force is required to 
separate cells joined by E-cadherin complexes compared to N-cadherin (Chu et al. 
2004).  
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Figure 1.0.13 Epithelial to mesenchymal transition 
Epithelial cells express tight junctions, desmosomes, gap junctions and adherens junctions 
to maintain the rigid, protective epithelial barrier. During EMT, these adhesive complexes 
are down regulated and the cell adopts a motile, invasive and migratory phenotype. Elevated 
expression of integrins and N-cadherin occurs alongside production of MMP for matrix 
degradation. The process of MET involves the reversal of this process. Modified from 
(Lamouille, Xu, and Derynck 2014) 
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Moreover, N-cadherin promotes cell mobility (Figure 1.0.12) (Cavallaro and 
Christofori 2004). The expression of α4β6-integrin increases cell invasiveness 
while maintaining the cell’s ability to interact with the surround ECM (Mamuya 
and Duncan 2012; Maschler et al. 2005).  
Changes in actin expression also occur during EMT. As previously outlined, the 
actin cytoskeleton is connected to tight junctions and cell adherens junctions. Actin 
maintains cell polarity in epithelial cells and loss of this apical-basal polarised 
phenotype during EMT results in a switch from cortical actin organisation to actin 
stress fibre formation, as depicted in Figure 1.0.13 (Vallenius 2013). The generation 
of filopodia and extended cytoplasmic processes facilitating cell migration also 
requires extensive actin remodelling. This is orchestrated by actin-myosin 
contraction and extension events (Haynes et al. 2011). The appearance of peri-
nuclear actin bundles is also common in cells undergoing EMT (Gay et al. 2011).  
Following the onset of the mesenchymal cell phenotype, the cell must excise itself 
from the tightly knit epithelial cell layer and migrate through the basement 
membrane and into the blood vessels. This occurs in type 2 and 3 EMT. 
Mesenchymal cells must express the necessary membrane-degrading molecules 
required to carry out this function. The cells produce MMP (MMP-2,3,9,14) and 
urokinase plasminogen-associated receptor (uPAR) which cause focal damage to 
laminin and type IV collagen in the basement membrane. This facilitates 
intravasation, cell migration and dissemination from original epithelial cell sites 
(Gupta et al. 2011; Jonathan M. Lee et al. 2006; Marudamuthu et al. 2015; Sillat et 
al. 2012).  
The phenomenon of partial EMT has also been described in cancer. This 
intermediate EMT state is a hybrid metastable phenotype along the EMT-MET axis 
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whereby the cells express both epithelial and mesenchymal cell markers such as E-
cadherin, keratins, vimentin and MMPs (Jonathan M Lee et al. 2006; Savagner 
2010) . Partial EMT has been coined as “epithelial mesenchymal plasticity” (EMP) 
and allows cancer cells to fluctuate between organised, partly polarised epithelial 
cells and more mobile, individual mesenchymal cells expressing residual cadherins  
proteins (Van Denderen and Thompson 2013; Pinto et al. 2013; Thompson and 
Haviv 2011). 
1.3.3 MET  
Following EMT, the cells undergo the reversal of the process where epithelial-
associated genes are upregulated and the epithelial cell phenotype is adopted once 
again. This is called mesenchymal to epithelial transition (MET). MET involves the 
loss of cell motility,  re-establishment of cell polarity, increased expression of 
cortical actin and the reacquisition of E-cadherin and other cell adhesion molecules 
at the cell membrane (Figure 1.0.13). 
The best studied examples of MET in development are kidney formation and the 
developing vertebrate somites.  Reciprocal communication between the developing 
uteric bud epithelium and the nephrogenic mesenchyme occurs during kidney 
development. The nephrogenic mesenchyme condenses around the developing 
uteric bud following bud branching and MET occurs to form the nephron. BMP-7, 
wilms tumor 1 (Wt1) and paired box 2 (Pax2) are involved in this MET event 
(Lipschutz 1998; Plisov et al. 2000). During somitogenesis, the presomitic 
mesoderm undergoes MET to epithelialise the boundary of each somite. This 
process involved the small Rho-GTPase Cdc42 and rac1 (Ferrer-Vaquer, Viotti, and 
Hadjantonakis 2010). 
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During epithelial cell repair, it is postulated that while EMT induces normal 
epithelial cell restitution following injury, the onset of MET is an important step to 
prevent prolonged EMT and the formation of fibrotic legions (McCormack and 
O’Dea 2013). BMP-7 has been shown to induce MET in adult renal fibroblasts via 
re-expression of E-cadherin and decreasing cell motility and type 1 collagen 
secretion (Zeisberg, Shah, and Kalluri 2005). HGF binding to c-met also reduces 
TGF-β signalling to restore epithelial cell phenotype and decrease the amount of 
MMP-9 in tubular epithelial cells (Yang and Liu 2002). 
MET in cancer is receiving more attention in recent years. The fact that metastatic 
tumours generally resemble the primary tumour population from which they arose 
led to the notion that mesenchymal cancer cells lose their metastatic properties and 
subsequently re-epithelialise during the process of neoplastic colonisation. It is 
understood that MET is involved in this process enabling the establishment and 
stabilisation of novel tumour sites. In a study of primary E-cadherin-negative breast 
cancer tumours, metastatic foci of the liver, lung and brain were found to be E-
cadherin positive. The authors concluded that the metastatic tumour 
microenvironment can induce MET and the induction of epithelial-related markers 
to promote cancer survival (Chao, Shepard, and Wells 2010). Re-epithelialisation 
could also allow mitotic events to occur in the nascent tumour site which would be 
advantageous for cancer growth. Studies in mice have shown that the loss of the 
transcriptional co-repressors Twist1 and Snail1, responsible for downregulating E-
cadherin, is associated with increased cell proliferation (Tsai and Yang 2013; Tsai 
et al. 2012). 
At present, it is unclear if different types of MET exist in the body, what signalling 
molecules are involved in the induction of MET and if these differ spatially and 
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temporally. In addition, it is not known whether the loss of EMT-related signals 
during development, epithelial wound repair or cancer cell metastasis is sufficient 
for the induction of MET or if specific MET signalling molecules exist. Further 
characterisation of the EMP phenotype may aid in elucidating MET processes in 
cancer.  
1.3.4 Growth factors and EMT 
The Wingless (Wnt) family of signalling molecules are involved in all three types 
of EMT. Wnt signals are transduced by the frizzled family of receptors and LDL-
receptor-related proteins 5 and 6 (LRP) coreceptors. In the absence of ligand 
binding, β-catenin is associated with the glycogen synthase kinase 3 (GSK3β) 
complex consisting of adenomatous polyposis coli (APC) and AXIN. β catenin is 
phosphorylated by GSK3β and this complex is actively ubiquitinated which results 
in proteosomal degradation. In the nucleus, Wnt target genes are inhibited due to 
interaction with the transcription factors and co-repressors T-cell factor (TCF) and 
Lymphoid enhancer-binding protein (LEF). Other β –catenin molecules are 
associated with adherens junctional complexes, offering protection from this 
degradative pathway. Following Wnt ligand binding, the receptor-associated 
Dishelleved (Dsh) protein is phosphorylated. This leads to the recruitment of AXIN 
to the cytoplasmic tail of LRP5/6 and the dissociation of the GSK3β complex. The 
activation of Dsh inhibits the phosphorylation of β-catenin by GSK3β which 
prevents degradation. Finally, unphosphorylated β-catenin accumulates in the 
cytoplasm and is either recruited for the formation of adhesion junction or 
translocated to the nucleus where is interacts with nuclear TCF and LEF, inhibiting 
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their transcriptional repression function (Komiya and Habas 2008; Moon et al. 
2004).  
Wnt signalling is essential to type 1 EMT and knockout studies of Wnt3 and Wnt8c 
resulted in the incorrect formation of the germ layers and the primitive streak. 
Exogenous introduction of Wnt8c lead to the development of numerous ectopic 
primitive streaks (Liu et al. 1999; Pöpperl et al. 1997).  Wnt interacts with different 
growth factor families during type 1 EMT such as the TGF- β family particularly 
Nodal and Vg1. Nodal signalling is involved in controlling the invagination of cells 
during gastrulation (Varlet, Collignon, and Robertson 1997). Vg1 is involved in 
primitive steak formation and interacts with Wnt8c (Skromne and Stern 2001).  
FGF receptors are involved in primitive streak formation via the phosphorylation 
of β-catenin and the induction of the E-cadherin transcriptional repressor, Snail. 
Furthermore, FGFR double-knockout mice have shown that while primitive streak 
formation begins in the absence of FGFR, its expression is vital for the normal 
progression of embryonic patterning (Ciruna and Rossant 2001). TGF- β and Wnt 
have also been shown to induce E-cadherin downregulation by inducing the 
expression of transcriptional repressors (Acloque et al. 2009).  
BMP signalling is essential to type I EMT events for example, BMP-4 homozygote 
knockout mice do not form a mesoderm and die between e6.5 and e9.6. In heart 
mitral valve formation, BMP signalling mediated through BMP-2 induces EMT in 
the myocardium and endocardium of the atrioventricular canal (McCormack and 
O’Dea 2013; Winnier et al. 1995).  
Similar pathways are activated in type 2 EMT. In the repair of renal tissue, Wnt 
induces EMT and prolonged Wnt signalling is associated with renal fibrosis 
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(Galichon and Hertig 2011; Jiang et al. 2013). During tissue regeneration in the 
lungs, TGF-β and BMP-4 have been shown to induce EMT in cultured mouse and 
human airway epithelial cells to facilitate epithelial restitution (McCormack, 
Molloy, and ODea 2013; Molloy et al. 2008). Conversely, BMP-7 has been shown 
to elicit the opposite effect on EMT progression and attenuates kidney, liver lung 
and intestinal fibrosis (Maric et al. 2012; Mitu and Hirschberg 2008; G. Yang et al. 
2013). HGF also reduces TGF-β signalling to restore epithelial cell phenotype and 
decrease the amount of MMP-9 in tubule epithelial cells (Yang and Liu 2002).  
In cancer cell progression and metastasis formation via type 3 EMT, the same 
signalling molecules of organogenesis and repair are involved. Conflicting reports 
exist regarding BMPs involvement in cancer progression and as previously 
outlined, both spatial and temporal properties appear to modulate the effect the 
BMP pathway. Exogenous TGF-β can induce type 3 EMT in human mammary 
gland epithelial cells, epidermal keratinocytes and murine mammary epithelial cells 
treated (Valcourt et al. 2005). Prolonged TGF- β signalling promotes type 3 EMT 
tumour formation and carcinogenesis in head and neck, breast and colorectal cancer 
(Derynck, Akhurst, and Balmain 2001).  
Other RTKs are involved in type 3 EMT to facilitate metastasis of primary tumours. 
In breast tumour cells, N-cadherin expression in the cells prevents FGFR-1 ligand 
induced trafficking and the subsequent reduction in cell signalling. In the presence 
of N-cadherin, FGF-2 led to sustained activation of membrane-bound FGFR-1 
which caused upregulation of MMP-9, the enzyme involved in focal degradation of 
the basement membrane. This signalling axis facilitated a more invasive and 
migratory phenotype in the tumour cells (Suyama et al. 2002).  
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In summary, a complex interplay of growth factors is involved in mediating EMT 
in cells. Growth factors facilitate epithelial and mesenchymal transition events and 
facilitate correct morphogenesis during development and cell repair following 
injury. In cases where abnormal growth factor signalling occurs due to 
overstimulation of the inflammatory system or otherwise, excessive growth factor 
signalling may lead to fibrosis and the development of malignant cancer tissues. 
1.3.5 EMT and phenotypic switching in cancer 
Numerous studies have shown that the EMT process is involved in phenotypic 
switching in cancer. Similar to the plasticity of the EMT-MET axis in the 
developing embryo, the phenotypic switching in cancer cells occurs readily 
between subpopulations. E-cadherin downregulation is the hallmark of EMT and 
occurs at the invasive front of many solid tumours (Perl et al. 1998). The 
progression of EMT in the tumour cell leads to reduced cell polarity and the loss of 
intercellular junctions ultimately resulting in more invasive, mesenchymal and 
migratory cells. The cell are capable of detaching from the solid primary tumour 
and invading the circulatory system before undergoing MET and developing 
nascent tumour sites (Li et al, 2015; Thiery et al, 2009; Thiery, 2002).  
1.3.6  Experimental aims 
BMP signalling is involved in lung morphogenesis. This signalling pathway is also 
believed to be reactivated during lung epithelium inflammation, repair and 
restitution. Altered BMP signalling has been shown to occur in both malignant and 
inflammatory diseases; however the role of BMP signalling in these processes is 
poorly understood. The main aim of this work was to gain a better insight into BMP 
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pathway activation in both healthy and diseased lungs. We aimed to determine the 
role of BMPs in EMT-mediated phenotypic switching. We hypothesised that BMP 
signalling is capable of inducing phenotypic switching in lung cancer cell 
populations. In addition, we hypothesised that BMP signalling is active in healthy 
adult airways and that signalling is sustained to mediate homeostasis in the lung 
epithelium. Finally, we hypothesised that BMP signalling is altered in inflammatory 
airways diseases and during active epithelial repair. 
Our lab has shown that BMP signalling can induce a migratory phenotype in airway 
epithelial cells during epithelial restitution (McCormack et al. 2013). Our first 
objective aimed to determine the role of BMP signalling in EMT and phenotypic 
switching in lung cancer cells. We speculated that the heterogeneous lung tumour 
cell line DLKP would be a suitable model to study EMT-mediated phenotypic 
switching. We aimed to characterise the DLKP clones more extensively to 
determine what stage of EMT each clone represented. Subsequently the DLKP 
clones were treated with recombinant BMP-4 and gremlin to examine the effect of 
altered BMP signalling on cell morphology and the expression of epithelial and 
mesenchymal markers. In addition, the role of E-cadherin gene processing was 
investigated in DLKP-SQ and DLKP-M clones with the aim to determine the 
significance of the cadherin axis in heterogeneous cell populations. E-cadherin 
reporter plasmids, previously designed by Dr. Joanne Masterson in the O’Dea Lab, 
were transfected into the DLKP clones by myself and Dr. Emer Molloy to examine 
the effect of E-cadherin gene overexpression in the clones.  
The second objective was to investigate whether a BMP signalling gradient exists 
in adult airways. For these studies, a healthy porcine lung model was chosen as the 
most readily-available clinically relevant large animal model. Following 
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histological analysis of the porcine airways, the expression of BMP receptors, BMP 
ligands, SMAD signalling molecules and BMP antagonists was determined by PCR 
and western blot in the descending left cranial pig bronchus.  
Based on the resulting data, hypotheses would be developed around the role of BMP 
signalling in proximal versus distal airways. A porcine tracheal explant model was 
developed to investigate the function of BMP signalling. Primary porcine tracheal 
explants were treated with recombinant BMP-4 in vitro to examine the effect of 
BMP signalling on epithelial cell phenotype and downstream signal activation. 
Finally, we aimed to determine if BMP signalling was present and active in non-
human primates and if BMP signalling was altered during allergic airway disease 
and subsequently, during epithelial repair. To address this aim, we used an 
established model of allergic airway disease in a rhesus macaque model. The 
expression of BMP signalling components was examined by immunofluorescence 
in the left cranial bronchus of healthy, asthmatic and recovering rhesus macaques.  
Overall, the aim of this research was to provide novel insights into the expression 
patterns of BMP signalling in healthy airways and to gain further insight into the 
role of BMP signalling in the pathophysiology of allergic airway disease and lung 
cancer.
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2 Chapter 2 
Material and methods 
2.1 Materials 
2.1.1 Reagents 
Product Company Address 
1kb ladder Invitrogen Dublin, Ireland 
4-20% mini-precast TGX BioRad Herts, UK 
7AAD Viability stain eBioscience Hatfield, UK 
Acetic acid Sigma Dublin, Ireland 
Agarose Sigma Dublin, Ireland 
Alcian blue Sigma Dublin, Ireland 
Amicon ultra 0.5ml 10k Millipore Cork, Ireland 
Antigen unmasking solution (citrate) Vector Labs Peterborough, UK 
Bench Top 100bp ladder Promega Madison, WI, USA 
B-mercaptoethanol Sigma Dublin, Ireland 
BMP-4 Immunotools Friesoythe, Germany 
QuickStart ™ Bradford assay reagent BioRad Herts, UK 
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Bovine Serum Albumin Sigma Dublin, Ireland 
cDNA synthesis kit with 
Superscript® III RT 
Thermo fisher 
scientific 
Loughborough, UK 
Chloroform Sigma Dublin, Ireland 
Complete mini EDTA-free protease 
inhibitor 
Roche West Sussex, UK 
Faramount mounting medium DAKO Glostrup, Denmark 
DAPI Sigma Dublin, Ireland 
dNTPs (dATP, dCTP, dGTP, dTTP) Promega Madison, WI, USA 
Dimethyl sulfoxide DMSO Sigma Dublin, Ireland 
DMEM Hams-  F12 Medium Sigma Dublin, Ireland 
Dnase for cDNA synthesis Invitrogen Dublin, Ireland 
DPX mounting medium Sigma Dublin, Ireland 
Eosin Y Solution Sigma Dublin, Ireland 
Ethanol, 200 proof Sigma Dublin, Ireland 
Ethyline diamine tetra-acetic acid 
EDTA 
Sigma Dublin, Ireland 
Foetal calf serum Sigma Dublin, Ireland 
10% formalin, neutral buffered 
solution 
Sigma Dublin, Ireland 
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G 418 Sigma Dublin, Ireland 
Gentamycin Sigma Dublin, Ireland 
GelRed nucleic acid stain BioTium Hayward, CA, USA 
GoTaq Flexi DNA polymerase kit Promega Madison, WI, USA 
Gremlin R&D Systems Minneapolis, MN, USA 
Happy Cell ® advanced suspension 
medium 
Brennan & Co. Dublin, Ireland 
Harris Haemotoxylin Solution Sigma Dublin, Ireland 
Hydrochloric acid Sigma Dublin, Ireland 
Isopropanol Sigma Dublin, Ireland 
L-Glutamine Gibco Loughborough, UK 
Magic Mark Invitrogen Dublin, Ireland 
Marvel – non-fat dried milkd Dunnes Stores Dublin, Ireland 
Methanol Sigma Dublin, Ireland 
MicroAmp Fast 96 well reaction 
plate 
Applied 
Biosystems 
Carlsbad, CA, USA 
Mini Protean Comb – 10 well 
0.75mm 
BioRad Herts, UK 
Mini protean precast TGX BioRad Herts, UK 
Mr Frosty Nalgene Loughborough, UK 
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MTS cell proliferation kit Promega Madison, WI, USA 
NaCl Sigma Dublin, Ireland 
Nitrocellulose Transfer Kit BioRad  Herts, UK 
Nuclease free water Promega Madison, WI, USA 
Oligo dT 12-18 primer Invitrogen Dublin, Ireland 
Optical adhesive covers 
Applied 
biosciences 
Carlsbad, CA, USA 
Phosphate Buffered Saline tablets Sigma Dublin, Ireland 
Penicillin-Streptomycin Gibco Loughborough, UK 
Periodic Acid Sigma Dublin, Ireland 
Polyacryl carrier MRC Cincinnati, OH, USA 
QiaShredder Qiagen West Sussex, UK 
Restore Western Blot stripping buffer ThermoFisher  Carlsbad, CA, USA 
RIPA buffer Sigma Dublin, Ireland 
Rnase away Invitrogen Dublin, Ireland 
RnaseOut – RNAse inhibitor Invitrogen Dublin, Ireland 
RPMI 1640 media Life Technologies Carlsbad, CA, USA 
Schiff Reagent Sigma Dublin, Ireland 
SeeBlue molecular weight ladder Invitrogen Dublin, Ireland 
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Sodium Chloride (NaCl) Sigma Dublin, Ireland 
Superscript III reverse transcriptase Invitrogen Dublin, Ireland 
SYBR green – Jump start Taq ready Sigma Dublin, Ireland 
Tris – hydoxymethyl aminomethane VWR Dublin, Ireland 
2x Tris Glycine SDS Buffer Invitrogen Dublin, Ireland 
10X Tris Glycine running buffer BioRad Herts, UK 
TriZol Reagent Invitrogen Dublin, Ireland 
Trypsin-EDTA Sigma Dublin, Ireland 
Tween-20 Sigma Dublin, Ireland 
WesternBright ECL HRP substrate Advansta Menlo Park, CA, USA 
Xylene Sigma Dublin, Ireland 
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2.1.2 Instruments  
Instrument Company Address 
Accuri C6 Cytometer BD Biosciences Oxford, UK 
Centrifuge 5804 Eppendorf Hauppauge, NY, USA 
Centrifuge 5817 R Eppendorf Hauppauge, NY, USA 
Gel Doc Imaging system BioRad Herts, UK 
G:BOX Chemi XT4 Syngene Cambridge, UK 
GeneSys Software Syngene Cambridge, UK 
GloMax multidetection platform Promega  
MiniProtean 3.0 electrophoresis rig BioRad Herts, UK 
Olympus BX61 fluorescent 
microscope 
Olympus Melville, NY, USA 
Olympus CK40 light microscope Olympus Germany 
Olympus IX81 Fluorescent 
microscope 
Mason 
technologies 
Dublin, Ireland 
Olympus QI Click 12vbit CCD 
camera 
Mason 
technologies 
Dublin, Ireland 
PowerPac™ basic power supply BioRad Herts, UK 
Quantity-One® Software Fannin Scientific Dublin, Ireland 
StepOnePlus™ Real-time PCR 
systems 
Thermo Scientific Paisley, UK 
Thermal Cycler – PTC 100 MJ Research Waltman, MA, USA 
Trans-Blot™ turbo transfer system BioRad 
Herts, UK 
 
Citadel ™ 2000 tissue processor Thermo Scientific Pasiley, UK 
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2.1.3 Antibodies 
 
 
Antibody Clone Raised In If Conc WB Conc Size Company 
Catalogue  
Actin 20-33 Rabbit 1/100 
1/2000 
TBSt 
43kDA 
Sigma 
A5060 
 
Afadin D1Y3Z Rabbit  
1/1000 
mTBSt 
205kDA 
Cell 
Signalling 
13531 
β-catenin 14 Mouse 1/200 1/500 TBS 92kDA BD Biosci 
610153 
BMPR-Ia H60 Rabbit 1/20 1/200 TBSt 66kDA Santa Cruz 
Sc-20736 
CD2AP n/a Rabbit  
1/1000 
mTBSt 
80kDA 
Cell 
Signalling 
2135 
Claudin-1 D5H1D Rabbit  
1/1000 
mTBSt 
20kDA 
Cell 
Signalling 
13255 
E-cadherin 36 Mouse 1/200 1/2000 TBS 120kDA BD Biosci 
610182 
ERK 1/2 n/a Rabbit  1/1000 
42kDA, 
44kDA 
Cell 
Signalling 
9102 
GAPDH 6C5 Mouse  
1/1000 
TBSt 
37kDA 
Santa Cruz 
Sc-32233 
N-cadherin 32 Mouse 1/200 1/2000 TBS 130kDA BD Biosci 
610920 
Pan-
Cytokeratin 
c-11 Mouse 1/150 1/1000 TBS 
45kda  K18 
52kDA  K8 
54kDA K13 
56kDA K10 
56kDA K6 
58kDA K5 
Sigma 
P2871 
p-ERK 1/2 n/a Rabbit  1/1000 
42kDA, 
44kDA 
Cell 
Signalling 
9101 
pSmad 1/5/8 41D10 Rabbit 1/50 1/1000 60kDA 
Cell 
Signalling  
D5B10 
Smad -1 A4 Mouse 1/50 1/200 56kDA Santa Cruz 
Sc-7965 
Smad 1/5/8 N18-R Rabbit 1/50 1/200 52-56kDA Santa Cruz 
Sc-6031 
Materials and methods 
  
 
67 
 
 
  
Antibody Clone Raised In If Conc WB Conc Size Company 
Catalogue  
Smad-5 D20  1/50 1/200 56kDA Santa Cruz 
Sc-7443 
Smad-6 H150 Rabbit 1/50 1/1000 54kDA Santa Cruz 
Sc-13048 
Smad-7 Z8-B Mouse 1/50 1/250 51kDA 
Santa Cruz 
Sc-101152 
Vimentin 13.2 Mouse 1/2000 1/1000 TBS  53kDA Sigma 
V5255 
YFP  Rabbit 1/3000  1/3000 TBS 26kDA Abcam 
A6556 
ZO-1 D7D12 Rabbit  
1/1000 
mTBSt 
200kDA 
Cell 
signalling 
8193 
α SMA 1A4 Mouse 1/3000 1/2000 42kDA Sigma 
A2547 
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2.1.4 Primers  
Gene Sp. Sequence 
Product 
(bp) 
Temp. 
(°C) 
MgCl2 
(nM) 
BMPRIa Hu 
F: 5’-ATGACCAGGGAGAAACCACA-3’ 
R: 5’ – ATTCTATTGTCCGGCGTAGC -3’ 
105 55 1.5 
BMPRIb Hu 
F: 5’- ACTCAAGGCAAACCAGCAAT -3’ 
R: 5’- TCTGTTCAAGCTCTCGTCCA -3’ 
204 58 1.5 
BMPRII Hu 
F: 5'- GCCCGCTTTATAGTTGGAGA -3' 
R: 5’- TCTGTTCAAGCTCTCGTCCA -3’ 
144 55 1.5 
SMAD7 Hu 
F: 5'- TCCAGATACCCGATGGATTT -3' 
R: 5'- GGGCCAGATAATTCGTTCC -3' 
94 55 1.5 
SMAD6 Hu 
F: 5’- GTCGTACACCGCATAGAGG -3’ 
R: 5’- GCCACTGGATCTGTCCGATT-3’ 
157 55 1.5 
BMP-4 Hu 
F: 5'- TACATGCGGGATCTTTACCG -3' 
R: 5'- ATGTTCTTCGTGGTGGAAGC -3' 
132 55 1.5 
ID-1 
Hu/
Ms 
F: 5'- GCAAAGTGAGCAAGGTGGAG -3' 
R: 5'- ATCGTCGGCTGGAACACAT -3' 
191 55 1.5 
N-cadherin 
Hu/
Mk 
F: 5’- TGTTTTGGACCGAGAATCAC -3' 
R: 5’- TAACACTTGAGGGGCATTGT -3' 
148 55 1.5 
GAPDH 
Hu/ 
Mse 
F: 5’- CTGCACCACCAACTGCTTAG -3' 
R: 5’-CCAGGAAATGAGCTTGACAAA-3' 
487 55 1.5 
E-cadherin 
Hu/ 
Mse 
F: 5'- GGCTGGACCGAGAGAGTT -3' 
R: 5'- CTGCTTGGCCTCAAAATCC -3' 
350 58 1.5 
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Gene Sp. Sequence 
Product 
(bp) 
Temp. 
(°C) 
MgCl2 
(nM) 
BMPRIa Pig 
F: 5’- ATGCAAGGATTCACCGAAAG-3’ 
R: 5’-TGCAGACAGCCATAGAAACG-3’ 
164 58 1.5 
BMPRIb Pig 
F: 5’- AAATGTGGGCACCAAGAAAG-3’ 
R:5’- ACAGGCATCCCAGAGTCATC-3’ 
171 58 1.5 
BMPRII Pig 
F:5’- GAAGACTGTTGGGACCAGGA-3’ 
R:5’- GGTTGCGCTCATTCTGCATA-3’ 
151 58 1.5 
BMP-2 Pig 
F:5’- CTTGCTAGTCACTTTCGGCC-3’ 
R:5’- TCATTCCAGCCCACATCACT-3’ 
150 58 1.5 
BMP-4 Pig 
F:5’- GGCTGGAATGACTGGATTGT -3’ 
R:5’- ACTCAGTTCGGTGGGAACAC-3’ 
158 58 1.5 
BMP-7 Pig 
F:5’- CTTCTCCTACCCCTACAAG-3’ 
R:5’- GGAAGAACTCTTTGTCGTG-3’ 
119 55 1.5 
SMAD-4 Pig 
F:5’- CTATGAACGAGTTGTATCACC-3’ 
R:5’- ATCCTTCACCAACATACCTG-3’ 
166 55 1.5 
SMAD-6 Pig 
F:5’- ACCCCATCTTCGTCAACTCC-3’ 
R:5’- TGATGAACTGCCGGGAGTAG -3’ 
225 58 1.5 
SMAD-7 Pig 
F:5’- GGGGCTTTCAGATTCCCAAC-3’ 
R:5’- TCCAAGGCAAAAGCCATTCC-3’ 
166 58 1.5 
BAMBI Pig 
F:5’- AAACAGGCACGAAACCACTC-3’ 
R:5’- TTGGAGGAAGTCAGCTCCTG-3’ 
191 58 1.5 
E-
cadherin 
Pig 
F:-5’- CATCTTCAACCCAACCTCGT-3’ 
R:5’-: ACGCCTTCATTGGTTACTGG-3’ 
167 58 1.5 
GAPDH Pig 
F:5’- GTCGGTTGTGGATCTGACCT-3’ 
R:5’- AGCTTGACGAAGTGGTCGTT-3’ 
191 58 1.5 
Gremlin Pig 
F:5’- CATGTGACGGAGCGCAAATA-3’ 
R:5’- GTTCAGGGCAGTTGAGTGTG -3’ 
238 55 1.5 
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Gene Sp. Sequence 
Product 
(bp) 
Temp. 
(°C) 
MgCl2 
(nM) 
Noggin  Pig 
F:5’TGGAGTTCTCCGAGAGGGTT-3’ 
R:5’-CATGAGCGCTTACTGAAGCA-3’ 
166 58 1.5 
Id-1 
(set1) 
Pig 
F:5’-TCATCGACTACATCTGGGA-3’ 
R:5’-GGAACACATGCTGTCTCTG-3’ 
130 58 1.5 
Id-2  
(set 2) 
Pig 
F:5’-CATCGACTACATCTGGGAC-3’ 
R:5’-GAACACATGCTGTCTCTGC-3’ 
128 58 1.5 
AQP-5 Pig 
F:5’- GTGGTGGAAATGATTCTGAC-3’ 
R:-5’- GAAGTAGATCCCCACAAGG-3’ 
127 58 1.5 
EpCAM Pig 
F:5’- GACCTACTGGATCATCATTG-3’ 
R:5’- TGATTACCTCCTTGAGTGC-3’ 
74 58 1.5 
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Gene Sp. Sequence 
Product 
(bp) 
Temp. 
(°C) 
MgCl2 
(nM) 
FOXA1 Pig 
F:5’- CAGGATGTTAGGGACTGTG-R’ 
R:5’- GGTATTCATGGTCATGTAGG-R’ 
160 58 1.5 
ITGA6 Pig 
F:5’- CCCTCTCAGACTCAGTAAC-R’ 
R:5’-GACGGAGATCAATTCTGTTAG-3’ 
72 55 1.5 
SFTPC Pig 
F:5’- CTGAGATGGTCCTAGAGATG-3’ 
R:5’- ACTAGAGCCAATGGAGAAG-3’ 
85 55 1.5 
K-18 Pig 
F:5’- TGAAGACTATCGAGGAACTG-3’ 
R:5’- CTCCGTCTCATACTTGACTC-3’ 
106 58  
ID-2 Pig 
F:5’- CGATGAGCCTGCTGTACAAC-3’ 
R:5’- GTGCAGGCTGACAATAGTGG-3’ 
173 58 1.5 
GATA-6 Pig 
F:5’-TGTGCAATGCTTGTGGACTC-3’ 
R:5’-GGAAGTTGGAGTCATGGGGA-3’ 
164 58 1.5 
SOX-9 Pig 
F:5’- TTCGAGCAAGAATAAGCCGC-3’ 
R:5’- CGCGGCTGGTACTTGTAATC-3’ 
240 58 1.5 
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  Methods 
2.2 Tissue culture 
2.2.1 Cell lines 
The human DLKP cell line was kindly provided by Prof. Martin Clynes, Dublin 
City University (Mcbride et al. 1998). The cells were derived from a lymph node 
metastasis of a primary tumour. The lung tumour was termed a “poorly 
differentiated squamous cell carcinoma” as described in (Law et al. 1992) . The 
parental DLKP line was subsequently cloned to three distinct populations DLKP-
SQ, DLKP-M and DLKP-I as described (Mcbride et al. 1998). The cells were 
routinely cultured in a 1:1 mixture of DMEM: Hams-F12 medium supplemented 
with 5% fetal bovine serum and 2mM L-Glutamine. Cell culture medium for 
DLKP-SQ Eprom, DLKP- SQ Em2, DLKP-M Eprom and DLKP-M Em2 was 
supplemented with 200 ug/ml G418. Cells were maintained in a humified 
atmosphere at 5% CO2 at 37 °C. Experiments were carried out within seven 
passages.   
2.2.2 Sub-culture  
DLKP cell lines were subcultured when the T-75 flask reached between 80-100% 
confluency. The culture medium was pipetted from the flask and the cells were 
rinsed with sterile 1XPBS solution. Trypsin-EDTA (0.5% w/v) was added to the 
flask which was incubated at 37 °C until the cells had completely detached from 
the flask – not exceeding 15 mins. Detachment of the cells was visualised using a 
light microscope. An equal volume of 5% serum-containing medium was added to 
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the flask to neutralise the trypsin enzyme. The entire content of the flask was 
transferred to a 30ml sterlin and spun at 259 x g for 5 mins in a bench top centrifuge. 
Following centrifugation, the supernatant was discarded and the cell pellet was 
resuspended in fresh medium. The cells were then used to re-seed culture flasks or 
for experimental set up.  
2.2.3 Cell freezing 
Cells were frozen to liquid nitrogen to maintain cell stocks. Freezing medium was 
prepared which consisted of 8ml DMEM:F12, 1ml FBS, 1ml DMSO. This medium 
was stored on ice and protected from the light. When the cells reached 60-70% 
confluency, the flask was trypsinised as above, and the resulting pellet was 
resuspended in 1ml freezing solution, in a dropwise fashion. The cell suspension 
was transferred to a cryovile and stored in Mr. Frosty apparatus at -80 °C overnight. 
The Mr. Frosty apparatus contains isopropanol which slowly freezes the cells at 1 
degree /minute. The cryoviles were transferred to liquid nitrogen for long term 
storage.  
2.2.4 Cell thawing 
The freezing solution used during liquid nitrogen preparation is toxic to cells at 
room temperature – due to its dehydrating effect on the cells. Prior to the removal 
of cells from liquid nitrogen, a 10% serum-containing medium was prepared and 
incubated at 37 °C (1:1 DMEM/F12, 10% FBS, 2 mM L-Glutamine). A small 
beaker of dH20 was heated to 37 °C. The cryovial was removed from liquid nitrogen 
and placed on ice. Cells were thawed by placing the cryovile in the heated water 
and swirling gently. Once the cells had thawed, the solution was quickly transferred 
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to the medium-containing sterilin. The cells were centrifuged at 259 x g for 5 mins. 
The supernatant was discarded and the cells were resuspended in 10% medium and 
placed in a tissue culture flask. The flask was placed in a 37 °C humidified 
environment with 5% CO2. The culture medium was replaced between 8-17 hours 
later to remove any residual DMSO and dead cells. 
2.2.5 Cell counting 
Following trypsinising, cells were suspended in 10ml medium. A glass 
haemocytometer was used to carry out a cell count to determine the number of cells 
per millilitre of medium. The haemocytometer was cleaned with ethanol and a 
coverslip was mounted by applying pressure with the fingertips. Newton’s rings 
were observed to ensure the correct depth between the haemocytometer and the 
coverslip. Approximately 10ul of cell suspension was pipetted onto the 
haemocytometer and the volume was drawn under the coverslip by capillary action. 
Cells present in each of the four corner were counted and an average cell 
concentration was obtained. This number was indicative of the number of cells x 
104 per ml of the original cell solution.  
2.2.6 Expansion of Eprom- and Em2-expressing DLKP-SQ and 
DLKP-M cells 
DLKP-SQ and DLKP-M cells were transfected with E-cadherin reported plasmids 
designed by Dr. Joanne Masterson in the O’Dea lab. The first contained the mouse 
E-cadherin promoter-CAT construct subcloned into the plasmid vector pEYFP-1. 
This plasmid was called Eprom. The second construct contained the full length 
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mouse E-cadherin gene from the pBATEM2 construct subcloned into the plasmid 
vector pEYFP-1. This plasmid was called Em2.  
Populations of DLKP-SQ and DLKP-M cells transfected with Eprom and Em2 
plasmids were grown in T-75 flasks by Dr. Emer Molloy. Cells were trypsinised 
and a cell suspension of 2 x 104 cells/ml was prepared of the mixed populations of 
DLKP-SQ Eprom, DLKP-SQ Em2, DLKP-M Eprom and DLKP-M Em2. DMEM-
F12 culture medium containing 400ug/ml G418 was prepared and cells were diluted 
according to the Corning ® Cell cloning by serial dilution in 96 well plate protocol. 
In brief, 100ul was pipetted into all wells in a 96 well plate except A1. 200ul of the 
cell suspension was added to A1 and a serial dilution along column 1 was carried 
out. A subsequent serial dilution across each row was carried out using a multi-
channel pipette. Medium was added so that each well contained 200ul of medium 
(see appendix Figure 8.0.1). The plate was left to incubate overnight at 37 °C in a 
humidified environment with 5% CO2. Clonal cells growing as a single colony were 
detected by brightfield microscopy and fluorescent microscopy was used to validate 
fluorescent colonies. Once characterised, all fluorescent colonies were expanded 
and cells were transferred from 96 well plate to 24 well plate, 6 well plate, T-25 
culture flask and finally to a T-75 culture flask. FACS was carried out to quantify 
the level of fluorescence in the DLKP-SQ Eprom, DLKP-SQ Em2, DLKP-M Eprom 
and DLKP-M Em2 cells.  This work was carried out by Dr. Emer Molloy, see 
appendix Figure 8.0.1. 
This clonal expansion protocol was repeated at the beginning of this project to 
prepare a purified population of DLKP-SQ Eprom cells as the stocks of this 
subclone had expired. 
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2.2.7 Spheroid cell culture 
Cells were counted and suspended in 2x Happy Cell® Medium at the correct 
seeding density for a chamber well slide or a 24-well plate. 250ul of this cell 
suspension was added to the plate. A 1:1 mix of 2x Happy Cell ® Medium and 
DMEM-F12 medium was prepared and supplemented with 2% FBS, 2mM L-
Glutamine and 200units/ml Pen-strep. 250ul of this cell medium was pipetted on 
top of the cell suspension of DLKP-SQ, DLKP-M, DLKP-SQ Eprom, DLKP-M 
Eprom, DLKP-SQ Em2 or DLKP-M Em2. Cells grown in Happy Cell ® medium 
began to form 3D spheroids after 4 days in culture.  
2.2.8 Acquisition of bright field images 
Phase contrast images were obtained using an Olympus CK40 light microscope. 
2.3 Primary porcine tracheal explant ALI culture 
2.3.1 Porcine tracheal tissue preparation 
Pig lungs were collected from the local abattoir and transported on ice to the lab. 
Wash medium had been previously prepared and incubated at 37 °C – 1:1 RPMI 
DMEM-F12 medium supplemented with 200units/ml penicillin and streptomycin, 
2.5ug/ml amphotericin, 50ug/ml gentamycin and 10mM L-glutamine. A bunsen 
burner was present on the bench once the lungs were removed from the ice to 
enhance sterility. The trachea was detached from the mouthparts and cut at the 
carina. The tracheal tissue was cleaned of all adventitia, connective tissues, blood 
and mucus. The trachea was cut along the trachealis (the cartilaginous axis) and 
divided into longitudinal sections. Each tissue section was submerged in sterile PBS 
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before being placed in wash medium. The tissue was rocked then for 5 minutes at 
room temperature before being placed at 37 °C for 40 minutes. Three washes were 
carried out over a period of 3 hours using fresh medium each time. All residual 
connective tissue attached to the exterior to the trachea was removed following each 
wash. The tracheal sections were cut into small explants, approximately 10mm x 
10mm in size which consisted of cartilage, respiratory mucosa and respiratory 
epithelium.  
2.3.2 Sub-culture on agar plugs 
Tracheal sections were removed from the wash medium and placed on 1% w/v 
agarose plugs with the epithelium facing upwards. The plugs were 5mm in height 
and were placed in the centre the well in a 12-well plate. 2ml of culture medium 
was added to the well so the plug and the basal surface of the tracheal explant were 
bathed in medium. Culture medium contained all components of the wash medium 
with 10mM L-Glutamine. A serum control containing 10% FBS was prepared for 
all experiments.The primary porcine tracheal explant culture protocol was 
developed in collaboration with Dr. Peter Riddell (O’Dea Lab). 
2.4 BMP Stimulation 
2.4.1 Reconstitution of recombinant BMP-4 
Human BMP-4 recombinant protein was purchased from Immunotools.  
The protein was reconstituted in 1ml DMEM-Hams F12 medium to yield a 
concentration of 10ug/ml. This stock solution was aliquoted into sterile Eppendorfs 
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and stored at -20 °C. A working concentration of 100ng/ml was used in all 
experiments. 
2.4.2 Reconstitution of gremlin  
Recombinant mouse gremlin was purchased from R&D systems. 50ug was 
reconstituted in 200ul of a 4mM HCL solution to yield a 250ug/ml solution. This 
stock solution was aliquoted into sterile Eppendorfs and stored at -20 °C. A working 
concentration of 3ug/ml was used in all experiments.   
2.4.3 BMP-4 or gremlin stimulation of DLKP-SQ, DLKP-M, 
DLKP-I cell lines 
Cells were trypsinised, counted and seeded as above. Reduced serum-containing 
medium (0.25% FBS) was added to the cells overnight to reduce the levels of any 
residual growth factors present in the serum. Medium was replaced after 24hrs with 
fresh medium (0.25% FBS) containing 100ng/ml BMP-4 or 3 ug/ml Gremlin. 
Cultures were maintained at 37 °C in a humidified incubator with 5% CO2. 
2.4.4 BMP-4 stimulation of pig tracheal explants 
Serum-containing and serum-free medium supplemented with 100ng/ml BMP-4 
was added to the wells containing the agar plugs and tracheal explants. Cultures 
were maintained at 37 °C in a humidified incubator with 5% CO2. 
Materials and methods 
  
 
79 
 
2.5 Rhesus macaques model of allergic airway disease 
The following procedures with rhesus macaques animals and tissues were carried 
out by trained staff at the California National Primate Research Centre (CNPRC) 
based at the University of California, Davis, USA prior to the present study. 
2.5.1 Selection of non-human primates 
All rhesus macaques in this study (Macaca mulatta) were chosen from the breeding 
colony at the California National Primate Research Centre at the University of 
California, Davis. All housing and care of the animals was in compliance with the 
provisions outlined by the Institute of Laboratory Animal Resources and followed 
the regulations of the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). The Institute of Animal Use and Care Committee 
reviewed and approved all animal experimental protocols prior to commencement. 
Neonates were removed from the mothers and following 2 days of bottle-feeding, 
they were randomly assigned to groups and placed in social cohorts within chamber 
nurseries for a further 28 days. Body weights within social groups were comparable 
and the animals were chosen based on negative intradermal skin test reactivity to 
Dermatophagoides farinae which is a common house dust mite allergen (HDMA).   
2.5.2 Asthma model 
The rhesus macaques chosen for the study were moved to specially designed air 
chambers. Each exposure chamber had a turnover of 30 filtered air changes per 
hour. All animals were diligently checked and monitored by trained CNPRC animal 
technician, care, research and veterinary staff.  
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The animal test groups were exposed to HDMA + O3 (n=6). The HDMA was 
supplied by Greer Laboratories (Lenoir NC) was used for inoculation and 
aerosolization in the treatment chambers as previously described  (Schelegle, 
Walby, et al. 2003). Ozone generation and supply was carried out as previously 
described (Schelegle, Miller, et al. 2003). Over a 5 day period, O3 was supplied to 
the chamber for 8hr per day at 0.5ppm in combination with aerosolized D. farinae 
during days 3, 4 and 5. HDMA was supplied to the chambers for 2.5hr/day at 
1mg/ml. These animals had been previously sensitized to D. farinae in alum at 14 
days old via subcutaneous inoculation and intramuscular injection of heat-killed 
Bortetella pertussis cells. At 28 days old an additional dose of HDMA in alum was 
provided. Following the 5 day treatment period, filtered air was supplied to the 
chamber for a further 9 days. This cycle of 14 days was repeated 11 times resulting 
in a 5 month exposure period.  
2.5.3 Regeneration model 
A separate cohort of animal was exposed to filtered air for a 6 month period 
following the initial 5 month HDMA + O3 exposure period. This was to assess the 
potential recovery of the lungs. These monkeys were exposed to HDMA + O3 for 
2hours at monthly intervals to maintain sensitivity.  Each exposure animal group 
(n=6) has a corresponding control animal group (n=6) housed in filtered air for the 
duration of the study. 
2.5.4 Necropsy and tissue preparation 
Following the period of six or twelve month treatment in HDMA + O3 or filtered 
air, the animals were sedated by an intramuscular injection of Telazol (8mg/kg) and 
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anaesthetized intravenously with Diprivan (0.2/0.2mg/kg/min). Sodium 
pentobarbital was supplied intravenously to deeply anaesthetise the already sedated 
animals. Following tracheal intubation, the animal underwent exsanguination via 
the systemic aorta.  
Following necropsy, the left cranial lobe was fixed in 1% paraformaldehyde. After 
fixation, the lobes were isotrophically oriented using an orientor and cut into 5-mm 
slabs. A smooth fractionator was used to sample the tissue (Gundersen et al. 1988). 
The tissue was embedded in paraffin and cut into 5-µm serial sections and stored at 
ambient temperature prior to deparaffinisation and immunofluorescence.  
2.6 RNA Isolation 
2.6.1 RNA Harvest from cells cultured in 24 well plates 
Culture medium was removed from the well. In the fume hood, 250µl Trizol© was 
added to each well, swirled and incubated at room temperature for 2-3minutes. All 
Trizol© solution for each time point was then pipetted from well and placed in a 
labelled eppendorf. Samples were stored at -20°C before phase separation and RNA 
isolation was carried out.  
2.6.2 RNA Isolation 
Once the homogenate was thawed, all samples and materials were moved to the 
fume hood and 5µl of Polyacryl Carrier is added to every tube. This is a polymer 
used to aid visualisation of the RNA pellet. 200µl Chloroform was added to each 
tube and the samples were shaken vigorously for 15seconds before an incubation 
period of 10minutes at room temperature. The tubes were centrifuged at 1,200rcf at 
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4°C for 15minutes. The aqueous RNA phase was transferred to new labelled tubes 
(350-450µl). 
2.6.3 RNA Precipitation and purification 
To the tube containing RNA, 500µl Isopropanol was added and the tubes were 
vortexed. Following incubation at room temperature for 5-10minutes, the tubes 
were centrifuged at 1,200rcf at 4°C for 15minutes. A pellet was seen at the bottom 
of each tube. The supernatant was removed into a waste bottle using a P1000. A 
small volume was left and the pellet was left undisturbed. 1ml of 75% ethanol was 
added to wash the pellet in each tube. The tubes were vortexed prior to 
centrifugation at 7,500g at 4°C for 5minutes. The ethanol was removed and the 
wash steps were then repeated twice more. Following the final centrifugation, all 
traces of ethanol were removed and the tubes were left to air dry in the fume hood 
for 4-5minutes.The pellet was dissolved in 40µl nuclease-free water. The 
concentration of RNA was determined using a NanoDrop Spectrophotometer. All 
samples were stored at -80°C. 
2.7 Polymerase Chain Reaction 
2.7.1 DNAse treatment  
RNA samples were treated with DNase to remove any DNA contamination. As an 
additional control, genomic samples of each sample were prepared. These samples 
did not receive cDNA synthesis reagents but received equal volumes of DEPC 
water in their place. Any amplification which occurred in the subsequent PCR was 
present due to DNA contamination and amplification of genomic DNA.  
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For each sample of RNA (500ng – 1µg), 1µl 10X DNase buffer and 1µl DNase 
enzyme were added. The volume of the tube was adjusted to 10µl with DEPC water. 
The samples were incubated at room temperature for 20minutes to allow full 
degradation of the DNA. 
To deactivate the DNase enzyme, 1µl EDTA was added to all samples and all 
samples were heated to 65°C for 10minutes. 
2.7.2  cDNA synthesis 
Following heat-deactivation of DNase, 1µl oligodT(12-18) primers and 1µl 10mM 
dNTPs were added to the samples. The genomic samples did not receive any 
oligodT and dNTPs. The solution was heated to 65°C for 5minutes before being 
cooled to 4°C and transferred to ice.  
The cDNAmastermix was then prepared for each sample as follows: 
4µl 5X First-Strand buffer 
1µl 0.1M DTT 
1µlRNaseOUT Recombinant RNase Inhibitor  
1µl Superscript III Reverse Transcriptase 
The reagents were mixed by pipetting gently up and down and 7µl of the mastermix 
was added to each of the active samples. An equal volume of DEPC-water was 
added to the genomic samples. The solution was incubated at 50°C for 60minutes 
on a PCR machine. To deactivate the reaction, the temperature was raised to 70°C 
for 15minutes. 
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2.7.3  Primer design 
Primers were designed using the NCBI database 
http://www.ncbi.nlm.nih.gov/pubmed. Once coding sequences for the gene of 
interest were obtained, “Primer3” software from the Whitehead Institute for 
Biomedical Research was used to generate specific primer sets. 
http://primer3.ut.ee/.  Each primer set was verified using a Basic Line Alignment 
Search Tool blast.ncbi.nlm.nih.gov  
Primers were reconstituted in DEPC water to give 100uM concentration. This 
volume was added to DEPC water to give a working concentration @ 10ul primer 
+ 56.6ul primer (1:6.66)= 15uM  OR 10ul primer + 90ul DEPC (1:10) =10uM OR 
10ul primer + 10ul DEPC (1:2)=50uM 
This working stock solution was diluted by 50 when added to the PCR mastermix 
(0.5ul to 25ul) giving 300nM, 200nM or 1000nM concentration respectively. 
2.7.4  Reverse Transcriptase PCR 
Firstly, 500µl micro-centrifuge tubes were labelled appropriately. A master-mix 
was prepared on ice as outlined below. The reagents were multiplied for the 
necessary sample number. 
 
 
 
 
 
 
 
 
Volume 
(µl) 
Reagent Final Concentration 
5 5X Green GoTaq Flexi buffer 1x 
1-2.25  25mM MgCl2 solution 1-2.25mM 
4 1.25mM  dNTP 200µM each nucleotide 
0.5 10-15µM Upstream primer  200-300nM 
0.5 10-15µM Downstream primer 200-300nM 
0.125 (5U/ µl) GoTaq DNA Polymerase 0.025U/µl 
To 25 DEPC  
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A total of 24.5µl of the master mix was added to each tube to which 0.5µl of the 
cDNA samples was added. The tubes were placed in the PCR machine and the 
appropriate programme was initiated. Initial denaturation for 2minutes at 95°C was 
followed by denaturation at 95°C for 1minute. The temperature was brought to 42-
60°C for annealing of the primers. Extension followed at 72°C for 1min/kb and 
final extension at the same temperature for 5 minutes. Following 25-35cycles, the 
samples were incubated at 4°C. 
For the primers –Electrophoresis 
The PCR products were separated by agarose gel electrophoresis. A 1X TAE buffer 
(40 mM Tris, 0.35 % v/v Acetic Acid, 0.5 mM EDTA) was poured into the 
electrophoresis apparatus A 1.5% w/v agarose gel was prepared with 100ml 1X 
TAE and 1.5g agarose powder. The solution was heated to dissolve and 10µl 
GelRed is added for DNA visualisation. A volume of 20µl of the PCR sample was 
added to each well and gel electrophoresis was carried out at 95V for 45minutes. A 
100bp or 1Kb DNA ladder was ran on the gel simultaneously to verify product size. 
Visualisation was carried out under UV light using a Biorad GelDoc System. PCR 
product was quantified using QuantityOne densitometry software. 
2.7.5  Real Time Quantitative PCR 
Quantitative PCR was carried out using the Applied Biosystems, StepOne 
Thermocycler. A mastermix containing 1 µl of cDNA, 5 µl SYBR green JumpStart 
Taq and primers at 400nM. The 10 µl SYBR mix was added to 96well plate and An 
initial denaturation step of 10 min at 95 ºC was carried out, followed by 40 cycles 
of 95ºC for 45 sec, annealing at 58ºC for 45 sec and extension for 1 min at 72ºC. A 
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final extension of 72ºC for 5 minutes was carried out on the final cycle. The samples 
were then cooled to 4ºC. 
The relative quantity of amplified PCR product was calculated using the 2^ -ΔΔCt 
method. Each sample ΔCt was compared to its GAPDH control, to generate the fold 
difference in PCR product. All samples and GAPDH controls were ran in duplicate.  
 GAPDH was chosen as a good housekeeping gene based on previous experiments 
in the lab (Dr. Emer Molloy, PhD thesis). In addition, actin and β-tubulin have been 
shown to be changed during EMT and as a GAPDH is an enzyme involved in 
glycolysis we believed it to be a more suitable housekeeping gene for experiments 
involving BMP-induced EMT-like processes.  
2.8 Immunofluorescence 
2.8.1 Methanol fixation 
This method of preservation was used on cell cultures growing in chamberwell 
slides prior to immunofluorescent staining. Medium was removed from each well 
and ice-cold PBS was used to rinse the cells three times. Methanol stored at -20ºC 
was gently pipetted down the well wall to fix the cells. The samples were incubated 
at -20ºC for five minutes. Methanol was blotted off and the samples were covered 
in parafilm and stored at -20ºC if not used immediately. 
2.8.2 Formaldehyde fixation 
This method of preservation was used on pig airways prior to immunofluorescent 
staining and histology. The samples were submerged in 10% formalin, neutral 
buffered solution for 24hrs at room temperature.  The samples were then placed in 
Materials and methods 
  
 
87 
 
plastic cassettes and loaded into the Thermo Scientific ™ Citadel 2000 tissue 
processor for overnight fixation. A series of dehydration steps in alcohol solutions 
and xylene were carried out over an 8 hour period. Once the final dehydration step 
was complete, the sample were incubated in molten paraffin wax.  
All cassettes were removed from the Thermo Scientific ™ Citadel 2000 tissue 
processor and placed in molten paraffin wax baths prior to embedding. The baths 
has been heated to 65ºC. Small plastic moulds 15mm x 15mm were used to embed 
the samples in paraffin wax. The well of the moulds was filled with wax before 
submerging the sample in the wax. A new plastic cassette was placed on top of the 
mould. The samples were labelled and allowed to cool. Once hardened, the plastic 
moulds were removed and the samples embedded in wax and fixed to the cassettes 
were stored at 4 ºC.  
A manual microtome was used to cut the paraffin embedded samples. All samples 
were cut at 5uM. Each section was mounted on positivity charged glass slides and 
incubated at 65 ºC for one hour to dry the samples to the slide. Slides were stored 
in cases at room temperature. 
2.8.3 Indirect immunofluorescence on cells 
Cells were removed from -20ºC and allowed to come to room temperature. 1 x Tris-
buffered saline (TBS: 0.01M-Tris, 0.15M-Nacl, pH 7.5) was added to each well for 
5 minutes to equilibrate the cells. The TBS was removed by blotting and 1% bovine 
serum-Tris solution was added. The cells were incubated at room temperature for 
30 minutes. This blocked non-specific binding sites such as Fc receptors on the 
surface of the cells.  
Materials and methods 
  
 
88 
 
Primary antibodies were prepared in TBS as per table. The primary antibody was 
pipetted onto each well and the chamberslides/plates were incubated at 4ºC 
overnight. Moist tissue was used as an incubating chamber to ensure the samples 
remained humidified during incubation.  When overnight incubation was complete, 
primary antibody was blotted off the cells and the cells were washed three times in 
0.1% v/v TBS-Tween20 solution. The cells were placed on a rocker at room 
temperature during each 5 minute wash. 
Secondary antibodies were prepared in 1% blocking solution at a 1/200 dilution. 
Cells were incubated for 30 minutes at room temperature in the dark. Cells were 
washed three times prior to secondary antibody incubation. Cells were 
counterstained with DAPI at 1/10000 for 5 minutes in the dark at room temperature. 
DAPI was blotted off and the cells were mounted with a coverslip using DAKO® 
Faramount aqueous mounting medium. Cells were viewed using an inverted 
Olympus IX81 fluorescent microscope. All software settings were kept consistent 
throughout imaging of controls and samples. Controls were prepared for all 
antibodies. Antibody controls were prepared where the primary antibody was 
omitted from the staining protocol. This controlled for non-specific fluorescent 
antibody staining.  Isotype controls were prepared where an irrelevant IgG was 
used. This controlled for non-specific primary antibody staining.   
2.8.4 Indirect immunofluorescence on tissue 
Paraffin-embedded samples on glass slides were de-waxed in xylene for 10 minutes 
(2 x 15minutes) in a chemical fume hood. The sections were rehydrated using a 
gradient of ethanol solutions. The slides were placed in 90% ethanol for 2 minutes, 
75% ethanol, for 2 minutes, 75% ethanol for 2 minutes and dH20 for 2 minutes. The 
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slides were then placed in a citrate based antigen retrieval solution (pH 6.0). The 
sections were boiled for 15 minutes (3 x 5 minutes). Sections were cooled in 
running tap water for 2-3 minutes. Once the slides had dried on the bench, an 
ImmEdge wax pen was used to encircle the tissue sections. The wax pen border was 
placed as close to the samples as possible to minimise the volume of antibody 
required. Blocking and antibody incubations were carried out as previously 
described. Briefly, the tissue sections were incubated in a 1% bovine serum solution 
to block non-specific receptors. Primary antibodies were incubated overnight at 4 
ºC in TBS. Sections were subsequently washed in 0.1% v/v TBS/Tween-20. 
Secondary antibodies were made up in the blocking solution and sections were 
incubated for 30 minutes in the dark at room temperature. Following a TBS/Tween-
20 wash, the cells were counterstained with DAPI. The slides were mounted with 
coverslips using DAKO faramount mounting medium.  
2.9 Histology 
2.9.1 H&E staining 
Following formaldehyde fixation and paraffin embedding, the slides were moved 
to the chemical fume hood and de-waxed in xylene for 10 minutes (2 x 5minutes). 
The samples were rehydrated in 100% ethanol for 5 minutes, 95% ethanol for 2 
minutes, 80% ethanol for 2 minutes and dH20 for 2 minutes. The slides were then 
placed in Harris haemotoxylin solution for 3 minutes and then rinsed in tap water 
for 40 seconds. The slides were submerged in 1% acid alcohol (1ml HCL, 69.3ml 
Isopropanol, 1ml dH20) for 5 minutes and rinsed in tap water for 5 minutes. The 
slides were then placed in Eosin Y solution (1g eosin powder, 1.6g Potassium 
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dichromate made up to 100ml dH20) for 3 minutes and rinsed in tap water for 40 
seconds. The slides were rehydrated in 80% ethanol for 5 minutes, 95% ethanol for 
5 minutes and 100% ethanol for 5 minutes. The slides were mounted with a 
coverslip using DPX mounting medium and viewed using a Olympus CX40 light 
microscope. 
2.9.2 PAS staining 
Following formaldehyde fixation and paraffin embedding, the slides were moved 
to the chemical fume hood and de-waxed in xylene for 10 minutes (2 x 5minutes). 
The samples were rehydrated in 100% ethanol for 5 minutes, 95% ethanol for 2 
minutes, 80% ethanol for 2 minutes and dH20 for 2 minutes. The slides were placed 
in 1% Alcian Blue in aqueous acetic acid solution for 15 minutes and then rinsed in 
tap water for 2 minutes. The slides were rinsed in dH20 before being placed in 0.5% 
Periodic Acid for 5 minutes. Following a rinse in dH20 the slides were place in 
Schiff’s reagent for 10 minutes and rinsed in tap water for 5 minutes. The samples 
were counter stained with Harris haematoxylin solution for 1 minute and rinsed in 
tap water for 2 minutes. Finally the slides were placed in 1% Acid alcohol for 20 
seconds before a 5 minute wash in tap water. The slides were rehydrated in 80% 
ethanol for 5 minutes, 95% ethanol for 5 minutes and 100% ethanol for 5 minutes. 
The slides were mounted with a coverslip using DPX mounting medium and viewed 
using a Olympus CX40 light microscope.  
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2.10 Western Blotting 
2.10.1 Protein harvest  
Cells in T25 flasks, 24 well plates or 12 well inserts were washed in ice-cold 
phosphate buffered saline (PBS) and scraped with a cell scraper or a pipette tip. The 
cells were centrifuged at 259 x g for 5 minutes at 4ºC.  The cell pellet was 
resuspended in chilled lysis buffer. Lysis buffer contained RIPA buffer (150 mM 
NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM 
Tris, pH 8.0) supplemented with 1x Complete Mini-Protease inhibitor cocktail. The 
samples were rocked for 15 minutes at 4ºC before being centrifuged at 12,000 x g 
for 5 minutes at 4ºC. The supernatant was collected and stored at -80ºC.  
For pig tracheal explants, the samples were cut into small segments and 
homogenized in lysis buffer for one minute on ice. The samples were rocked for 15 
minutes at 4ºC before being centrifuged at 12,000 x g for 5 minutes at 4ºC. The 
supernatant was collected and stored at -80ºC. 
2.10.2  Bradford Quantification 
Protein was quantified using a BioRad Bradford assay. A standard curve was 
prepared using bovine serum albumin ranging from 0 mg/ml to 1.4 mg/ml. Samples 
were diluted 1/10 and all samples and standards were prepared in duplicate in a 96 
well plate. Bradford reagent was added to the samples in a 1/50 dilution and the 
samples were incubated for 5 minutes. Absorbance was read at 620nm. The quantity 
of protein in the samples was calculated using the standard curve.  
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2.10.3  Sample preparation 
Following quantification of the samples, the samples were prepared for gel 
electrophoresis. A loading dye consisting of 1:20 solution of β-mercaptoethanol and 
2x loading buffer (Tris base, HCl, acrylamide, bisacrylamide, TEMED, APS, and 
highly purified water) was prepared. 15ug of protein was added to an equal volume 
of loading dye and the samples were boiled for 5 minutes at 95ºC. This process 
denatures the protein and allows protein separation during gel electrophoresis. The 
samples were placed on ice following the boiling step.  
2.10.4  Sodium Dodecyl Sulphate- Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
BioRad 4-20% mini-precast TGX gels were routinely used for gel electrophoresis. 
The gels were loaded into the cassettes and the chambers was filled with 1X Tris-
Glycine-SDS buffer (25 mM Tris, 192 mM glycine and 0.1% SDS, pH approx. 8.6). 
A chemiluminescent protein standard, MagicMark™ was loaded on each gel to 
track the molecular weight of the proteins (125 mM Tris-HCl (pH 6.8), 10 mM 
DTT, 17.4% Glycerol, 3% SDS, and 0.025% Bromophenol Blue). A colorimetric 
SeeBlue® ladder was added in the final lane to track correct protein separation and 
transfer (Tris-HCl, Formamide, SDS, and Phenol Red). Samples were loaded into 
the wells and the gel was electrophoresed at 200V for 45 minutes.  
2.10.5  Semi-dry transfer 
In the final five minutes of electrophoresis, two stacks of blotting paper and a 
nitrocellulose membrane were cut to size and equilibrated in 1x Transfer Buffer. 
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One stack of blotting paper was placed onto the tray of the BioRad Trans-Blot®  
Turbo™ System. The nitrocellulose membrane was placed on top of the blotting 
paper stack. Once electrophoresis was complete, the gel was removed from the 
running chamber and placed onto the membrane-blotting paper stack. The final 
blotting paper stack was placed on top of the gel and a roller was pressed across the 
sample to remove any air bubbles. The lid of the tray was replaced and the tray was 
inserted into the machine. The Trans-Blot® Turbo ™ 7 minutes programme for 
mixed molecular weights was carried out at 2.5A constant.  
2.10.6 Immunoblotting 
Following transfer, the gels were removed from the stack and placed in InstantBlue 
(Solubilisers, Coomassie Brilliant Blue, Phosphoric Acid, Ethanol) which stained 
any residual proteins present on the gel. This provided an additional control for 
correct transfer. The bottom right hand corner of the nitrocellulose membrane was 
scored for orientation and placed in a blocking solution of 20% BSA or dried milk 
powder in TBS-0.1 % Tween20 (5mM Tris, 150mM NaCl) depending on the 
primary antibody of choice. Blocking was carried out for 1hr at room temperature 
with gentle rocking. Phosphorylated antibodies were always blocked in BSA 
solution as casein present in milk would induce excessive background staining. 
Primary antibodies were incubated for 1hr at room temperature or overnight at 4ºC. 
Once incubation was complete, the blot was washed for 15 minutes (3 x 5 minutes) 
in 0.1% TBS-Tween-20 on the rocker. Secondary antibodies coupled to horseradish 
perioxidase-labelled (HRP labelled) were added for 1hr at room temperature. All 
secondary antibodies were made up in the blocking solution. Following secondary 
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incubation, the blot was washed for 15 minutes (3 x 5minutes) in 0.1% TBS-Tween-
20 on the rocker. The blot was placed in TBS solution before being developed. 
2.10.7  Chemiluminescence 
The blot was placed on cling film and the enhanced chemiluminescence (ECL) 
western blotting detection reagents WesternBrite were added for 2 minutes. 
Excessive solution was poured off the blot and the cling film was folded down on 
top of the blot. Visualisation of the proteins was carried out using a Syngene G-box 
Visualiser and the Genesys image acquisition software. The primate western blots 
were visualised using a Cell Biosciences FluorChem E. 
2.11 Flow Cytometry 
2.11.1 Sample preparation 
Cells growing in flasks or wells were rinsed with 1ml PBS before trypsinisation, as 
outlined above. Following 10minutes at 37 °C, the appropriate volume of FBS was 
added to neutralise the reaction. Cells were transferred to FACS tubes and 
centrifuged at 259*g for 5minutes at 4 °C. The supernatant was discarded and the 
cells were resuspended in PBS. Centrifugation at 259*g for 5 minutes at 4 °C was 
repeated. The final cell pellet was resuspended in a small volume of PBS to be read 
on the Accuri FACS machine.  
2.11.2 7AAD staining of pig tracheal explants 
Tracheal explants were removed from the culture medium and the epithelium was 
microdissected from the underlying cartilage and connective tissue. The epithelium 
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was placed in trypsin for 3 minutes at 37 °C. Following digestion, 1ml of FBS was 
added to neutralise the reaction. The cells were rinsed through a 70uM nylon mesh 
using a 10ml syringe pump. The cell suspension was centrifuged at 300*g for 5 
minutes and the supernatant was discarded. The pellet was resuspended in PBS to 
rinse. This washing step was repeated two times. Following final resuspension in 
60ul PBS, 3ul of 7AAD was added to the suspension and the Eppendorf was 
incubated for 15 minutes at 4 °C. 100ul of FACS buffer (1x PBS + 2% FBS) was 
added to the tube and the cells were spun at 300*g for 5 minutes at 4 °C. The 
supernatant was discarded and the cell pellet was resuspended in 100uL FACS 
buffer to be read on the Accuri FACS machine. An un-stained control was prepared 
for all timepoints and treatments. This allowed accurate gating of the stained cell 
population. 
2.12  Stereology 
2.12.1 Sample preparation 
Tissue mounted onto glass slides was processed for immunofluorescence as 
outlines in above in section 0  
2.12.2 Generation of DIC super-image 
A super-image of the entire epithelial surface on the slide was generated by 
determining the perimeter co-ordinates of the section. This super-image consisted 
of between 9 and 16 images stitched together by the software. A region of interest 
(ROI) was determined on the super-image by tracing around the epithelium and 
basal lamina using the marker tool in Stereology toolbox ®. This ROI was then 
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randomly sampled by the morphometric software, generating approximately 25 
sample images per section. A DIC and a fluorescent image was captured for each 
sample image to facilitate stereologic quantification. Stereology toolbox 
version1.1, Morphometrix, Davis, CA was used. 
2.12.3 Quantification of surface epithelial staining 
Using point and intercept counting on a cycloid grid, the volume of fluorescently 
labelled cells per unit basal lamina was quantified. This has previously been 
described in detail (Coppens et al. 2009). In brief, by counting the volume of 
positive cells per unit volume of interstitial epithelium (Vv) on the fluorescent 
image and the surface length of basal lamina per unit volume of the interstitial 
epithelium (Sv) on the corresponding DIC image, the number of positive cells per 
unit length of basal lamina was calculated (Vs). The following equation was used 
where P= number of points counted, I= intersections, bl=basal lamina, 
epi=epithelium, l/p = length per point which was calculated as 86µm, txred= Alexa 
568 positive stain).   
Volume per volume Vv Calculation:  Vv txred/epi = Ptxred / (Pepi  + Ptxred) 
Surface per volume Sv Calculation:  Sv bl/epi = ((*Ibl)/2) / ((l/p)*Pepi)  
Volume per surface Vs Calculation:  Vs txred/bl = Vv txred/epi / Sv bl/epi 
All exposure settings were maintained at constant milliseconds based on the 
negative secondary IgG control. The calculations were corrected for the grid size 
used. Statistical analysis was calculated using One-Way ANOVA tests and paired 
2-tailed t-test in Prism Version 5.00. p values less than 0.05 were considered 
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significant. Immunofluorescent images and DIC images were captured on an 
Olympus BX61 and Metamorph software. 
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3 Chapter 3 
The effect of BMP-related signalling 
on the lung cancer cell line DLKP  
 
3.1  Introduction 
Tumour heterogeneity defines the differences that exist between cancer cells in a 
tumour (intra-tumour heterogeneity). (Burrell et al. 2013). Tumour heterogeneity 
can arise by genetic or non-genetic means. Tumour heterogeneity is also introduced 
by dynamic phenotypic switching events between the different cancer 
subpopulations (Ferrao et al. 2015; Marusyk et al. 2012) 
Phenotypic switching involves changes in cellular and molecular signalling events 
to adopt a more advantageous phenotype in a given environment. This can occur in 
heterogeneous tumour cells to facilitate evasion of chemotherapeutic stresses or to 
increase the survival of the cancer by forming metastatic tumours (Sharma et al. 
2010). EMT has been implicated in the process of phenotypic switching in cancer 
and tumour progression. EMT makes tumour cells more invasive and causes them 
to be released into the circulation and establish distant metastatic sites (Lee et al, 
2006; Pierre Savagner, 2007; Talmadge, 2007).  EMT involves changing from an 
organised, polarised, adherent epithelial cell to an invasive, elongated mesenchymal 
cell. The process involves downregulation of the tumour-suppressor and adherens 
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junction protein E-cadherin and other cell adhesion proteins in conjunction with 
upregulation of matrix degrading enzymes (Kalluri and Weinberg 2009).  
The DLKP lung cancer cell lines contains three distinct clonal subpopulations 
designated DLKP-SQ, DLKP-M and DLKP-I. DLKP-SQ cells grow in small 
squamous-shaped colonies. DLKP-M cells are larger and more mesenchymal with 
extended neurite-like processes. DLKP-I cells are the smallest of the three clones 
and grow in tightly packed colonies with a distinct outer boundary. Interestingly, 
when the parental population are grown in culture, interconversion events are 
evident between DLKP-SQ, DLKP-M and DLKP-I clones (Mcbride et al. 1998). 
These interconversion events resemble phenotypic switching in this heterogenous 
tumour population. In order to determine the role of EMT in phenotype switching 
between these two clonal populations, we investigated the effect of modulating the 
BMP signalling pathway. 
Previous literature has shown that EMT is a critical process involved in 
embryogenesis and correct organ formation. During wound healing and normal 
reparative processes, epithelial cells downregulate adherens junction proteins and 
undergo EMT to migrate onto the damaged area and restore epithelial integrity. 
EMT is also linked to tumour progression and the formation metastases (Kalluri 
and Weinberg 2009). Our lab has previously demonstrated a relationship between 
EMT and the BMP pathway, reviewed in (McCormack and O’Dea 2013).. BMP 
mediated signalling can induce a mesenchymal and migratory phenotype in the 
normal bronchial epithelial cell line Beas2b and also in normal primary airway 
epithelial cells (AECs). Furthermore, BMPs increase the rate of cell migration of 
AECs during epithelial restitution (McCormack et al. 2013; Molloy et al. 2008). In 
this study we investigated the role of the BMP signalling in the induction of EMT 
E-cadherin gene processing in DLKP 
  
 
101 
 
and the control of the phenotypic switching events that occur between the clonal 
subpopulations of the DLKP cell line. 
Given the distinct morphological differences that exist between the DLKP clones 
and the spontaneous interconversion events that occur in parental DLKP cell 
culture, we hypothesise that the DLKP-SQ and DLKP-M clones may be an ideal 
model for investigating phenotypic switching between heterogeneous tumour 
populations. We propose that DLKP-SQ cells are a more “epithelial”-like clonal 
population that represent normal cells more closely than DLKP-M cells.  
We hypothesise that by agonising and antagonising the BMP pathway we could 
induce phenotypic switching between these clonal populations (Figure 3.1).   
Following BMP-4 stimulation we hypothesise that DLKP-SQ cells would undergo 
EMT and resemble DLKP-M clones. Conversely, we speculate that DLKP-M cells 
treated with gremlin would undergo MET, or partial MET and convert to DLKP-
SQ or DLKP-I cells. We hypothesise that there would be no change in DLKP-M 
cells treated with BMP-4 as they already represent a mesenchymal, migratory 
clonal population. Finally, given the spontaneous interconversion events which 
occurred between DLKP-SQ and DLKP-M cells in culture we hypothesised that 
DLKP-I cells represented a stem cell-like clone capable of readily undergoing 
phenotypic switching events. We hypothesise that DLKP-I would convert to the 
more mesenchymal DLKP-M cells following BMP-4 stimulation and DLKP-SQ 
cells following gremlin stimulation.  
  
+ gremlin 
DLKP-I 
DLKP-SQ DLKP-M 
+ BMP-4 
Figure 3.0.1 Hypothesis of BMP-mediated phenotypic switching in DLKP 
clones 
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3.1.1 Expression of tight junction proteins in DLKP-SQ, DLKP-
M and DLKP-I clones  
Given the morphological differences that exist between the DLKP-SQ, DLKP-M 
and DLKP-I clones, we hypothesised that the DLKP-SQ clones represent a more 
epithelial-like cell population. We hypothesised that DLKP-M have undergone 
phenotypic changes to become a more mesenchymal cell population. As tight 
junction proteins (TJP) are expressed in epithelial cells, we examined the 
expression levels of TJP in the DLKP clones by western blot.  
Significant differences in the expression of TJP was observed between DLKP-SQ, 
DLKP-I and DLKP-M clones. DLKP-SQ and DLKP-I cells express afadin, ZO-1 
and claudin-1 while DLKP-M cells do not. CD2AP was the only tight junction 
protein examined that was expressed in all DLKP cell lines (Figure 3.0.2). These 
results supported the hypothesis that DLKP-SQ represented a more differentiated, 
epithelial-like cell population compared to DLKP-M cells. 
GAPDH was chosen as a suitable housekeeping gene as protein expression 
remained unchanged between experiments irrespective of treatments and 
stimulations. GAPDH was a more suitable than other common housekeeper genes 
such as actin or tubulin as their expression can change following BMP-4 treatment 
and during EMT. 
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Figure 3.0.2 Western blot of tight junction proteins in DLKP-SQ, DLKP-M 
and DLKP-I cells 
Representative western blots of claudin-1, afadin, ZO-1 and CD2AP in DLKP-SQ, 
DLKP-M and DLKP-I clones. There was no detectable expression of afadin, ZO-1 
or claudin-1 in DLKP-M compared to DLKP-SQ and DLKP-M. CD2AP was 
expressed in all cell lines. GAPDH was used as a loading control, n=2.  
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3.1.2 Gene expression analysis of DLKP-SQ, DLKP-M, DLKP-I 
Gene expression analysis was carried out on the DLKP clones to examine BMP 
receptor and ligand expression. This was carried out by our collaborators in DCU 
(Dr Helena Joyce). DLKP-SQ expressed the highest level of BMPRIa protein. 
DLKP-M expressed the highest level of BMPRII. Analysis of endogenous BMP-7 
mRNA revealed that DLKP-SQ cells expressed higher levels of this BMP ligand 
compared to DLKP-I. Unfortunately no information was available for DLKP-M 
cells, but we hypothesise a similar level of expression to DLKP-I cells. In addition, 
DLKP-M and DLKP-I expressed higher levels of CRMP-1, α-integrin-V and scatter 
factor expression compared to DLKP-SQ (Figure 3.0.3, Appendix).  
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Figure 3.0.3 Gene expression analysis of DLKP clones 
Gene expression analysis of endogenous mRNA expression of BMP receptors 
and mesenchymal markers was investigated in the three subclonal DLKP 
populations. This work was carried out by our collaborator Dr. Helena Joyce 
in DCU. DLKP-SQ expressed higher BMPRIa levels compared to DLKP-M 
and DLKP-I. DLKP-M expressed higher levels of BMPRII compared to 
DLKP-SQ and DLKP-I. DLKP-SQ expressed the lowest level of CRMP-1, 
α-integrin-V and scatter factor genes.  Statistical significance was obtained 
using a One-way ANOVA test, * p<0.05, ** p<0.005, *** p<0.0005  n=3 
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3.1.3 BMP pathway activation in DLKP-SQ following BMP-4 
stimulation 
To assess whether DLKP-SQ clones respond to BMP stimulation, the cells were 
cultured in the presence of 100 ng/ml BMP-4 for 24 hrs. Serial dilution and 
timecourse experiments previously carried out in the O’Dea lab determined that this 
concentration of BMP-4 ligand was optimal (Dr. Natasha McCormack). The level 
of activation and localised expression of various SMAD signalling molecules were 
investigated by immunofluorescence. DLKP-SQ cells were also grown in the 
presence of 100 ng/ml BMP-4 for 2hr, 4hr and 24hr to assess ID-1, SMAD-6 and 
SMAD-7 mRNA expression. 
The expression of SMAD-1 and SMAD-5 did not appear altered in response to 
BMP-4 treatment at 24 hrs (Figure 3.0.4). SMAD-1 and SMAD-5 were localised in 
the cytoplasm of the DLKP-SQ cells which remained unchanged following BMP-
4 treatment. SMAD-4 was evident in the cytoplasm in untreated DLKP-SQ cells. 
Following 24 hrs, SMAD-4 was localised in the nucleus (Figure 3.0.4 i-l). 
Similarly, elevated nuclear expression of pSMAD 1/5/8 occurred in DLKP-SQ cells 
treated with BMP-4 compared to control cells. There was some evidence of nuclear 
pSMAD 1/5/8 localisation in the untreated DLKP-SQ cells (Figure 3.0.4 m-p).  
Larger images are presented in the appendix (Figure 8.0.11). 
SMAD-6 expression was localised in the cytoplasm in the untreated DLKP-SQ cells 
whereas increased nuclear protein expression was present in cells stimulated for 24 
hrs (Figure 3.0.4 q-t).  SMAD-7 protein localisation was altered from the cytoplasm 
to the nucleus following BMP-4 stimulation for 24 hrs, as indicated by the white 
arrows (Figure 3.0.4 u-x).  
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The expression of ID-1, SMAD-6 and SMAD-7 mRNA was examined by rt-PCR. 
ID-1 expression increased in a time-dependent manner following BMP-4 
stimulation. There was no significant change in SMAD-6 and SMAD-7 mRNA 
expression occurs following BMP-4 treatment (Figure 3.0.5). 
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Figure 3.0.4 Immunofluorescence of intracellular SMAD signalling in 
DLKP-SQ cells following BMP-4 stimulation 
Representative micrographs of SMAD-1 (a-d), SMAD-4 (e-h) , SMAD-5 (i-l) , 
pSMAD-1/5/8 (m-p), SMAD-6 (q-t) and SMAD-7 (u-x) localisation in DLKP-
SQ cultured with 100ng/ml BMP-4 for 24 hrs. There is little evidence of altered 
SMAD-1 (a-d) and SMAD-5 (i-k) signalling following 24 hr BMP-4 treatment. 
Nuclear translocation of SMAD-4 (e-h) and pSMAD 1/5/8 (m-p) from the 
cytoplasm was evident following BMP-4 treatment, as indicated by the arrows. 
iSMADs SMAD-6 (q-t) and SMAD-7 ( u-x) were expressed in the nucleus 
following BMP-4 treatment. All scale bars represent 50uM, white arrows indicate 
relative cytoplasmic or nuclear staining n=2. Additional images are included in 
the appendix. 
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Figure 3.0.5 mRNA expression of ID-1, SMAD-6 and SMAD-7 following 
BMP-4 stimulation in DLKP-SQ cells 
Representative graphs of quantified ID-1, SMAD-6 and SMAD-7 mRNA 
expression in DLKP-SQ cells following 2 hr, 4 hr, 24 hr treatment with 100 ng/ml 
BMP-4. (A) ID-1 is an early responder to the BMP-4 stimulation and increases in 
transcript expression can be seen in a time dependent manner. (B)(C) No significant 
change in SMAD-6 or SMAD-7 expression was evident following statistical 
anaylsis. n=3 
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3.1.4 BMP pathway activation in DLKP-M following BMP-4 
stimulation 
To assess whether DLKP-M clones are responsive to BMP signal activation, the 
cells were cultured in the presence of 100 ng/ml BMP-4 for 24 hrs. The level of 
activation and localised expression of various SMAD signalling molecules were 
investigated. DLKP-M cells were also grown in the presence of 100 ng/ml BMP-4 
for 2hr, 4hr and 24hr to assess the level of ID-1, SMAD-6 and SMAD-7 mRNA 
expression.  
SMAD-1 and SMAD-5 were detected in the cytoplasm and peri-nuclear region in 
both untreated and treated DLKP-M cells (Figure 3.0.6 a-h). Examination of 
SMAD-4 localisation showed increased nuclear translocation of SMAD-4 
following 24 hr stimulation with 100 ng/ml BMP-4, as indicated by the white 
arrows (Figure 3.0.6 i-l). Similarly, bright nuclear pSMAD 1/5/8 expression was 
apparent in DLKP-M cells following 24 hr BMP-4 treatment (Figure 3.0.6 m-p). 
This increase in nuclear localisation of pSMAD 1/5/8 is highlighted by the white 
arrows. Similar to DLKP-SQ cells, endogenous nuclear pSMAD 1/5/8 was present 
in untreated DLKP-M cells. Elevated cytoplasmic and nuclear SMAD-6 staining 
was present in BMP-4 treated DLKP-M cells (Figure 3.0.6 q-t). Similarly, SMAD-
7 was localised in the cytoplasm in untreated DLKP-M cells. Increased nuclear 
localisation of SMAD-7 occurred following BMP-4 stimulation (Figure 3.0.6 u-x). 
Larger images are presented in the appendix (Figure 8.0.12). 
The expression of ID-1, SMAD-6 and SMAD-7 mRNA was examined by rt-PCR. 
ID-1 expression increased in a time-dependent manner following BMP-4 
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stimulation. There was no significant change in SMAD-6 and SMAD-7 mRNA 
expression occurs following BMP-4 treatment (Figure 3.0.7). 
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Figure 3.0.6 Immunofluorescence of intracellular SMAD signalling in DLKP-
M cells following BMP-4 stimulation 
Representative micrographs of SMAD-1 (a-d), SMAD-4 (e-h) , SMAD-5 (i-l) , 
pSMAD-1/5/8 (m-p), SMAD-6 (q-t) and SMAD-7 (u-x) localisation in DLKP-M 
cells cultured with 100ng/ml BMP-4 for 24 hrs. SMAD-1 was localised in the 
cytoplasm and around the nucleus in treated and untreated cells (a-d). There was 
no change in the weak peri-nuclear and cytoplasmic staining of SMAD-5 
following treatment (e-h). Both SMAD-4 and pSMAD 1/5/8 localisation became 
nuclear following exposure to BMP-4 (i-l). SMAD-6 expression was increased in 
the cytoplasm with increased nuclear translocation (q-t). SMAD-7 was 
translocated from the cytoplasm to the nucleus. All scale bars represent 50uM, 
white arrows indicate relative cytoplasmic or nuclear staining, n=2 
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Figure 3.0.7 mRNA expression of ID-1, SMAD-6 and SMAD-7 following BMP-
4 stimulation in DLKP-M cells 
Representative graphs of quantified ID-1, SMAD-6 and SMAD-7 mRNA 
expression in DLKP-M cells following 2 hr, 4 hr, 24 hr treatment with 100 ng/ml 
BMP-4. (A) ID-1 increased in a time dependent manner following BMP-4 
stimulation (B)(C) No change in SMAD-6 or SMAD-7 expression was evident 
following statistical analysis. n=3 
A 
B 
C 
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3.1.5 BMP pathway activation in DLKP-I following BMP-4 
stimulation 
To assess whether DLKP-I cells BMP signals, the cells were cultured in the 
presence of 100 ng/ml BMP-4 for 24 hrs. The level of activation and localised 
expression of various SMAD signalling molecules were investigated. DLKP-I cells 
were also grown in the presence of 100 ng/ml BMP-4 for 2hr, 4hr and 24hr to assess 
the level of ID-1, SMAD-6 and SMAD-7 mRNA expression. 
Similar to both DLKP-SQ and DLKP-M cells, SMAD-1 and SMAD-5 expression 
in DLKP-I remained unchanged following 24 hr BMP-4 treatment. SMAD-1 and 
SMAD-5 were detected in the cytoplasm and peri-nuclear straining could be seen 
in the untreated and treated cells alike (Figure 3.0.8 a-h). Increased nuclear 
localisation of SMAD-4 was detected following BMP-4 stimulation (Figure 3.0.8 
i-l). Similarly, an elevated level of nuclear pSMAD 1/5/8 was present in BMP-4 
treated cells (Figure 3.0.8 m-p). Elevated levels of both iSMADs were evident in 
the cytoplasm and nucleus following BMP-4 treatment (Figure 3.0.8 q-x). Larger 
images are presented in the appendix (Figure 8.0.13). 
The expression of ID-1, SMAD-6 and SMAD-7 mRNA was examined by rt-PCR. 
ID-1 expression increased in a time-dependent manner following BMP-4 
stimulation. There was no significant change in SMAD-6 and SMAD-7 mRNA 
expression occurs following BMP-4 treatment of DLKP-I cells (Figure 3.0.9). 
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Figure 3.0.8 Immunofluorescence of intracellular SMAD signalling in DLKP-
I cells following BMP-4 stimulation 
Representative photomicrographs of SMAD-1 (a-d), SMAD-4 (e-h) , SMAD-5 (i-
l) , pSMAD-1/5/8 (m-p), SMAD-6 (q-t) and SMAD-7 (u-x) localisation in DLKP-
I cells cultured with 100ng/ml BMP-4 for 24 hrs. SMAD-1 was localised in peri-
nuclear patterns and in the cytoplasm and expression was elevated in the same 
regions following BMP-4 treatment for 24 hrs (a-d). SMAD-5 was detected in the 
cytoplasm and in peri-nuclear regions in both the control cells and following BMP-
4 treatment (e-h). There was evidence of elevated nuclear localisation of both 
SMAD-4 (i-l) and pSMAD 1/5/8 (m-p) following BMP-4 stimulation. SMAD-6 
was localised in the nucleus in treated and untreated cells (q-r) SMAD-7 was 
present in cytoplasmic and nuclear localisation occurred following BMP-4 
stimulation. All scale bars represent 50uM, white arrows indicate relative 
cytoplasmic or nuclear staining n=2 
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Figure 3.0.9 mRNA expression of ID-1, SMAD-6 and SMAD-7 following BMP-
4 stimulation in DLKP-I cells 
Representative graphs of quantified ID-1, SMAD-6 and SMAD-7 mRNA 
expression in DLKP-I cells following 2 hr, 4 hr, 24 hr treatment with 100 ng/ml 
BMP-4. (A) ID-1 mRNA expression increased in a time dependent manner 
following BMP-4 stimulation (B)(C) No change in SMAD-6 or SMAD-7 
expression was evident following statistical analysis. n=3 
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3.1.6 Morphological changes in DLKP-SQ following BMP-4 and 
gremlin stimulation 
Given the previous results that demonstrated DLKP-SQ cells are responsive to 
BMP-4 stimulation, we wanted to determine if BMP-4 induced EMT-mediated 
phenotypic switching in this squamous, epithelial-like population. Changes in 
morphology were assessed over 5 days (day 1, day 3 and day5) following 
stimulation with 100 ng/ml BMP-4 or 3 ng/ml gremlin. The cells were grown in 
0.25% serum-containing medium as serum-free medium was suboptimal for 
growing DLKP clones (Mcbride et al. 1998).  
DLKP-SQ treated with 100 ng/ml BMP-4 adopted a mesenchymal phenotype after 
one day in culture. The treated cells displayed reduced cell-cell contact compared 
to control cells and neurite-like extended cytoplasmic processes began to form, as 
highlighted by the white arrow in Figure 3.0.10 A. This mesenchymal transition 
was maintained to day 5 post-stimulation. BMP-4 has a half-life of approximately 
48-72 hr suggesting autocrine BMP-4 activity may be present at day 5. The DLKP-
SQ cells adopted a mesenchymal-like phenotype by day 5. Untreated DLKP-SQ 
growing in 0.25% medium grew in tightly packed colonies with characteristic 
“cobblestones” formations and cell-cell contact. No evidence of EMT was detected 
in the untreated cell populations at day 1, day 3 and day 5 (Figure 3.0.10).  
DLKP-SQ cells treated with gremlin displayed similar morphology to untreated 
cells (Figure 3.0.10 B). Tightly packed “cobblestone”-like colonies grew in both 
treated and untreated cell populations. No apparent loss of cell contact was evident 
in gremlin-treated cells and no EMT was present.  
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Figure 3.0.10 BMP-4 and gremlin treatment induced morphological changes 
in DLKP-SQ cells 
Representative micrographs of DLKP-SQ at day 1, day 3 and day 5 in 0.25% serum 
containing medium with 100ng/ml BMP-4 and 3ng/ml gremlin. (A) Untreated cells 
were squamous with cobblestone-like morphology (a-c). BMP-4 treatment at day 
1, day 3 and day 5 induced a mesenchymal-like cell phenotype and cytoplasmic 
extensions in DLKP-SQ cells (d-f) as indicated by the white arrows. (B) Untreated 
DLKP-SQ cells were squamous with distinct cell boundaries (g-i). Gremlin 
treatment at day 1, day 3 and day 5 maintained the squamous-like phenotype and 
prevented the formation of any mesenchymal extensions as seen following BMP-4 
treatment (j-l). All scales bars represent 50uM, n=3  
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3.1.7 Morphological changes in DLKP-M following BMP-4 and 
gremlin stimulation 
Previous results here demonstrated that DLKP-M cells are responsive to BMP-4 
induced SMAD signalling and downstream target activation. To assess the role of 
BMP-4 in EMT-mediated phenotypic switching, changes in DLKP-M morphology 
were assessed over 5 days (day 1, day 3 and day5) following treatment with 100 
ng/ml BMP-4 or 3 ng/ml gremlin. The cells were grown in 0.25% serum-containing 
medium as serum-free medium had previously been deemed suboptimal for 
growing DLKP clones (Mcbride et al. 1998).  
Untreated DLKP-M cells grew as large, mesenchymal-like cells with extended 
neurite-like processes in reduced serum conditions. Following BMP-4 simulation a 
striking change in cell morphology was detected. DLKP-M cells began to join 
together and lose their individual cell morphology by day 1. On day 3, large 
colonies of DLKP-M cells had formed with bright, distinct outer boundaries. The 
individual cell membranes were no longer distinguishable and the colony appeared 
as one mass of cells. On day 5, the colonies of DLKP-M had undergone extensive 
morphological changes and the bulbous structure indicated that cell piling and 
aggregation had taken place. A distinct cell boundary was evident around the colony 
(Figure 3.0.11 A).  
Morphological changes in DLKP-M cells following treatment with 3 ng/ml gremlin 
for 1, 3 and 5 days were examined by brightfield microscopy. An increase in cell 
contact between gremlin treated DLKP-M cells was detected at day 5 and smaller, 
tightly packed colonies emerged (Figure 3.0.11 B).  
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Figure 3.0.11 BMP-4 and gremlin treatment induced morphological changes 
in DLKP-M cells 
Representative micrographs of DLKP-M at day 1, day 3 and day 5 in 0.25% serum 
containing medium with 100ng/ml BMP-4 and 3ng/ml gremlin. (A) Untreated cells 
had a mesenchymal-like phenotype with extended processes (a-c). BMP-4 
treatment caused the cells to form colonies with distinct outer boundaries. By day 
5, a mass had formed with a bright outer boundary (d-f). (B) Untreated DLKP-M 
cells were mesenchymal with extended neurite-like processes (g-i). DLKP-M cells 
following gremlin treatment for 1,3 and 5 days become more isolated from the 
surrounding cells with shorter cell processes (j-l). All scales bars represent 50uM, 
n=3  
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3.1.8 Morphological changes in DLKP-I following BMP-4 and 
gremlin stimulation 
Previous results presented here established that DLKP-I cells are responsive to 
BMP-4 induced SMAD signalling. To assess the role of BMP-4 in EMT-mediated 
phenotypic switching, changes in DLKP-I morphology were assessed over 5 days 
(day 1, day 3 and day5) following treatment with 100 ng/ml BMP-4 or 3 ng/ml 
Gremlin. The cells were grown in 0.25% serum-containing medium as serum-free 
medium was deemed suboptimal for growing DLKP clones (Mcbride et al. 1998).  
DLKP-I cells grew in small tightly packed colonies that displayed indistinct 
boundaries between individual cells but a bright, well-defined border between 
colonies. Cells treated with BMP-4 formed larger colonies with defined boundaries. 
The cells resembled DLKP-M cells treated with BMP-4 (Figure 3.0.12 A).  
Growing DLKP-I cells in the presence of 3 ng/ml Gremlin for up to five days 
induced a significant change in morphology. DLKP-I displayed increased cell-cell 
contact and formed small, tightly packed colonies that resemble the “cobblestone” 
morphology of DLKP-SQ cells (Figure 3.0.12 B).  
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Figure 3.0.12 BMP-4 and gremlin treatment induced morphological changes 
in DLKP-I cells 
Representative micrographs of DLKP-I at day 1, day 3 and day 5 in 0.25% serum 
containing medium with 100ng/ml BMP-4 and 3ng/ml Gremlin. (A) Untreated 
DLKP-I cells grew in tightly packed colonies with indistinct cell boundaries 
between the cells. There is evidence of some DLKP-SQ and DLKP-M at the 
periphery of the colonies (a-c). BMP-4 treatment caused the cells to form more 
colonies (d-f). (B) Untreated DLKP-I cells grew in packed colonies with some 
conversion to DLKP-SQ and DLKP-M at the periphery of the colonies (g-i). DLKP-
I cells following gremlin treatment for 1,3 and 5 days adopted DLKP-SQ phenotype 
and grew as tightly packed squamous-like colonies with distinct cell boundaries (j-
l). All scales bars represent 50uM, n=3  
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3.1.9 Expression of EMT markers in DLKP-SQ following BMP-4 
stimulation 
Following the observation that BMP-4 treatment caused morphological changes in 
DLKP-SQ towards a more mesenchymal cell phenotype that resembled the DLKP-
M clone, we investigated if the expression and localisation of EMT-related 
structural proteins were altered in this process. Immunofluorescence performed at 
day 1, day 3 and day 5 and targets included vimentin, α –smooth muscle actin 
(SMA), β-catenin, N-cadherin, E-cadherin and actin.  
Untreated DLKP-SQ cells displayed weak cytoplasmic vimentin staining at day 1, 
3 and 5 however, following BMP-4 stimulation, elevated vimentin protein 
expression was detected at all time points (Figure 3.0.13-15 a-d). Vimentin was 
localised at the extended processes of the DLKP-SQ cells treated with BMP-4 
ligand. The increase in vimentin expression following BMP-4 treatment was 
examined by western blot. Increased vimentin expression was detected at all time 
points and significantly higher protein expression was confirmed at day 3 and day 
5 by densitometry (Figure 3.0.16). 
Weak cytoplasmic staining of α –SMA was detected in the DLKP-SQ untreated 
populations at all time points. Following BMP-4 stimulation, slight increases in α 
–SMA protein expression were detected by immunofluorescence (Figure 3.0.13-15 
c-h).  
No change in β-catenin, N-cadherin or E-cadherin was detected at any of the time 
points following BMP-4 stimulation (Figure 3.0.13-15 i-l, m-p, q-t). Weak 
cytoplasmic staining of the three epithelial-like cell markers was evident in both 
treated and untreated cell.  
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Localisation of the cytoskeletal marker actin was investigated by 
immunofluorescence. Evidence of peri-nuclear actin staining was detected in 
DLKP-SQ cells treated with BMP-4 at all time points compared to cytoplasmic 
staining in untreated cells (Figure 3.0.13-15 u-x).   
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Figure 3.0.13 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-SQ cells at day 1 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-SQ at day 1 post stimulation with 
100ng/ml BMP-4 in 0.25% serum containing medium. Elevated levels 
cytoplasmic vimentin and α –SMA were present following BMP-4 treatment. 
Peri-nuclear staining of actin was detected in treated cells. No change in β-
catenin, N-cadherin and E-cadherin was detected following BMP-4 stimulation. 
Changes in expression are highlighted by the white arrows, scale bars represent 
50uM, n=2. 
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Figure 3.0.14 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-SQ cells at day 3 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-SQ at day 3 in 0.25% serum containing 
medium with 100ng/ml BMP-4. Elevated levels cytoplasmic vimentin and α –SMA 
were detected following BMP-4 treatment. Peri-nuclear staining of actin was 
present in treated cells. No change in β-catenin, N-cadherin and E-cadherin was 
detected following BMP-4 stimulation. Changes in expression are highlighted by 
the white arrows, scale bars represent 50uM, n=2 
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Figure 3.0.15 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-SQ cells at day 5 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-SQ at day 5 in 0.25% serum containing 
medium with 100ng/ml BMP-4. Elevated levels of cytoplasmic vimentin and α –
SMA were detected following BMP-4 treatment. Peri-nuclear staining of actin was 
evident in treated cells. No change in β-catenin, N-cadherin and E-cadherin was 
seen following BMP-4 stimulation. Changes in expression are highlighted by the 
white arrows, scale bars represent 50uM, n=2. 
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Figure 3.0.16 BMP-4 treatment induced elevated vimentin expression in 
DLKP-SQ 
(A) Representative blots of vimentin at day1, day3 and day5 in DLKP-SQ cells 
treated with 100ng/ml BMP-4. (B) Densitometry revealed a statistically significant 
increase in expression at day 3 and day 5, * = p<0.05, n=3 
Day1                      Day3                Day5 
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3.1.10 Expression of EMT markers in DLKP-M following BMP-4 
stimulation 
Following the observation that BMP-4 treatment caused morphological changes in 
DLKP-M, we investigated if the expression and localisation of EMT-related 
structural proteins were altered. Immunofluorescence was performed at day 1, day 
3 and day 5 and targets included vimentin, α-SMA, β-catenin, N-cadherin, E-
cadherin and actin.  
Elevated cytoplasmic vimentin expression was detected in DLKP-M cells following 
BMP-4 stimulation at day 1, day 3 and day 5, by immunofluorescence. Vimentin 
was present at the extended processes of the DLKP-M cells and at the boundary of 
the newly formed colonies (Figure 3.0.17 -19 a-d). The level of increased vimentin 
expression was determined by western blot and quantified by densitometry. 
Vimentin expression was significantly increased at day 5 (Figure 3.0.20). 
Peri-nuclear and cytoplasmic staining of α-SMA was detected in DLKP-M cells at 
all time points (Figure 3.0.17-19 e-h). β-catenin was localised at the cell membrane 
as a “chickenwire”-like pattern in untreated and treated DLKP-M cells (Figure 
3.0.17-19 i-l). Neither α-SMA or β-catenin localisation was altered following BMP-
4 treatment. Western blotting revealed a significant increase in β-catenin protein 
expression in DLKP-M cells stimulated with BMP-4 at day 3 and day 5 (Figure 
3.0.21).  
N-cadherin was localised at the cell membrane of DLKP-M cells (Figure 3.0.17 m-
p). Following BMP-4 treatment, no change in N-cadherin localisation was detected. 
A significant increase in N-cadherin expression at day 3 was determined by western 
blot and densitometry (Figure 3.0.22). 
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Weak cytoplasmic expression of E-cadherin was detected in untreated DLKP-M 
cells. No change in E-cadherin localisation or expression occurred in DLKP-M cells 
following BMP-4 treatment (Figure 3.0.17-19 q-t).  
Finally, actin localisation was investigated by immunofluorescence. Cytoplasmic 
and peri-nuclear actin expression was present in untreated and treated DLKP-M 
cells at day 1, day3 and day 5 (Figure 3.0.17 u-v).  
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Figure 3.0.17 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-M cells at day 1 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-M at day 1 in 0.25% serum containing 
medium with 100ng/ml BMP-4. Increased expression of vimentin, α -SMA, β-
catenin, N-cadherin was evident following BMP-4 treatment. Elevated peri-nuclear 
actin staining was detected in treated cells. No change in E-cadherin staining 
occurred. White arrows indicate changes in protein localisation, scale bars represent 
50uM, n=2. 
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Figure 3.0.18 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-M cells at day 3 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-M at day 3 in 0.25% serum containing 
medium with 100ng/ml BMP-4. Increased expression of vimentin, α -SMA, β-
catenin, N-cadherin was evident following BMP-4 treatment. Elevated peri-
nuclear actin staining was present in treated cells. No change in E-cadherin staining 
occurred. White arrows indicate changes in protein localisation, scale bars 
represent 50uM, n=2. 
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Figure 3.0.19 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-M cells at day 5 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-M at day 5 in 0.25% serum containing 
medium with 100ng/ml BMP-4. Increased expression of vimentin, α -SMA, β-
catenin, N-cadherin was detected following BMP-4 treatment. Elevated peri-
nuclear actin staining was present in treated cells. No change in E-cadherin staining 
occurred. White arrows indicate changes in protein localisation, scale bars represent 
50uM, n=2. 
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Figure 3.0.20 BMP-4 treatment induced elevated vimentin expression in 
DLKP-M 
A) Representative blots of vimentin at day1, day3 and day5 in DLKP-M cells 
treated with 100ng/ml BMP-4. (B) Densitometry revealed a statistically significant 
increase in expression at day 5, * = p<0.05, n=3 
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Figure 3.0.21 BMP-4 treatment induced elevated β -catenin expression in 
DLKP-M cells 
(A) Representative blots of β-catenin at day1, day3 and day5 in DLKP-M cells 
treated with 100ng/ml BMP-4. Elevated protein expression was detected (B) 
Densitometry a revealed a statistically significant increase in protein expression at 
day 3 and day 5, * = p<0.05, n=3 
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Figure 3.0.22 BMP-4 treatment induced elevated N-cadherin expression 
in DLKP-M cells 
(A) Representative blots of N-cadherin at day1, day3 and day5 in DLKP-M 
cells treated with 100ng/ml BMP-4. Elevated protein expression was seen (B) 
Densitometry revealed a significant increase N-cadherin expression at day 3. 
*=p<0.05, n=3 
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3.1.11 Expression of EMT markers in DLKP-I following BMP-4 
stimulation 
Although BMP-4 treatment of DLKP-I cells did not induce extensive 
morphological changes compared to gremlin treatment, we wanted to investigate if 
the expression and localisation of EMT-related structural proteins were altered in 
response to the treatment. Immunofluorescence was performed at day 1, day 3 and 
day 5 and targets included vimentin, α-SMA, β-catenin, N-cadherin, E-cadherin and 
actin.  
Vimentin was localised at the extensions of the membrane and along the border of 
the DLKP-I colonies. Increased vimentin expression was evident in 
immunofluorescence images at all time points (Figure 3.0.23-25 a-d). This 
observation was supported by western blotting and densitometry. A significant 
increase in vimentin protein expression in cells treated with BMP-4 was detected at 
day 5 (Figure 3.0.26). 
Weak α-SMA expression was detected in the cytoplasm of untreated DLKP-I cells 
and there was evidence of peri-nuclear staining following BMP-4 treatment at day 
1, day 3 and day 5 (Figure 3.0.23-25 e-f). β-catenin and N-cadherin were localised 
at the cell membrane of untreated DLKP-I cells (Figure 3.0.23-25  i, j, m, n). 
Following BMP-4 treatment, both β-catenin and N-cadherin remained localised at 
the cell membrane (Figure 3.0.23-25 k, l, o ,p). Western blotting revealed a 
significant increase in β-catenin protein expression following BMP-4 treatment at 
day 1 and day 5 (Figure 3.0.27).  No difference in N-cadherin protein expression 
was revealed by western blot (Figure 3.0.28). 
E-cadherin gene processing in DLKP 
  
 
138 
 
Similar to DLKP-SQ and DLKP-M cells no change in E-cadherin expression or 
localisation occurred in DLKP-I clones following BMP-4 treatment  
Cytoplasmic actin staining was detected in untreated DLKP-I cells (Figure 3.0.23-
25 u, v). There was evidence of nuclear translocation and peri-nuclear staining at 
day 1 and day 3 following BMP-4 treatment (Figure 3.0.23-25 w,x).  
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Figure 3.0.23 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-I cells at day 1 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-I at day 1 in 0.25% serum containing 
medium with 100ng/ml BMP-4. 
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Figure 3.0.24 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-I cells at day 3 
Representative micrographs of vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and actin localisation in DLKP-I at day 3 in 0.25% serum containing 
medium with 100ng/ml BMP-4. 
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Figure 3.0.25 BMP-4 treatment induced changes in EMT marker localisation 
in DLKP-I cells at day 5 
Representative micrographs of Vimentin, α -SMA, β-catenin, N-cadherin, E-
cadherin and Actin localisation in DLKP-I at day 5 in 0.25% serum containing 
medium with 100ng/ml BMP-4. 
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Figure 3.0.26 BMP-4 treatment induced increased vimentin expression in 
DLKP-I cells 
(A) Representative blots of vimentin at day1, day3 and day5 in DLKP-I cells 
treated with 100ng/ml BMP-4. (B) Densitometry revealed a statistically 
significant increase in expression at day 5, * = p<0.05, n=3 
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Figure 3.0.27 BMP-4 treatment induced an increase in β -catenin expression in 
DLKP-I cells 
(A) Representative blots of β-catenin at day1, day3 and day5 in DLKP-I cells 
treated with 100ng/ml BMP-4. Elevated protein expression was seen (B) 
Densitometry revealed a statistically significant increase in expression at day 1 and 
day 5, * = p<0.05, n=3 
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Figure 3.0.28 BMP-4 treatment did not induce an increase in N-cadherin 
expression in DLKP-I cells 
(A) Representative blots of N-cadherin at day1, day3 and day5 in DLKP-I cells 
treated with 100ng/ml BMP-4. (B) Densitometry revealed no change in protein 
expression following treatment, * = p<0.05, n=3 
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3.1.12 Expression of EMT marker in DLKP-SQ, DLKP-M and 
DLKP-I following Gremlin stimulation 
The results presented here have shown that BMP-4 can induce morphological 
changes and cause the upregulation of EMT markers in DLKP cell populations. 
Gremlin is also capable of inducing morphological changes in DLKP-M and 
DLKP-I populations. Next, we investigated the effect of gremlin stimulation on the 
expression of EMT-related structural proteins. 
N-cadherin and vimentin expression were reduced in DLKP-M and DLKP-I 
following gremlin treatment. DLKP-SQ expressed low levels of β-catenin and did 
not express N-cadherin. No change in expression was detected in β-catenin or N-
cadherin (Figure 3.0.29).  
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Figure 3.0.29 Gremlin treatment altered EMT-related structural protein 
expression in DLKP clones 
Representative blots of vimentin, β-catenin and N-cadherin at day5 in DLKP-SQ, 
DLKP-M, DLKP-I cells treated with 3 ng/ml gremlin. Reduced β-catenin and N-
cadherin expression was present in DLKP-M and DLKP-I cells following gremlin 
treatment. A reduction in vimentin expression was evident in DLKP-M cells. Red 
boxes indicate samples that were ran on the same gel. Each red box indicates a 
different gel therefore the expression of the EMT markers in SQ,M and I cannot be 
compared by density analysis. n=3. 
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3.2 Discussion 
Our research group is interested in the mechanisms underlying the regulation of cell 
phenotypes in the airways. Phenotypic switching and trans-differentiation can be 
controlled by the EMT-MET process. EMT is classified into three main types in the 
body and result in very different biological consequences (Kalluri and Weinberg 
2009). Our lab has previously demonstrated the relationship between EMT and the 
BMP pathway. In this study we investigated the role of the BMP signalling and type 
III EMT between heterogeneous clonal populations of the DLKP cell line. The 
results indicate that DLKP-SQ cell represent a more “normal” epithelial phenotype 
compared to mesenchymal-like DLKP-M cells. In addition, DLKP clonal 
populations were responsive to BMP-mediated signalling. BMP pathway activation 
induced EMT in this adult cancer model and abrogation of the BMP signalling 
pathway altered cell morphology, in a process resembling MET. Our results 
highlight the dynamic role of BMP signalling on the induction of phenotypic 
switching in this cell model.  
We hypothesised that the DLKP-SQ clonal population resemble “normal” airway 
epithelial cells more closely than DLKP-M cells. In cultures of the parental cell 
line, spontaneous interconversion events occur between DLKP-SQ, DLKP-M and 
the intermediate DLKP-I clonal population. The cells are morphologically distinct 
and the changes between the small, cuboidal, tightly packed DLKP-SQ cells to the 
larger, extended mesenchymal-like DLKP-M cells appear to resemble a process 
morphologically similar to EMT (Mcbride et al. 1998). DLKP-I cells resemble a 
small stem cell-like colonies capable of interconverting to either DLKP-SQ or 
DLKP-M. Gene expression data showed that CRMP-1, α-integrin-V and scatter 
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factor expression were higher in DLKP-I and DLKP-M compared to DLKP-SQ 
cells. This highlighted again that DLKP-SQ were more associated to normal 
epithelial cells than the other two clones (Figure 3.0.3).  
Furthermore, we examined the expression of tight junction proteins by western 
blotting. These proteins are involved in epithelial cell polarity, mediating the 
impermeable intercellular junctions between adjacent cells and ensuring that the 
integrity of the epithelial barrier is upheld (Acharya et al. 2004; Balda and Matter 
2000; Hervé 2008; Tang and Brieher 2013). In addition, the loss of tight junction 
proteins is associated with increased cell invasiveness in cancer and the adoption of 
a more mesenchymal, migratory cell phenotype in breast cancer tumours  (Costello 
et al. 2010; Ikenouchi et al. 2003).  DLKP-SQ and DLKP-I expressed afadin, 
claudin-1 and ZO-1 whereas all three TJP were absent from DLKP-M clonal 
populations (Figure 3.0.2).  The finding that CD2AP is present in DLKP-SQ, 
DLKP-M and DLKP-I clones highlighted that some maintenance of actin 
cytoskeletal interaction with cell adherens junctions is required in DLKP-M cells 
despite their evident loss of epithelial-related structural proteins. TJP could be 
downregulated in DLKP-M cells by the transcriptional co-repressor Snail which 
was show to bind directly to the promoter region of occuldin and claudin genes in 
epithelial cells, Eph4 and CSG1. Snail-induced downregulation of TJP caused the 
cells to adopt mesenchymal, mobile cell characteristics (Ikenouchi et al. 2003). In 
summary, these preliminary findings indicated that DLKP-SQ represent a more 
epithelial-like cell population compared to DLKP-M cells. In addition, DLKP-I 
cells may represent an EMP cell phenotype as they still possess epithelial-related 
tight junction proteins but also express mesenchymal-like markers. 
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We believe that BMP-2, -4 and -7 are key regulators of airway epithelial cell 
differentiation and phenotype in both health and disease. In this study, we 
investigated if DLKP clones are responsive to BMP-mediated signalling. BMP 
signal transduction occurs via phosphorylation of the R-SMAD complex at either 
SMAD-1, SMAD-5 or SMAD-8. This occurs following ligand binding and is the 
hallmark of active BMP signalling. R-SMADs and co-SMAD both contain a 
nuclear localisation signal (NLS) and a nuclear export signal (NES). These signals 
facilitate nucleocytoplasmic shuttling and allow SMAD interactions with DNA 
transcription factors in the nucleus to occur  and the activation/repression of BMP 
specific genes to proceed (Zhan Xiao et al. 2003; Xiao et al. 2001). In experiments 
carried out by our collaborator in DCU, gene expression analysis revealed 
endogenous expression of the type I and type II BMP receptors in the DLKP clones. 
This indicated that the cells are responsive to BMP ligands. SMAD-1 and SMAD-
5 were detected in the cytoplasm of untreated DLKP-SQ, -M and –I cells. In 
addition, nuclear localisation of pSMAD 1/5/8 occurred independent of SMAD-4 
nuclear localisation in untreated DLKP-SQ, DLKP-M and DLKP-I cells. We 
speculate that nuclear translocation occurs via the NLS of the R-SMAD protein. 
This demonstrates that activated R-SMADs could play a role in regulating 
homeostatic gene expression. Following BMP-4 stimulation, elevated nuclear 
expression of pSMAD 1/5/8 and SMAD-4 was detected in the cells.  We propose 
that the nuclear localisation of both of these signalling molecules in tandem in the 
DLKP cell lines maintains BMP pathway activation following BMP-4 treatment. 
Early studies have also highlighted this phenomenon in BMP signalling whereby 
nuclear translocation of activated R-SMADs does not require SMAD-4 in colon 
carcinoma cells, (Hoodless et al. 1999; Liu et al. 1997). Similar signalling events 
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occurs in human Beas-2b cells treated with BMP-2 and BMP-4 ligands (E. L 
Molloy, Shirley O’Dea lab). 
iSMAD localisation was examined by immunofluorescence following 24 hr 
stimulation with BMP-4 in DLKP-SQ, DLKP-M and DLKP-I. In resting state cells, 
SMAD-6 was localised in the nuclei. Lower levels of SMAD-7 protein were found 
in the nuclei. While little is known about the NLS and NES of iSMADs this 
difference in protein localisation could be attributed to the altered rate of nuclear 
trafficking in the cells. Following BMP-4 stimulation, elevated iSMAD protein 
expression was present in the cytoplasm and nucleus of all three cell lines. The 
expression of SMAD-7 in the clones could indicate the presence of TGF- β 
signalling as SMAD-7 regulates both BMP and TGF signalling pathways.  
The presence of nuclear iSMADs at 24 hrs post BMP-4 stimulation indicates 
sustained pathway regulation in these cells. This suggests the establishment of a 
negative feedback mechanism in the cells. While rt-PCR data demonstrated a time-
dependent induction of ID-1 mRNA expression in DLKP cells, no significant 
difference in SMAD-6 or SMAD-7 expression was found following BMP-4 
treatment. However, as described, immunofluorescence showed changes in protein 
localisation. This indicated that endogenous control of BMP signalling may be 
present in DLKP cells and that following BMP-4 treatment iSMADs alter their 
localisation to regulate the pathway. 
In summary, the DLKP cell lines are responsive to BMP-4 mediated signalling and 
induce the nuclear translocation of p-SMAD 1/5/8 and SMAD-4 for the activation 
of BMP responsive genes. Our results indicate that endogenous BMP pathway 
regulation occurs in these cells and is mediated through iSMADs.   
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We hypothesised that by agonising and antagonising the BMP pathway we could 
induce EMT-mediated phenotypic switching between these clonal populations. 
EMT involves altered cell morphology, loss of cell polarity and upregulation of 
mesenchymal-associated proteins. Firstly, we hypothesised that DLKP-SQ cells 
would undergo EMT following BMP treatment and adopt a morphology similar to 
DLKP-M cells. Conversely, we hypothesised that DLKP-SQ cells treated with 
gremlin would remain unchanged. In these experiments, DLKP-SQ cells lost their 
cuboidal shape and no longer grew in tightly organised “cobblestone”- like colonies 
following BMP-4 stimulation. A ventral lateral polarity was established and the cell 
membrane became stretched with cytoplasmic extensions. The cells expressed an 
elevated level of vimentin protein which was localised at the newly formed 
extended mesenchymal processes. This cell phenotype resembled DLKP-M cells 
(Figure 3.0.10). Peri-nuclear staining of actin was also evident following BMP-4 
treatment at day 1, day 3 and day 5. Both elevated vimentin expression and this 
actin staining pattern are associated with changes in cell architecture that occur 
during EMT (Gay et al. 2011). This indicated that BMP-4 stimulation induced 
EMT-like changes in DLKP-SQ cells.  
Gremlin is a well-studied antagonist of the BMP pathway and binds to BMP ligands 
outside the cell to prevent receptor-mediated signal activation. No significant 
change in cell phenotype was detected following gremlin stimulation of DLKP-SQ 
cells for five days and no change in vimentin expression was evident by western 
blot. This indicated that DLKP-SQ cells may not produce endogenous BMP ligands 
(BMP-2, BMP-4 or BMP-7) to maintain cell phenotype as gremlin elicited no 
change in cell morphology. However endogenous BMP-7 mRNA expression was 
higher in DLKP-SQ compared to DLKP-I (Figure 3.0.3) A recent study in human 
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kidney tubule cells and HEK-293 cells showed that gremlin preferentially binds to 
BMP-2 and BMP-4 over BMP-7 (Church et al. 2015).  Thus, we speculate that 
DLKP-SQ cells may produce endogenous BMP-7 as opposed to BMP-4 or BMP-2 
thus there was no significant phenotypic alteration following gremlin treatment. As 
shown in a mouse model of chronic renal injury, BMP-7 has the ability to reverse 
epithelial to mesenchymal transition and elicit a more “normal” cell phenotype 
(Zeisberg et al. 2003). This supports our hypothesis that DLKP-SQ could be 
producing BMP-7 to maintain a squamous-like phenotype which is unaltered 
following gremlin treatment. Future experiments investigating endogenous 
expression of BMP ligands using PCR and western blotting would be an important 
step to begin elucidating this hypothesis. 
To conclude, these results indicate that DLKP-SQ undergo EMT in response to 
BMP-4 treatment and that BMP-7 mediated signalling may be involved in 
maintaining DLKP-SQ cell phenotype.  
Secondly, we hypothesised that DLKP-M cells would be unchanged following 
BMP-4 treatment and exposure to gremlin would induce MET and promote a 
DLKP-SQ-like phenotype. Contrary to our original hypothesis, DLKP-M cells 
treated with BMP-4 underwent extensive morphological changes. The cells formed 
large cell clusters and the extended neurite-like processes in the DLKP-M cells were 
no longer observed. Individual cell outline was no longer visible in the large colony 
and the outer border of these colonies were very distinct and resembled DLKP-I 
cells at day 3 following BMP-4 treatment. Furthermore, the cells expressed elevated 
levels of vimentin and N-cadherin, both common markers upregulated during EMT 
(Figure 3.0.20-21). Vimentin staining was localised along the distinct cell border of 
the newly formed DLKP-I-like colonies as seen by immunofluorescence. β-catenin 
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was also elevated in DLKP-M cells treated with BMP-4 at day 1, day 3 and day 5. 
Due to the lack of E-cadherin in these cells, we speculate that the elevated level of 
β-catenin is related to the increase in N-cadherin expression. β-catenin attaches to 
the cell adherens molecule N-cadherin at the cell adherens junction, linking the 
complex to α-catenin and subsequently to the cell cytoskeleton. 
At day 5, the cells had developed from DLKP-I like colonies into a large fibrotic 
mass (Figure 3.0.11). Cell piling and aggregation were evident and long neurite-
like processes were observed. BMP-4 has a half-life of between 24-48 hrs thus we 
speculate that endogenous BMP-4 production may be occurring at day 5 in these 
DLKP-M cell masses which could establish a feed-forward mechanism and results 
in further morphological changes and cell aggregation. DLKP-M cells also 
expressed the highest level of BMPR-II compared to DLKP-SQ and DLKP-I cells 
which could account for the cells’ hyper-responsiveness to BMP-4 stimulation 
(Figure 3.0.3). Given the mesenchymal nature of the cells and change in 
morphology following BMP-4 treatment we hypothesise that this fibrotic mass 
could be induced by excessive EMT in these cancer cells, whereby these already 
mesenchymal cells begin to form colonies and pile on top of one another to form a 
tumour-like mass. BMP mediated EMT has been shown in primary airway 
epithelial cells and these results support the hypothesis that excessive EMT and the 
lack of MET could lead to tissue fibrosis. In this case, excessive EMT results in the 
formation of a tumour cell mass with what appears to be excessive cell proliferation 
and piling  (McCormack et al. 2013). Future experiments should address this cell 
processes to elucidate the cellular events that occur following BMP-4 treatment. 
When DLKP-M cells were treated with gremlin for up to five days, downregulation 
of vimentin, N-cadherin and β-catenin occurred in conjunction with a 
E-cadherin gene processing in DLKP 
  
 
154 
 
morphological change that resembled DLKP-SQ cells. Increased cell-cell contact 
was evident and the larger DLKP-M cell shape was replaced by tightly packed, 
smaller cells in some regions of the culture. These changes indicated an MET 
process in DLKP-M cells mediated through removal of BMP ligands. We speculate 
that DLKP-M cells produce endogenous BMP ligands which maintain their 
mesenchymal cell phenotype.  
In conclusion, these results showed that modulating BMP-4 mediated signalling in 
DLKP-M cells greatly alters cell morphology along the EMT-axis. BMP-4 
mediated signalling can induce a fibrotic-like cell phenotype due to excessive signal 
activation and the potential establishment of an autocrine feed forward loop.   
Finally, we hypothesised that DLKP-I cells represented an intermediate phenotype. 
Given the spontaneous interconversion events which occurred between DLKP-SQ 
and DLKP-M cells in culture we hypothesised that DLKP-I cells represented a stem 
cell-like clone capable of phenotypic switching. We postulated that DLKP-I cells 
would undergo EMT when treated with BMP-4 to adopt DLKP-M like phenotype 
and an MET process following gremlin treatment to adopt DLKP-SQ like 
phenotype. Following BMP-4 treatment, DLKP-M-like cells were observed the in 
DLKP-I cell culture. Cells began to form colonies that resembled DLKP-M cells 
treated with BMP-4. The individual cell membranes became indistinguishable 
within the large colonies (Figure 3.0.12). We speculate that these colonies would 
have developed into large fibrotic masses similar to DLKP-M cells treated with 
BMP-4 if the time points were increased.  
Following gremlin treatment the cell-cell contact between DLKP-I colonies 
increased and individual cells became more distinct. The cells adopted a squamous, 
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“cobblestone”-like morphology and resembled DLKP-SQ clones (Figure 3.0.12). 
Decreased expression of vimentin, N-cadherin and β-catenin protein expression 
occurred in the DLKP-I cells following gremlin treatment which indicated an MET 
process. We postulate that the loss of β-catenin was related to disassembly of the 
ADJ, as DLKP-SQ cells do not expression N-cadherin or E-cadherin at the 
membrane. In addition, the fact that gremlin treatment elicited a change in 
morphology indicted that DLKP-I clones may produce endogenous BMP ligands 
which maintain their cell phenotype, specifically BMP-2 or BMP-4 as opposed to 
BMP-7. Thus, BMP ligands could be acting in an autocrine fashion and could 
dictate the morphology of the cells in the intermediate DLKP-I colonies. A BMP 
ligand gradient may exist in culture and cells further away from DLKP-I clusters 
may be exposed to lowered BMP-4 or BMP-2 mediated signalling and this causes 
phenotypic switching- for example, to DLKP-SQ cells. Higher levels of BMP-4 
induce a DLKP-M phenotype. This speculation is confounded by the low level of 
nuclear localisation of SMAD-4 and pSMAD 1/5/8 in untreated DLKP-I cells. We 
postulate this potential autocrine activity may be also be partly controlled via non-
canonical BMP, non-SMAD pathways or by other factors involved in controlling 
cell morphology. 
We propose that DLKP-M have progressed along the EMT axis and committed to 
a mesenchymal-cell fate rather than the EMP-like status of DLKP-I cells. This 
would account for the DLKP-I interconversion events that occur readily in parental 
cell culture.  
Taken together these results depict a dynamic model of EMT-mediated phenotypic 
switching which can be controlled by BMP agonists and inhibitors. We highlight a 
potential divergent role between BMP-4 and BMP-7 ligands in these cells. Our 
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results also indicate that different states of EMT are represented by the 
heterogeneous DLKP clonal populations. We propose that DLKP-SQ cells 
represent an early stage of EMT, DLKP-I cells represent an intermediate EMP-like 
cell and DLKP-M cells possess a mesenchymal-like cell which has progress further 
along the EMT axis. By increasing BMP pathway activation in these different 
clonal subpopulations via BMP-4 stimulation, it was possible to direct DLKP-SQ 
towards a DLKP-M-like mesenchymal phenotype. Likewise, inhibiting BMP 
pathway activation by administering gremlin led to DLKP-I conversion to DLKP-
SQ clones. DLKP-M cells represented a mesenchymal population which were 
capable of excessive cell aggregation and formation of a fibrotic mass following 
BMP-4 stimulation. Conversely, DLKP-M cells adopted a DLKP-SQ phenotype 
following gremlin treatment. 
Following on from our original hypothesis (Figure 3.1), we propose that a BMP 
gradient is responsible for phenotypic switching between the DLKP clones (Figure 
3.0.30). Based on the results presented here we speculate that high levels of BMP-
7 and low BMP-4 expression in DLKP-SQ maintain the squamous, epithelial-like 
cell phenotype. On the other hand, we postulate that endogenous BMP-4 or BMP-
2 mediated signalling in DLKP-I and DLKP-M cells maintain their respective cell 
phenotypes. It is unknown if an intermediate cell phenotype exists between DLKP-
SQ and DLKP-M but we propose that DLKP-I cells represent an EMP-like cell 
phenotype which expresses both epithelial and mesenchymal properties. Treatment 
of DLKP-I or DLKP-M cells with the BMP antagonist gremlin results in the loss of 
this endogenous signalling cascade and the cells convert to DLKP-SQ-like clones. 
We propose that DLKP-M cells are the most mesenchymal and invasive cell 
population of the three. 
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Further experiments should utilise BMP-2 and BMP-7 to investigate the effect of 
these ligands on motility and EMT. In addition the role of TGF-β has not been 
explore in DLKP cells lines. Firstly, the level of expression of endogenous TGF-β 
ligands and receptors would be investigated in DLKP cell lines. In addition, 
targeted inhibition of TGF-β / BMP signalling using siRNA or neutralising 
antibodies would provide a greater insight into the role of BMP and TGF-β 
signalling in EMT. By silencing BMP signalling in DLKP-M cells, their 
mesenchymal metastatic properties may be reversed. These experiments could also 
elucidate the role of BMP signalling with proliferation in DLKP cell populations. 
Future experiments investigating BMP signalling and EMT should be carried out. 
Treatment experiments involving DLKP-M clones and BMP-4 could lead to 
important findings regarding growth factor induced EMT and fibrosis. The role of 
BMP signalling in vivo during tissue fibrosis would be of particular interest and 
could highlight BMP as a potential therapeutic target.  
In conclusion our results have highlighted a role for BMP signalling in the induction 
of phenotypic switching between the clonal subpopulations of a heterogenous lung 
tumour. Furthermore, we have demonstrated the potential importance of BMP 
gradients in driving carcinogenic tumour properties and identified BMP-4 as an 
important target for cancer therapeutics  
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Figure 3.0.30 BMP gradients and EMT-mediated phenotypic switching in DLKP 
clones 
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Chapter 4 
Investigation of E-cadherin gene 
processing in the heterogeneous 
lung cancer cell line DLKP 
 
4.1  Introduction 
We have provided evidence that DLKP-SQ cells represent a more “normal” 
epithelial cell population compared to the invasive, mesenchymal counterpart 
DLKP-M. We have demonstrated that DLKPSQ and DLKP-M are on the EMT-
axis and that BMP-4 induced EMT-mediated phenotypic switching events between 
DLKP-SQ and DLKP-M cells. E-cadherin downregulation and N-cadherin 
upregulation is a well characterised hallmark of EMT (Gravdal et al. 2007). 
Interestingly, neither DLKP-SQ nor DLKP-M cells express membrane bound E-
cadherin thus, we hypothesise that this heterogeneous cell population represents a 
very suitable model to investigate cadherin switching. 
Two E-cadherin reporter plasmids have previously been designed in the O’Dea lab 
by Dr. Joanne Masterson (PhD, Masterson 2008).  The first contained the mouse E-
cadherin promoter construct subcloned into the plasmid vector pEYFP-1. This 
plasmid was called Eprom and transfection into MLE-12 and MAECs resulted in 
YFP protein expression in the cytoplasm. Eprom served as a control for E-cadherin 
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promoter efficacy. The second construct contained mouse E-cadherin cDNA from 
the pBATEM2 construct subcloned into the plasmid vector pEYFP-1. This plasmid 
was called Em2. Transfection of Em2 into Beas2b cells resulted in E-cadherin-YFP 
fusion protein expression at the cell membrane. Expression of the fusion protein at 
the membrane indicated that the cells contain the necessary machinery to facilitate 
correct E-cadherin mRNA translation and subsequent trafficking to the plasma 
membrane.  
Transfection of both Eprom and Em2 into DLKP-SQ and DLKP-M cells was 
originally carried out by Dr. Emer Molloy and stable clones were generated (Shirley 
O’Dea lab). Preliminary analysis of the subclones by Dr. Emer Molloy revealed no 
significant difference in proliferation or migration of DLKP-SQ Eprom, DLKP-SQ 
Em2 , DLKP-M Eprom or DLKP-M Em2 . Dr. Emer Molloy examined the DLKP-
SQ subclones further and a change in actin localisation was evident in DLKP-SQ 
Em2 cells compared to DLKP-SQ and DLKP-SQ Eprom cells. The same stable 
subclones prepared by Dr. Emer Molloy were used for this project except for 
DLKP-SQ Eprom subclones. An additional subcloning and expansion experiment 
protocol was carried out for DLKP-SQ Eprom cells as the stock of this subclone 
had expired. A mixed population of DLKP-SQ Eprom were subcloned by limiting 
dilutions in 96 well plates. Single fluorescent cells were identified and expanded in 
G418-containing medium to generate DLKP-SQ Eprom subclonal populations (see 
Appendix). 
Given the preliminary data demonstrating evidence of altered cell phenotype but no 
change in cell proliferation following E-cadherin gene transfection, we hypothesise 
that a cadherin switch is a possible mechanism involved in phenotypic switching 
events between these two DLKP clonal populations. As neither cell line expresses 
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endogenous E-cadherin protein, we postulate that re-introduction of the E-cadherin 
gene would result in MET in DLKP-SQ and DLKP-M cells. We hypothesise that 
DLKP-M cells have undergone phenotypic re-programming to become a more 
invasive and mesenchymal population. Furthermore, we hypothesise that 
transfection of the E-cadherin gene into DLKP-M cells will cause conversion to 
DLKP-SQ cells.   
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4.1.1 Endogenous E-cadherin mRNA expression in DLKP-SQ 
and DLKP-M 
The E-cadherin to N-cadherin switch is a hallmark of EMT and phenotypic 
switching events. We wanted to elucidate the phenotypic reprogramming events 
that have occurred in the DLKP clones and investigate if overexpression of an E-
cadherin gene in the cells induces MET. Firstly, endogenous E-cadherin mRNA 
expression in DLKP-SQ and DLKP-M cells was determined by semi-quantitative 
rt-PCR. E-cadherin mRNA expression was inconsistent and irregular in both 
DLKP-SQ and DLKP-M cells (Figure 4.0.1).   
E-cadherin 
DLKP-M DLKP-SQ + 
GAPDH 
Figure 4.0.1 Endogenous E-cadherin expression in DLKP-SQ and DLKP-M 
cells 
Representative image of endogenous E-cadherin expression in DLKP-SQ and 
DLKP-M clones grown in 5% serum-containing medium. E-cadherin mRNA 
expression was inconsistent in the clones. A549 was the positive control, GAPDH 
was used as a loading control. 
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4.1.2 Generation of DLKP-SQ and DLKP-M cell lines stably 
expressing Eprom and Em2 reporter plasmids  
All plasmid design and cloning was carried out by Dr. Joanna Masterson in the 
O’Dea lab. In brief, the E-cadherin promoter construct was sub-cloned into the 
pEYFP-1 plasmid, upstream of the YFP gene. This reporter plasmid is termed 
“Eprom” hereafter. To generate the E-cadherin-YFP construct, the mouse E-
cadherin gene from pBATEM2 was inserted into the pEYFP-1 plasmid. This 
generated the E-cadherin-fluorescent fusion protein under the control of the E-
cadherin promoter – termed Em2, hereafter (Figure 4.0.2) (Behrens et al. 1991; 
Nose, Nagafuchi, and Takeichi 1988). Following clonal expansion and selection of 
fluorescence clones, FACS was carried out to analyse the expression of YFP 
fluorescent protein in the subclonal populations. This was carried out by Dr. Emer 
Molloy (see Appendix).   
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Eprom: 
E-cadherin promoter driving  
YFP gene expression 
Em
2
: 
E-cadherin promoter driving YFP-tagged 
E-cadherin gene expression 
YFP protein  E-cadherin YFP fusion protein 
YFP  YFP  E-cad 
Figure 4.0.2 The Eprom and Em2 reporter plasmids 
The Eprom plasmid contained the mouse E-cadherin promoter construct subcloned 
into the pEYFP-1 plasmid. When transfected into cells and following correct 
transcription and translation, the Eprom plasmid generated fluorescent YFP. The 
Em2 plasmid contained the mouse E-cadherin gene from the pBATEM2 construct 
subcloned into the pEYFP-1 plasmid. When transfected into cells and following 
correct transcription and translation, the Em2 reporter construct generated E-
cadherin protein tagged with fluorescent YFP. These constructs were designed and 
constructed by Joanne Masterson, PhD (Shirley O’ Dea lab). The transfection 
experiments were carried out by Dr. Emer Molloy (Shirley O’Dea lab). 
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4.1.3 3D culture of DLKP-SQ and DLKP-M clones 
We utilised HappyCell® advanced suspension medium to investigate the effect of 
E-cadherin expression on cell growth patterns in a more biologically relevant 3D 
environment. Happy Cell ® is an optimised suspension DMEM-based media which 
facilitates 3D spheroid culture of cells. Both normal and neoplastic cells have been 
shown to grow as spheroids in suspension medium. DLKP-SQ cells did not grow 
complete spheroids in HappyCell® but instead formed small cell clusters. These 
cell aggregates had irregular shapes and formations. A similar growth pattern was 
evident in DLKP-SQ Eprom cell (Figure 4.0.3 A).  These cells were fluorescent 
indicating the presence of YFP protein. In contrast to both DLKP-SQ and DLKP-
SQ Eprom, DLKP-SQ Em2 formed distinct, discrete spheroid bodies with a defined, 
smooth and regular boundary when cultured in Happy Cell ® medium. These 
spheroids were also fluorescent (Figure 4.0.3 A). 
DLKP-M, DLKP-M Eprom and DLKP-M Em2 cells grew as distinct spheroids in 
the HappyCell® advanced suspension medium (Figure 4.0.3 B). The DLKP-M 
spheroids possessed the same regular, smooth outer boundary as the DLKP- SQ 
Em2 spheroids however, DLKP-M spheroids possessed extended neurite-like 
processes. The DLKP-M Eprom spheroids were fluorescent in contrast to the 
DLKP- M Em2 spheroids (Figure 4.0.3 B). 
 
  
E-cadherin gene processing in DLKP 
  
 
167 
 
 
  
DLKP-M DLKP-M Eprom DLKP-M Em
2
 
b
ri
g
h
tf
ie
ld
 
fl
u
o
re
sc
en
ce
 
DLKP-SQ DLKP-SQ Eprom DLKP-SQ Em
2
 
b
ri
g
h
tf
ie
ld
 
fl
u
o
re
sc
en
ce
 
A 
B 
Figure 4.0.3 3D culture of DLKP-SQ and DLKP-M subclones 
Representative micrographs of DLKP-SQ, DLKP-SQ Eprom, DLKP-SQ Em
2 
and DLKP-
M, DLKP-M Eprom, DLKP-M Em
2  
grown in HappyCell® medium for nine days. (A) 
DLKP-SQ and DLKP-SQ Eprom grew in aggregated cell clusters but did not form 
spheroids. DLKP-SQ Eprom aggregates were fluorescent. DLKP-SQ Em
2  
formed 
fluorescent discrete and compact spheroids with a defined outer boundary. (B) DLKP-M, 
DLKP-M Eprom and DLKP-M Em
2 
cells formed distinct discrete spheroids in HappyCell® 
culture. The DLKP-M Eprom spheroids were fluorescent and the DLKP-M Em2 were less 
fluorescent.. The DLKP-M spheroids possessed extended process and were larger than 
the DLKP-SQ Em
2 
 structures. Brightfield and fluorescent images were taken of different 
fields of view. 
YFP Ecad-YFP 
YFP Ecad-YFP 
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4.1.4 Expression of epithelial markers in DLKP-SQ clones grown 
in 3D culture 
Given the evidence presented here that DLKP-SQ and DLKP-SQ Eprom 
populations formed aggregated cell clusters in Happy Cell ® suspension medium 
while DLKP-SQ Em2 formed discrete compact spheroid with smooth, regular and 
defined outer boundaries, we wanted to investigate what cell adherens proteins were 
involved in the formation of the spheroids. The cells were grown on chamber-well 
slides for nine days in Happy Cell® before immunofluorescence was carried out. 
The cells were stained for YFP, E-cadherin and N-cadherin.  
DLKP-SQ cell clusters did not express membrane-localised E-cadherin or N-
cadherin when grown in Happy Cell ® suspension medium. E-cadherin and N-
cadherin were expressed weakly in the cytoplasm. DLKP-SQ cells did not express 
YFP (Figure 4.0.4). Similar to DLKP-SQ cell aggregates, DLKP-SQ Eprom cell 
clusters expressed E-cadherin and N-cadherin weakly in the cytoplasm. YFP 
protein was present in the cytoplasm of DLKP-SQ Eprom, by immunofluorescence 
(Figure 4.0.5).  
As previously noted, DLKP-SQ Em2 developed large spheroid bodies in Happy Cell 
® culture with a distinct, regular boundary. When protein localisation patterns were 
examined by immunofluorescence, E-cadherin-YFP fusion protein was expressed 
at the cell membrane. The spheroids did not express N-cadherin at the cell 
membrane (Figure 4.0.6). This indicated that E-cadherin protein expression was 
involved in spheroid formation in Happy Cell ® suspension culture.   
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Figure 4.0.4 Immunofluorescence of DLKP-SQ spheroids 
Representative micrographs of DLKP-SQ cells grown in HappyCell® medium for 
9 days and stained for E-cadherin, YFP and N-cadherin. Very dull E-cadherin and 
N-cadherin expression was present in DLKP-SQ cels. DLKP-SQ cells were YFP-
null. Cells were counterstained with DAPI. Scale bars represent 50uM and 20uM 
respectively 
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Figure 4.0.5 Immunofluorescence of DLKP-SQ Eprom spheroids 
Representative micrographs of DLKP-SQ Eprom cells grown in HappyCell® 
medium for 9 days and stained for E-cadherin, YFP and N-cadherin. E-cadherin, 
YFP and N-cadherin expression was weak and cytoplasmic. Cells were 
counterstained with DAPI. Scale bars represent 50uM and 20uM respectively 
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Figure 4.0.6 Immunofluorescence of DLKP-SQ EM2 spheroid 
Representative micrographs of DLKP-SQ Em
2 
cells grown in HappyCell® medium 
for 9 days and stained for E-cadherin, YFP and N-cadherin. E-cadherin and YFP 
were localised at the cell membrane in a chicken-wire pattern. N-cadherin 
expression was weak and cytoplasmic. Cells were counterstained with DAPI. Scale 
bars represent 50uM and 20uM respectively. 
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Figure 4. 0.7 Antibody controls 
Representative micrographs of immunofluorescence controls of DLKP-SQ, 
DLKP-SQ Eprom and DLKP-SQ Em
2
 cells. Secondary controls were incubated 
overnight in TBS in place of the omitted primary antibodies. The Alexa488-
conjugated anti-mouse and Alexa488-conjugated anti-rabbit antibodies were then 
added. Cells were counterstained with DAPI. Scale bars represent 50uM and 20uM 
respectively. 
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4.1.5 Expression of epithelial markers in DLKP-M clones grown 
in 3D culture 
Given the evidence presented here that all of the DLKP-M subclones grew as 
spheroids in HappyCell® medium, we wanted to investigate what cell adhesion 
molecules were involved in DLKP-M spheroid formation. The cells were grown on 
chamber-well slides for six days in Happy Cell® before immunofluorescence was 
carried out. The cells were stained for YFP, E-cadherin and N-cadherin. 
Immunofluorescence of the DLKP-M cells showed that the cells expressed low 
levels of cytoplasmic E-cadherin. DLKP-M spheroids did not express YFP protein 
(Figure 4. 0.8). N-cadherin protein was expressed at the membrane of the DLKP-
M spheroid in a characteristic “chicken-wire” pattern. Similar N-cadherin protein 
localisation was evident in DLKP-M Eprom and DLKP-M Em2 cell spheroids. 
DLKP-M Eprom population expressed bright cytoplasmic YFP protein and dull 
cytoplasmic E-cadherin similar to DLKP-M spheroids (Figure 4.0.9). DLKP-M 
Em2 expressed dull cytoplasmic YFP protein and no membrane bound E-cadherin, 
in striking contrast to DLKP-SQ Em2 (Figure 4. 0.10). These results indicated that 
N-cadherin was involved in spheroid formation in DLKP-M, DLKP-M Eprom and 
DLKP-M Em2 cells. 
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Figure 4. 0.8 Immunfluorescence of DLKP-M spheroids 
Representative micrographs of DLKP-M cells grown in HappyCell® medium for 9 
days and stained for E-cadherin, YFP and N-cadherin. E-cadherin expression was 
weak and cytoplasmic and the cells were negative for YFP. The DLKP-M spheroids 
expressed N-cadherin at the membrane. Cells were counterstained with DAPI. 
Scale bars represent 50uM and 20uM respectively. 
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Figure 4.0.9 Immunofluorescence of DLKP-M Eprom spheroids 
Representative micrographs of DLKP-M Eprom cells grown in HappyCell® 
medium for 9 days and stained for E-cadherin, YFP and N-cadherin. E-cadherin 
expression was weak and cytoplasmic. YFP was localised in the cytoplasm. N-
cadherin was expressed at the cell membrane. Cells were counterstained with 
DAPI. Scale bars represent 50uM and 20uM respectively. 
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Figure 4. 0.10 Immunofluorescence of DLKP-M Em2 spheroids 
Representative micrographs of DLKP-M Em
2 
cells grown in HappyCell® medium 
for 9 days and stained for E-cadherin, YFP and N-cadherin. E-cadherin expression 
was weak and cytoplasmic. YFP was expressed weakly in cytoplasm. N-cadherin 
was expressed at the cell membrane in a chicken-wire pattern. Cells were 
counterstained with DAPI. Scale bars represent 50uM and 20uM respectively. 
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Figure 4.0.11 Antibody controls 
Representative micrographs of immunofluorescence controls on DLKP-M, DLKP-
M Eprom and DLKP-M Em
2 
cells. Secondary controls were incubated overnight in 
TBS in place of the omitted primary antibodies. The Alexa488-conjugated anti-
rabbit and Alexa488-conjugated anti-mouse antibodies were then added. Cells were 
counterstained with DAPI. Scale bars represent 50uM and 20uM respectively. 
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4.1.6 Expression of epithelial markers in DLKP-SQ, DLKP-SQ 
Eprom and DLKP-SQ Em2 in 2D culture 
We hypothesised that DLKP-SQ cells transfected with the E-cadherin reporter 
plasmid Em2 would express E-cadherin at the cell membrane, undergo MET and 
that the expression of other epithelial-related markers would increase as a result. 
Immunofluorescence and western blotting were carried out to examine the 
localisation patterns and expression levels of E-cadherin, YFP, actin, β-catenin and 
cytokeratin in the subclonal populations. In these experiments, a monoclonal 
antibody generated against the C-terminal end of the full length E-cadherin protein 
(735/883) was used. The expected molecular weight was 120kDA. A polyclonal 
antibody against full length GFP was used. This antibody is reactive to YFP. The 
expected molecular weight was 27kDA.  
Immunofluorescence showed that E-cadherin protein was localised at the cell 
membrane of the DLKP-SQ Em2 cells (Figure 4.0.12). The characteristic “chicken-
wire” like staining of E-cadherin at the cell membrane formed a distinct boundary 
between each cell. Cytoplasmic E-cadherin protein was visible in DLKP-SQ and 
DLKP-SQ Eprom cells and no membrane bound E-cadherin was present (Figure 
4.0.12). E-cadherin protein expression was examined by western blotting, using 
both an E-cadherin antibody and an YFP antibody. E-cadherin expression was 
absent in DLKP-SQ and DLKP-SQ Eprom. In DLKP-SQ Em2 cells a band was 
present at approx. 150kDA when whole cell protein was probed with either 
antibody (Figure 4. 0.13). This 150kDA size band is approximately equal to the 
molecular weights of E-cadherin and YFP combined. This indicated that the E-
cadherin gene tagged with YFP was successfully transfected and that gene 
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incorporation, transcription, translation and processing to the membrane took place 
in DLKP-SQ Em2 cells.  
DLKP-SQ cells did not express YFP. Immunofluorescence showed that YFP was 
present in the cytoplasm of DLKP-SQ Eprom subclones and localised at the cell 
membrane of DLKP-SQ Em2 subclones (Figure 4.0.12). Western blots probed with 
a YFP antibody revealed a 27kDA band in the whole cell protein extracted from 
DLKP-SQ Eprom cells (Figure 4. 0.13). DLKP-SQ Em2 expressed a 150kDA size 
band, indicative of the E-cadherin-YFP fusion protein. These results confirmed that 
the E-cadherin promoter was successfully driving both YFP and E-cadherin-YFP 
transcription and subsequent protein production in DLKP-SQ Eprom and DLKP-
SQ Em2, respectively. 
Because membrane-bound E-cadherin protein was present in DLKP-SQ Em2, the 
expression of other proteins associated with the epithelial phenotype and EMT 
progression such as actin, β-catenin and cytokeratins were investigated. Actin re-
polarisation was evident in DLKP-SQ Em2 cells (Figure 4.0.12). Compared to 
DLKP-SQ or DLKP-SQ Eprom cells, actin was localised at the cell membrane in 
DLKP-SQ Em2 as indicated by the white arrows. In the DLKP-SQ and DLKP-SQ 
Eprom cells, actin was dispersed throughout the cytoplasm, as indicated by the 
white arrows. This result supported previous experiments carried out by Dr. Emer 
Molloy (O’Dea lab). The level of actin expression was investigated from whole cell 
protein extracted from the cells. Higher levels of actin protein were evident in 
DLKP-SQ Em2 compared to DLKP-SQ and DLKP-SQ Eprom cells. This result was 
confirmed by densitometry (Figure 4. 0.13). 
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Immunofluorescence revealed β-catenin localisation at the cell membrane in 
DLKP-SQ Em2 subclones. The white arrows highlight regions expressing 
membrane bound β-catenin (Figure 4.0.12). Low levels of membrane bound β-
catenin was evident in DLKP-SQ and DLKP-SQ Eprom cells. A low level of β-
catenin expression was also present in these cells by western blot (Figure 4. 0.13). 
Conversely, DLKP-SQ Em2 displayed a significantly higher level of β-catenin 
protein expression by western blot. This result was confirmed by densitometry.  
Finally, cytokeratin expression was investigated. A pan cytokeratin antibody 
detecting K 4, 5, 6, 8, 10 and 13 was used. There was evidence of cytokeratin re-
organisation at the cell membrane in DLKP-SQ Em2 cells following 
immunofluorescence. DLKP-SQ and DLKP-SQ Eprom cells displayed cytoplasmic 
cytokeratin expression with some non-uniform expression at the cell membrane 
(Figure 4.0.12). No detectable change of cytokeratin protein was found by western 
blot (Figure 4. 0.13). 
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  Figure 4.0.12 DLKP-SQ subclones display alters adhesion junctions and 
cytoskeletal organisation 
Representative micrographs of localisation patterns of E-cadherin, YFP, Actin, β-
catenin and cytokeratin in DLKP-SQ cells transfected with Eprom and Em
2
. E-
cadherin was expressed at the membrane in DLKP-SQ Em
2 
subclones as indicated 
by the white arrows (a-c). YFP was expressed in the cytoplasm of DLKP-SQ Eprom 
and at the membrane of Em
2
 cells (d-f). Actin re-polarisation was evident in DLKP-
SQ  Em
2
 compared to DLKP-SQ and DLKP-SQ Eprom, as indicated by the white 
arrows (g-i). β-catenin was re-organised in DLKP-SQ Em
2 
and elevated expression 
at the membrane was present compared to DLKP-SQ cells or DLKP-SQ Eprom 
cells, as indicated by the white arrows (j-l). Cytokeratin expression localised at the 
cell membrane in DLKP-SQ  Em
2
 (m-o). All scale bars represent 50uM, n=2 
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Figure 4. 0.13 Western blot of adherens and cytoskeletal proteins on DLKP-
SQ, DLKP-SQ Eprom and DLKP-SQ Em2 cells 
(A) Representative western blots of E-cadherin, YFP, actin, β–catenin and 
cytokeratin in DLKP-SQ, SQ Eprom and SQ Em
2
. There was an increase in E-
cadherin, actin and β–catenin expression in DLKP-SQ Em
2
. DLKP-SQ Eprom 
expressed YFP. No change in any cytokeratin expression was detected between the 
cell lines. GAPDH was used as a loading control, n=2 (B) Densitometry showed a 
significant increase in actin and β–catenin protein in DLKP-SQ Em
2 
compared to 
DLKP-SQ and DLKP-SQ Eprom cells. **p<0.005, ***p<0.0005, n=3 
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4.1.7 Expression of epithelial markers in DLKP-M, DLKP-M 
Eprom and DLKP-M Em2 
We hypothesised that DLKP-M cells, like DLKP-SQ, would incorporate the E-
cadherin gene and that E-cadherin protein would be present at the cell membrane. 
This would cause DLKP-M cells to undergo MET and result in a more stable cell 
phenotype, reducing the mesenchymal and migratory properties of the cells. DLKP-
M subclonal 3D culture data (presented in section 3.1.5) indicated that this was not 
the case. DLKP-M and DLKP-M subclones were grown in 2D cultures and 
immunofluorescence was carried out to investigate the localisation of epithelial cell 
markers. Western blotting was used to quantify any possible changes in protein 
expression. 
When examined by immunofluorescent using an anti-E-cadherin antibody, weak 
cytoplasmic staining of E-cadherin protein was observed in DLKP-M, DLKP-M 
Eprom and DLKP-M Em2. There was no evidence of membrane bound E-cadherin-
YFP fusion protein in DLKP-M Em2 subclones (Figure 4. 0.14). This was 
unexpected as the DLKP-M Em2 cells previously displayed high levels fluorescence 
by FACS which indicating the presence of YFP protein (see Appendix). The level 
of E-cadherin protein expression was investigated by western blot. Both an E-
cadherin and YFP antibody were used to probe all three cells lines. DLKP-M, 
DLKP-M Eprom and DLKP-M Em2 showed no detectable levels of E-cadherin 
(Figure 4. 0.15). 
When examined by immunofluorescence using a YFP antibody DLKP-M cells did 
not display YFP staining (Figure 4. 0.14). In contrast DLKP-M Eprom displayed 
cytoplasmic YFP expression indicating that the E-cadherin promoter was 
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functioning correctly and driving YFP transcription and downstream protein 
expression successfully. Western blotting supported this result and strong YFP 
protein expression was detected in DLKP-M Eprom cells (Figure 4. 0.15). DLKP-
M Em2 cells stained for YFP displayed very dull cytoplasmic protein expression 
(Figure 4. 0.14). However, this YFP protein was not detected by western blot of 
DLKP-M Em2 cells (Figure 4. 0.15).  
The expression of other proteins associated with the epithelial phenotype and EMT 
progression such as actin, β-catenin and cytokeratins were investigated in the 
DLKP-M subclonal populations. Immunofluorescence and western blotting for all 
three proteins in DLKP-M Eprom and DLKP-M Em2 subclones did not indicate any 
change compared to DLKP-M clones (Figure 4. 0.14). Actin expression was 
dispersed throughout the cytoplasm with no evidence of re-polarisation and no 
increase in protein expression by western blot (Figure 4. 0.15). β-catenin protein 
expression was localised throughout the  cytoplasm with some weak membrane 
localisation (Figure 4. 0.14). There was no change in β-catenin expression levels 
between the subclones by western blot (Figure 4. 0.15). Similarly with cytokeratin, 
no difference in protein localisation was evident by immunofluorescence and no 
increased in protein expression was present by western blot between DLKP-M and 
Eprom and Em2 subclones. Cytokeratin protein expression was dispersed 
throughout the cytoplasm. No distinct pattern was discernible in the membrane 
staining (Figure 4. 0.14, Figure 4. 0.15). 
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Figure 4. 0.14 DLKP-M subclones do not display altered adhesion junction 
proteins and cytoskeletal organisation 
Representative micrographs of localisation of E-cadherin, YFP, Actin, β-catenin 
and cytokeratin in DLKP-M, DLKP-M Eprom and DLKP-M Em
2
 .E-cadherin was 
expressed in the cytoplasm of DLKP-M and DLKP-M Eprom and no change in E-
cadherin localisation was evident in DLKP-M Em
2
 (a-c). YFP was present in the 
cytoplasm of both DLKP-M Eprom and Em
2
 cells (d-f). Actin was expressed in the 
cytoplasm of DLKP-M cells with no change in DLKP-M Eprom and Em
2 
(g-i). β-
catenin was localised at the membrane of DLKP-M, DLKP-M Eprom and Em
2 
cells. 
(j-l). Cytokeratin expression was dull and cytoplasmic in DLKP-M, DLKP-M 
Eprom and DLKP-M Em
2
 (m-o). All scale bars represent 50uM, n=2 
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Figure 4. 0.15 Western blot of adherens and cytoskeletal proteins in DLKP-
M, DLKP-M Eprom and DLKP-M Em2 cells 
Representative western blots of E-cadherin, YFP, Actin, β –catenin and cytokeratin 
in DLKP-M cells following transfection of Eprom and Em2 constructs. There was 
no detectable E-cadherin bands in DLKP-M and DLKP-M Eprom cells and no 
increase in E-cadherin protein expression in DLKP-M Em2. YFP protein was 
present in DLKP-M Eprom cells. There was no difference in Actin, β –catenin or 
cytokeratin expression. GAPDH was used as a loading control, n=3 
27 kDA 
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4.1.8 Expression of tight junction proteins in DLKP-SQ and 
DLKP-M clones and subclones 
Tight junction protein expression is indicative of the epithelial cell phenotype. We 
examined if any changes in TJP expression occurred following transfection of the 
E-cadherin gene in DLKP-SQ and DLKP-M cells. 
Significant differences in the expression of TJP was observed between DLKP-SQ 
and DLKP-M clones, as previously stated (chapter 3). The DLKP-SQ cells 
expressed claudin-1, afadin and ZO-1 while DLKP-M cells do not. No change in 
TJP expression was observed following re-introduction of the E-cadherin gene. 
CD2AP was the only tight junction protein examined that was expressed in both 
DLKP-M and DLKP-SQ cell lines (Figure 3.0.2).  
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Figure 4.0.16  Western blot of tight junction proteins in DLKP-SQ, DLKP-
SQ Eprom, DLKP-SQ Em2, DLKP-M, DLKP-M Eprom and DLKP-M Em2. 
Representative western blots of and CD2AP in all DLKP-SQ and DLKP-M clones 
and subclones. There was no detectable expression of claudin-1, afadin or ZO-1 in 
DLKP-M, DLKP-M Eprom or DLKP-M Em
2
 compared to DLKP-SQ, DLKP-SQ 
Eprom and DLKP-SQ Em
2
. CD2AP was expressed in all cell lines. GAPDH was 
used as a loading control, n=2 
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4.1.9 E-cadherin cleavage enzyme expression in DLKP-SQ and 
DLKP-M clones  
The results presented here indicated that DLKP-SQ and DLKP-M clones 
transfected with Em2 resulted in very different processing events. E-cadherin-YFP 
fusion protein was successfully translated and processed to the cell membrane in 
DLKP-SQ Em2 subclones. In contrast, immunofluorescence showed that the 
DLKP-M Em2 subclones did not express E-cadherin-YFP fusion at the cell 
membrane and only weak cytoplasmic E-cadherin and YFP expression was 
detected by immunofluorescence (Figure 4. 0.14). However, flow cytometry data 
demonstrated that DLKP-M Em2 subclones were fluorescent indicating that correct 
gene processing and translation of YFP is occurring in these cells (see Appendix).  
Assuming that the YFP-E-cadheirn construct was still functioning correctly in the 
cells, we postulated that the E-cadherin-YFP gene was correctly translated in 
DLKP-M Em2 subclones however, a possible cleavage event may be occurring 
intracellularly which prevents E-cadherin trafficking to the membrane in these cells. 
This would account for the low level of E-cadherin and YFP staining by 
immunofluorescence and the presence of fluorescence by FACS. The gene 
expression of E-cadherin cleavage enzymes calpain and presenilin were 
investigated by our collaborators in Dublin City University (Dr. Helena Joyce).  
Subsequent analysis of the results indicated a significant increase in both calpain 
and presenilin enzymes in DLKP-M compared to DLKP-SQ (Figure 4.0.17). 
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Figure 4.0.17 Gene expression of calpain and presenilin in DLKP-SQ and 
DLKP-M clones 
Representative graphs of calpain and presenilin expression following gene 
expression analysis which was carried out in Dublin City University, Ireland. 
Higher levels of both calpain and presenilin expression were observed in DLKP-M 
cells compared to DLKP-SQ. * p < 0.05. ** < 0.005, n=3 
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4.2  Discussion 
In multicellular organisms, phenotypic plasticity enables normal developmental 
processes and cellular functions to occur. This dynamic process is sustained in 
cancer and contributes to the formation of heterogeneous tumour populations 
(Scheel and Weinberg 2011). In this study, we investigated the cadherin switch in 
EMT-mediated phenotypic switching in a heterogeneous lung cancer cell line, 
DLKP.  
Both of the DLKP clones studied here, DLKP-SQ and DLKP-M, were E-cadherin 
null and by using E-cadherin reporter plasmids we demonstrated that these 
subcloned populations differentially regulate the expression of an E-cadherin 
transgene. In contrast to DLKP-M cells, DLKP-SQ displayed similar morphology 
to epithelial cells, lacked E-cadherin processing enzymes and contained the 
machinery required to correctly process the exogenous E-cadherin gene and express 
E-cadherin protein at the cell membrane. The expression of membrane-localised E-
cadherin protein in transfected DLKP-SQ cells enabled spheroid formation in 3D 
culture and increased the expression of epithelial-related structural proteins. DLKP-
SQ maintained tight junction expression following E-cadherin transfection. No 
change in TJP expression occurred in DLKP-M subclones. DLKP-M cells 
expressed N-cadherin at the cell membrane which facilitated spheroid formation. 
This suggests that the DLKP-SQ clones represent a different stage of the EMT 
process and that DLKP-M cells have undergone phenotypic re-programming to 
adopt a more invasive mesenchymal phenotype capable of resisting MET via a 
switch to N-cadherin expression. Our results suggest that a cadherin switch is 
involved in EMT-mediated phenotypic switching in this model of lung cancer.  
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The loss of E-cadherin expression or function causes tumour progression and 
increased tumour invasiveness in head and neck, breast, lung and liver cancer. As 
a result, E-cadherin is known as a tumour suppressor protein (Ino et al. 2002; Mao 
et al. 2008; Wang et al. 2011). As described 1.1.4, E-cadherin is involved in 
homodimeric interepithelial ADJ complexes which maintains tight epithelial cell 
contact and the quasi-immobility of the epithelial sheath. E-cadherin acts as a 
negative regulator of cell motility in this way. In addition, the loss of E-cadherin at 
the cell membrane is a hallmark of EMT and the adoption of motile, invasive cell 
properties. Previous experiments in the lab using E-cadherin reporter plasmids 
(Eprom and Em2) transfected into DLKP-SQ and DLKP-M cells showed that E-
cadherin introduction did not have any effect on cell proliferation. Following six 
days in culture, proliferation rates remained unchanged between DLKP-SQ, DLKP-
M and the subclonal populations (Dr. Emer Molloy, O’Dea lab, unpublished data). 
Additional experiments highlighted that despite not altering cell proliferation, 
introduction of the E-cadherin gene caused actin re-polarisation at the cell 
membrane of DLKP-SQ cells. This is a common characteristic of epithelial cells 
indicating that E-cadherin restoration could promote a switch in cell phenotype 
toward a more epithelial-like cell.  
Given that E-cadherin is a tumour suppressor protein, downregulation of E-cadherin 
is involved in the induction of EMT-mediated tumour progression and the 
preliminary data from the lab regarding altered structural protein expression 
following E-cadherin restoration, we used the same reporter plasmids to investigate 
the role of EMT as a mechanism of phenotypic switching between DLKP-SQ and 
DLKP-M cells. The functionality of the reporter plasmids was determined by FACS 
following transfection and sub-cloning of DLKP-SQ and DLKP-M clones to 
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generate DLKP-SQ Eprom, DLKP-SQ Em2, DLKP-M Eprom and DLKP-M Em2. 
A significant increase in fluorescence was present in the transfected subclones 
compared to DLKP-SQ or DLKP-M cells. It is worth noting that reduced 
fluorescence was evident in the Em2 subclones compared to Eprom subclones. The 
exact reason for this is unknown but we speculate that the reduced MFI could be 
attributed to the larger gene size in these cells compared to YFP.  
Spheroid culture represents a more physiologically relevant culture environment 
and we hypothesised that the cells would form spheroids. DLKP-M and the 
subclones DLKP-M Eprom and DLKP-M Em2 formed spheroids in 3D culture. 
However, further investigation into the cell adhesion molecules responsible for 
spheroid formation in DLKP-M cells demonstrated that the mesenchymal cell 
marker N-cadherin was involved (Figure 4. 0.10). This ADJ protein was localised 
at the membrane of the DLKP-M Em2 cells by immunofluorescence. In addition, 
the spheroids possessed extended cytoplasmic processes and appeared to be larger 
than the DLKP-SQ Em2 spheroids. N-cadherin expression was absent from DLKP-
SQ and DLKP-SQ subclones. DLKP-SQ Em2 subclones formed discrete, distinct 
spheroids with smooth regular boundaries with membrane-localised E-cadherin-
YFP fusion protein expression (Figure 4.0.3). The expression of N-cadherin by the 
DLKP-M clones support the hypothesis that these cells have progressed further 
along the EMT axis to become more invasive and mesenchymal compared to E-
cadherin. The switch between E-cadherin and N-cadherin expression is a 
characterised and well-characterised event during EMT and tumour progression 
(Gravdal et al. 2007; Hazan et al. 2004). 
As DLKP-SQ cells are E- and N-cadherin null, the fact that no large spheroids form 
in the DLKP-SQ and DLKP-SQ Eprom suggests that interactions between cell 
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adherens molecules are required for the formation of spheroids in vitro. The 
presence of either E-cadherin in the case of DLKP-SQ Em2 cells or N-cadherin in 
DLKP-M, DLKP-M Eprom and DLKP-M Em2 cells appeared to mediate spheroid 
formation. Previous studies of the mouse mammary epithelial cell lines EpH4 and 
SCP2 also highlighted the role of the cell adherens junction proteins in spheroid 
formation (Somasiri et al., 2000). 
 Both normal and neoplastic tissues have been shown to form spheroids in different 
3D culture techniques and our results indicate that the divergent populations DLKP-
SQ and DLKP-M can both form spheroids, albeit by the presence of different cell 
adhesion molecules. The formation of spheroids in DLKP-SQ Em2 cells can be 
viewed as a normal process driven by the epithelial cell adhesion molecule E-
cadherin. Due to the size and nature of the DLKP-M spheroids, we hypothesise that 
these structures represent mesenchymal spheroids whose formation is mediated by 
N-cadherin. We conclude that these findings supported the hypothesis that DLKP-
SQ cells represent a more epithelial-like cell phenotype and that DLKP-M have 
undergone phenotypic re-programming to downregulate tight junction protein 
expression, express mesenchymal cell markers and form large spheroid structures 
with extended neurite-like processes.  
We hypothesised that E-cadherin introduction into DLKP-SQ cells would result in 
E-cadherin expression at the membrane and the subsequent induction of MET.  E-
cadherin protein tagged with YFP was localised at the cell membrane in both 3D 
and 2D cell cultures. E-cadherin was present as the characteristic “chicken-wire” 
pattern (Figure 4.0.6, Figure 4.0.12). To support this result, western blotting using 
both an E-cadherin and YFP antibody detected a 150kDA band, indicative of the E-
cadherin-YFP fusion protein. These results show that the E-cadherin null DLKP-
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SQ clonal cells have retained the machinery required to process the E-cadherin gene 
and correct transcription and translation results in membrane-bound protein 
expression of the E-cadherin protein.  
MET is the reverse process of EMT. MET results in a more epithelial-associated 
cell phenotype characterised by expression of E-cadherin at the cell membrane and 
the loss of invasive mesenchymal properties. The process of MET and re-
expression of E-cadherin has been observed in metastatic foci present in lung, liver 
and brain of primary E-cadherin negative breast cancer tumours (Chao et al. 2010). 
In addition, metastasis forming MDA-MB-231 mesenchymal cells underwent MET 
and re-expressed E-cadherin following injection into the fat pad of mice (Chao et 
al. 2010).. In our study, overexpression of the E-cadherin transgene in DLKP-SQ 
cells appeared to induce MET and caused increased epithelial-specific protein 
expression and reorganisation of the cytoskeletal architecture. Alongside the 
expression of E-cadherin, actin repolarisation and increased expression of 
membrane localised β-catenin was evident by immunofluorescence (Figure 4.0.12). 
Elevated levels of actin and β-catenin expression were also demonstrated by 
western blot and confirmed by densitometry. We postulate that the introduction of 
the E-cadherin gene stimulated increased actin and β-catenin production in the cells 
during the onset of MET. This enabled increased exocytosis of the cell adherens 
junction and increased stabilisation of the complex. High levels of actin and β-
catenin facilitated association of the structural proteins with E-cadherin and 
recruitment to the ADJ to cause re-epithelialisation of DLKP-SQ cells. 
We conclude that E-cadherin gene introduction and subsequent E-cadherin-YFP 
fusion protein expression at the cell membrane induced a more epithelial-like cell 
phenotype in the DLKP-SQ cells. This MET-like process caused by acquisition of 
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membrane-bound E-cadherin increased cell polarity by elevated actin expression, 
stimulated increased β-catenin expression and re-organised cytoskeletal 
architecture. Although the DLKP-SQ clones do not express endogenous E-cadherin 
protein and thus have developed a carcinogenic phenotype, the cells have 
maintained the ability to process the E-cadherin gene which links the EMT process 
with tumour progression in this clonal population.  
Transfection of the E-cadherin gene tagged with YFP into DLKP-M cells did not 
result in a similar process. DLKP-M Em2 cells did not express the E-cadherin-YFP 
fusion protein at the cell membrane and no detectable E-cadherin protein or YFP 
protein was detected by western blot (Figure 4. 0.15). This is in contrast to the 
obvious E-cadherin-YFP fusion protein expression in DLKP-SQ Em2 cells. 
However, the presence of detectable fluorescence by FACS and the expression of 
weak cytoplasmic YFP protein by immunofluorescence in DLKP-M Em2 cells 
suggested that YFP was being produced in these cells, if only at a low level. 
The Em2 reporter construct contained the full length mouse E-cadherin gene 
subcloned into the pEYFP-1 plasmid (Masterson 2008). The stop codon sequence 
of the E-cadherin gene was mutated to a glycine residue using site directed 
mutagenesis. This resulted in production of an E-cadherin-YFP fusion protein by 
transfected cells when correct transcription and translation occurred. As the YFP 
gene was downstream of the E-cadherin sequence and the E-cadherin gene lacked 
a functioning stop codon the production of YFP protein in the cells was dependent 
on E-cadherin protein production and vice versa.  Analysis of the fluorescent data 
generated by DLKP-M Eprom cells demonstrated that the E-cadherin gene 
promoter was functioning correctly. These cells contained the Eprom construct in 
which the mouse E-cadherin promoter was driving YFP gene transcription. YFP 
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was localised in the cytoplasm of these cells by immunofluorescence and YFP 
protein was detected by western blot. This excluded any problems with 
transcription of the E-cadherin promoter in the DLKP-M Em2 cells.  
While DLKP-M Em2 cells displayed weak E-cadherin expression in the cytoplasm 
by immunofluorescence, we postulated that this E-cadherin is not functional as it 
has not been processed correctly and exported to the membrane to form ADJ. 
Further evidence that no functional E-cadherin protein was produced in the DLKP-
M Em2 was provided by examining epithelial-related structural proteins by 
immunofluorescence (Figure 4. 0.14). Actin expression remained cytoplasmic and 
no repolarisation was evident in the DLKP-M Em2 subclones. This was in direct 
contrast to DLKP-SQ Em2 cells where cortical actin was localised at the cell 
membrane and levels of actin protein were increased compared to DLKP-SQ cells 
(Figure 4. 0.13). The level of β-catenin protein expression and β-catenin localisation 
also remained unchanged between DLKP-M, DLKP-M Eprom and DLKP-M Em2. 
Again, this was the opposite of what was observed in the DLKP-SQ Em2 subclone.  
We originally hypothesised that DLKP-M would undergo MET following E-
cadherin gene re-introduction and resemble DLKP-SQ cells more closely. 
Assuming the reported plasmid was still expressed correctly in these cells, we 
conclude that DLKP-M did not process the E-cadherin gene as hypothesised. 
Overexpression of E-cadherin in DLKP-M cells did not cause MET and there was 
no change in E-cadherin expression at the cell membrane, epithelial-associated 
protein expression or tight junction protein expression. We conclude that DLKP-M 
cells have undergone a cadherin switch to express the mesenchymal marker N-
cadherin and may have lost or supressed the ability to correctly process the 
epithelial-related E-cadherin gene. 
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Given the results thus far, we hypothesised that the E-cadherin-YFP fusion protein 
was being produced in the DLKP-M Em2 but that subsequent post-translational 
modifications prevented correct downstream processing of the fusion protein. 
Assuming that the FACS analysis was robust and that the Em2 plasmid was 
functioning correctly, we speculated that post-translational cytoplasmic cleavage of 
the E-cadherin-YFP fusion protein was taking place. This would cause degradation 
of the E-cadherin protein and would account for the low level of both E-cadherin 
and YFP expression detected in the cytoplasm by immunofluorescence and the 
fluorescence evident in the DLKP-M Em2 subclonal population by FACS. Post-
translational control of E-cadherin occurs through a variety of different processes 
and these changes have been linked to neoplastic transformation and cancer 
progression, as reviewed in (Masterson and Dea 2007). While cleavage of pro-E-
cadherin by the subtilisin-like proprotein convertase is essential for E-cadherin 
activation and trafficking to the cell membrane, additional cleavage events have 
been shown to disrupt E-cadherin mediated cell adhesion (Hirohashi 1998). Nascent 
E-cadherin is trafficked from the trans-Golgi network with catenins for 
incorporation as cell adherens junctions. In our cell model, it appears that E-
cadherin is cleaved before exocytosis to the cell membrane occurs. We hypothesise 
that enzymes such as calpain or presensilin-1 (PS-1) could be involved in this 
intracellular cleavage event.  
E-cadherin cleavage by calpain occurs upstream of the β- and α-catenin binding 
domains on the cytoplasmic tail of E-cadherin. The calpain cleavage site is between 
residues 782-787 which are present in the full length E-cadherin gene used in this 
construct (Rios-Doria et al. 2003). This cleavage event would release the full length 
YFP protein into the cytoplasm. The E-cadherin antibody used in these experiments 
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detects the C-terminal tail of the E-cadherin protein between residues 735-883. We 
postulate that a segment of the cleaved E-cadherin C-terminal tail is detected in the 
cytoplasm by this antibody following immunofluorescence (Figure 4. 0.14). The 
protein expression was possibly too weak to be detected by western blot. It is 
common for antibodies to detect shorter cleaved products and this E-cadherin 
antibody can detect the cleaved products such as 24kDA, 29kDA, 35kDA fragments 
which occur in MDCK cells following the addition of staurosporine (Steinhusen et 
al. 2001). We detected weak cytoplasmic staining of YFP by immunofluorescence 
in 2D culture using an antibody reactive to the full length YFP. This YFP protein 
was not detected by western blot. This could be because the YFP signal was too 
weak in DLKP-M Em2 cells or perhaps the remaining C-terminal residues attached 
to the YFP protein following calpain cleavage resulted in protein degradation or 
masking of antibody epitopes.  
The cytoplasmic processing and cleavage of E-cadherin-YFP fusion protein could 
also be due to PS-1. This enzyme has been shown to cleave E-cadherin between 
residues Leu731 and Arg732 at the interface with the cell membrane. These 
residues are present in the Em2 E-cadherin reported construct used in these 
experiments. Cleavage by PS-1 disassembles the E-cadherin-catenin complex and 
prevents expression of the correct ADJ at the cell membrane. As previously stated 
the E-cadherin antibody used in these experiment detects the C-terminal tail of the 
E-cadherin protein between residues 735-883, which would be undisturbed 
following presenilin-mediated cleavage. This accounts for the dull cytoplasmic 
staining of E-cadherin found in the DLKP-M Em2 cells as this hypothesis would 
cause cytoplasmic accumulation of the cleaved E-cadherin fragment (Figure 4. 
0.14).  
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Our hypothesis regarding calpain- or presenilin-mediated cleavage of intercellular 
E-cadherin in DLKP-M Em2 is supported by gene expression analysis of the DLKP 
clones. This work was carried out by our colleagues in Dublin City University and 
the results showed a significantly higher level of calpain and presenilin expression 
in DLKP-M cells compared to DLKP-SQ cells (Figure 4.0.17). This result also 
supports the hypothesis that DLKP-SQ cells are a more epithelial-associated cell 
population as they do not express a high level of this E-cadherin cleavage enzyme.  
Alternatively, the Em2 plasmid may have stopped functioning correctly in these 
cells. An important future experiment to address this question would be to isolate 
RNA from the DLKP-SQ Em2 and DLKP-M Em2 cells and carry out rt-PCR to 
confirm that the YFP message was still present. In addition, FACS analysis should 
be repeated to ensure that the same level of fluorescence was present in the cell 
population and that transient loss of the plasmid had not occurred over time. 
Additional clonal expansion experiments of the mixed populations of fluorescent 
DLKP-SQ and DLKP-M subclones would ensure that no discrepancies or errors 
have been introduced over the course of this project.  
To conclude, the DLKP-M cell line appear to have developed a mechanism to 
suppress the expression of E-cadherin at the cell membrane thus preventing any 
EMT-mediated phenotypic switching. Assuming that the plasmids are functioning 
correctly, we speculate that DLKP-M cells could use E-cadherin cleavage enzymes 
to prevent normal E-cadherin membrane localisation. The ability to repress E-
cadherin protein trafficking to the membrane prevented the cells from undergoing 
a MET-like process similar to DLKP-SQ Em2 cells. These results also supported 
the hypothesis that DLKP-M clones represent a more invasive tumour grade that 
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have progressed along the EMT axis and exist as a mesenchymal, invasive 
population. 
In summary, we have shown that DLKP-SQ and DLKP-M cells represent two 
different populations along the EMT axis. The changes that occur during EMT can 
induce phenotypic switching both in normal and neoplastic development and here, 
we have shown that a switch to N-cadherin expression during EMT is an important 
process involved in phenotypic switching between two heterogeneous 
subpopulations of a lung cancer cell line. The definition of an epithelial cell is one 
that possesses tight junctions, cell polarity between apical and lateral domains, 
maintains cell interactions with neighbouring cells and displays a pseudo-
immobility between itself and the microenvironment (Savagner 2007). Based on 
these definitions, our results indicate that DLKP-SQ, as opposed to DLKP-M cells, 
possess more epithelial-associated traits. The ability of DLKP-SQ cells to 
successfully process the transfected E-cadherin transgene to induce E-cadherin 
protein expression at the cell membrane further supports this hypothesis. 
Further characterisation of these clones would be beneficial and provide further 
insights into the re-programming events that have occurred to give rise to the 
different cell phenotypes. This would provide important information regarding 
potential therapeutic targets for cancer treatments. 
Future experiments in this project should investigate the effect of the E-cadherin 
reporter plasmids in DLKP-I clones. These cells express N-cadherin, similar to 
DLKP-M but lack E-cadherin. They represent an EMP population between DLKP-
SQ and DLKP-M on the EMT axis. Transfection of DLKP-I cells would further 
elucidate where on the cadherin axis this “intermediate” population exists. Future 
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experiments should also address the potential cleavage events and downregulation 
of the E-cadherin protein which occurs in DLKP-M cells following E-cadherin 
overexpression.  
The DLKP cell line was harvested from a primary lymph node metastasis of a 
primary poorly differentiated lung cell carcinoma (Law et al. 1992). This finding 
itself demonstrates that the cells of the DLKP parental population must possess the 
ability to undergo EMT and disseminate from the primary lung tumour. These cells 
were capable of migrating through the body and interacting with extracellular 
matrix proteins to undergo some form of MET and establish a metastatic site at a 
new location, the lymph node in this instance. The results presented here and in 
chapter 3 demonstrate that the DLKP subpopulations are a unique and dynamic 
model of studying EMT-mediated phenotypic switching in heterogeneous lung 
cancer cell line (Figure 4.0.18). Understanding the mechanisms controlling this 
process is important for the development of more clinically relevant cancer 
therapeutics directed against heterogeneous tumours. 
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Figure 4.0.18 DLKP clones represent different stages of EMT 
DLKP-SQ cells present a more “normal” epithelial phenotype in the early 
stages of EMT-mediated phenotypic switching. DLKP-I cells represent an 
EMP-like phenotype with a hybrid of epithelial and mesenchymal 
characteristics. DLKP-M cells represent late-stage EMT and possess 
mesenchymal-like markers and an elongated, motile phenotype. Modified 
from SpringerImages. 
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Chapter 5 
Mapping the BMP Pathway in 
healthy porcine airways and 
investigating the role of a BMP 
signalling gradient in the lung 
epithelium  
 
5.1 Introduction 
The development of the lungs from an amniotic fluid-filled sac in the embryo to a 
complex arborized respiratory system responsible for oxygenation of the blood is a 
finely tuned and complicated process. Growth factors and morphogens such as 
Fibroblast Growth Factor (FGF), Wnt-βcatenin, Notch and Bone Morphogenetic 
Proteins (BMP) produced by the underlying mesoderm and developing endoderm 
form a complex signalling network co-ordinating this developmental processes. 
BMP signalling, specifically, orchestrates the branching events in the nascent lung 
and the correct epithelial cell distribution along the proximal-distal axis (Alejandre-
Alcázar et al. 2007; Weaver et al. 1999; Weaver, Dunn, and Hogan 2000). 
While BMP signalling in the developing lung has been extensively studied, BMP 
pathway expression in healthy airways remains largely unaddressed. A study by 
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Kariyawasam et al. 2008 demonstrated the presence of BMP ligands and receptors 
in the lung epithelium of healthy human subjects. Similar expression of BMP 
ligands, BMPRIb and BMPRII was found in the bronchial epithelium of healthy 
mice (Rosendahl et al. 2002). This is in contrast to studies of the mouse lung 
epithelium which showed a BRE-eGFP reporter was barely detectable and pSMAD 
1/5/8 expression was absent in the airways of healthy adult mice (Sountoulidis et 
al. 2012). In inflammatory and fibrotic lung diseases, there is growing evidence that 
the BMP pathway becomes re-activated and is involved in the repair of the damaged 
epithelium and/or perpetuating the disease phenotype (Koli et al. 2006; Masterson 
et al. 2011; Mccormack et al. 2013; Rosendahl et al. 2002). Despite the importance 
of BMP signalling during epithelium repair and disease, BMP signalling during 
adult airway homeostasis and the concept of BMP signalling gradients existing 
along the respiratory tract remains largely unexplored. 
We hypothesise that the BMP signalling pathway is active during adult lung 
homeostasis. We set out to map the expression of BMP ligands, SMAD signalling 
molecules and antagonists of the BMP pathway in the descending lung epithelium 
of a large animal model. In addition, we aim to investigate the function of BMP 
signalling gradients in the lung epithelium and explore the role of BMP signalling 
in differentiated lung epithelium. 
To address our aim in a large animal model, we used porcine lungs due to the 
comparative lung size, physiology, anatomy and biochemistry between adult human 
and pig lungs (Judge et al. 2014; Rogers et al. 2008)  
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5.1.1 Examination of lung architecture and histology in the large 
porcine airways  
Porcine lungs were used in this study due to the robust comparative lung biology 
between pigs and humans. The porcine lung shares similar morphological structure 
and architecture to the human lung with similar bronchial generations and an 
inverse relationship between airway diameter and length and bronchial tree 
bifurcations (Dondelinger et al. 1998; Maina and van Gils 2001). 
Porcine lungs were obtained from two local abattoir at Rosderra Irish Meats, 
Edenderry, Co. Meath and Coogan Meats, Trim, Co. Meath. The porcine lungs were 
harvested from pigs weighing 70 kg reared in the Irish countryside prior to 
slaughter. The lungs were removed from the fully grown pigs and transported on 
ice to the lab in Maynooth University, Maynooth, Co. Kildare, Ireland. Once in the 
lab, the lungs were submerged in pre-warmed medium, each lobe was dissected and 
sterile water was used to flush out any residual mucus. Approximately five pig lungs 
were obtained to learn and improve the dissection technique and carry out the H&E 
and PAS staining and E-cadherin immunofluorescence. 
The large porcine airways were dissected as per the map designed in the O’Dea lab 
previously by Dr. Eoin Judge (Figure 5.0.1) (Judge et al. 2014). This standardised 
classification of the porcine airways did not exist prior to the present study. 
Therefore, alternate classifications of the lung bronchi and bronchioles were 
assigned for the purpose of this study. The right lung consists of four lobes so the 
right bronchus was classified numerically according to each lobe, RB1-4. RB1 was 
described as cranial and caudal branches. The RB4 was separated to superior and 
inferior sections because of its length. Similar classifications were assigned for LB1 
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and LB2. Large airway dissections were carried out and subsequent H&E, PAS and 
immunofluorescence of the sections was performed.  
 
  
Figure 5.0.1 Map of the large airways in porcine lungs 
The four bronchi in the right porcine lobe are divided 1-4. The two bronchi in the 
left porcine lobe are divided 1-2. Each section is assigned a number from 1-14 for 
ease of section identification. This map was designed previously in the O’Dea lab 
by Dr. Eoin Judge. 
RB= right bronchus, LB= left bronchus, cr=cranial, cd = caudal, sup=superior, inf 
= inferior 
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Using H&E and PAS staining, the architecture of the lung epithelium throughout 
the airways was examined. The sections were arranged according to decreasing 
airway size. The progression from pseudostratified columnar epithelium in the 
trachea to ciliated columnar epithelium lining the small bronchi and bronchioles 
was observed. The complex nature of the descending lung epithelium was also 
evident in the sections and the diverse range of epithelial cells could be seen in the 
sections. Ciliated epithelial cells, basement membrane, basal cells, goblet cells, 
lamina propria, submucosal glands, smooth muscle cells and underlying connective 
tissue and cartilage were present in the sections (Figure 5.0.2 -3). 
By using PAS staining techniques to detect polysaccharides and mucosubstances 
such as mucins in the lung epithelium, the frequency of goblet cells and submucosal 
glands in the descending porcine airways was examined. In the epithelium of the 
upper airways, there was a large volume of goblet cells and submucosal glands, as 
evidenced by the positive dark PAS stain (Figure 5.0.2). 
The distribution of epithelial cells was examined in the large airways of the pig lung 
by immunostaining for E-cadherin expression (Figure 5.0.4). The tall, 
pseudostratified epithelial cells of the trachea and upper airways was clearly visible 
in sections 1-7. As the airways became narrower and the bronchi develop into 
smaller bronchioles, the tall pseudostratified epithelial cells developed into ciliated 
columnar cells, as seen in section 14. These experiments were also performed to 
optimise the techniques required for subsequent experiments in this study in 
addition to providing an extensive histological analysis of the lung epithelium in 
the descending airways of porcine lungs.   
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Figure 5.0.2 H&E and PAS staining of large porcine airways arranged 
according to decreasing size (part I/II) 
Representative micrographs of H&E and PAS staining throughout the large 
porcine airways. Scale bars represent 20uM and 50uM respectively. Sections 
represent lung regions in figure 5.0.1. 
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Figure 5.0.3 H&E and PAS staining of large porcine airways arranged 
according to decreasing size (part II/II) 
Representative micrographs of H&E and PAS staining throughout the large 
porcine airways. Scale bars represent 20uM and 50uM respectively. Sections 
represent lung regions in figure 5.0.1. 
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E-cadherin 
Figure 5.0.4 E-cadherin immunofluorescence staining of large porcine 
airways arranged according to decreasing size 
Representative micrographs of E-cadherin immunofluorescence throughout the 
large porcine airways. The “chicken-wire” characteristic E-cadherin staining was 
detected in the descending epithelium. DAPI counterstain is shown in blue. Scale 
bars represent 50uM. Sections represent lung regions in figure 5.0.1. 
 
DAPI E-cadherin DAPI 
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5.1.2 Examination of lung architecture in the left cranial 
bronchus of porcine airways 
The left cranial lobe was chosen for our study of the descending airways because 
of its similarities to the human left cranial lobe and the overlap with another study 
examining BMP signalling in the left cranial lobe of rhesus macaques (Lynn et al. 
2015). To ensure that the tissue remained intact during the experimental procedure 
histological profiling was carried out on sequential sections of the left cranial 
bronchus. The sections were characterised as trachea, conduction airways 
(section2-5) and distal bronchioles (6-9) for the purpose of this study (Figure 5.0.5). 
Approximately five pig lungs were obtained to perfect the dissection of the left 
cranial lobe and carry out subsequent processing.  
The epithelium and underlying connective tissue of the descending airways 
remained intact following dissection. Examination of the sections showed the 
presence of pseudostratified ciliated epithelium descending into ciliated columnar 
epithelium. There was a reduction in the frequency of goblet cells in the distal 
epithelium compared to the trachea and upper airways, as demonstrated by the 
positive dark PAS staining (Figure 5.0.6).  
E-cadherin immunofluorescence served as an additional control to ensure that the 
epithelium remained intact following tissue processing. The characteristic 
“chicken-wire” pattern of staining around the cell membrane of the epithelial cells 
was detected by immunofluorescence (Figure 5.0.7). Small cuboidal basal cells 
lining the basement membrane were also evident in the sections. There was 
evidence of submucosal glands in the trachea and upper sections of the left 
bronchus, which are also E-cadherin positive.  
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Figure 5.0.5 Sequential sections of the left cranial bronchus 
Sequential sections were dissected from the left cranial lobe along the main stem 
bronchus. Each section was measured to 10mm and subsequently fixed in 
paraformaldehyde or prepared for RNA or protein harvest. The sequential 
sections were characterised as trachea, conduction airways (section2-5) and 
distal bronchioles (6-9) for the purpose of this study. 
Distal bronchioles 
section 6-9 
Conducting airways 
section 2-5 
Trachea 
section1 
BMP signalling in porcine airways 
  
 
217 
 
 
  
1 
2 
3 
7 
8 
9 4 
5 
6 
H&E PAS H&E PAS  
7 
8 
9 
6 1 
2 
3 
4 
5 
Figure 5.0.6 H&E and PAS staining of descending sections of the left cranial 
bronchus 
Representative images of H&E and PAS staining in the descending left cranial 
bronchus. Scale bars represent 20uM. Sections represent lung regions in figure 
5.0.5. 
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E-cadherin DAPI combined 
Figure 5.0.7 E-cadherin immunofluorescence staining of descending sections 
of the left cranial bronchus. 
The intact epithelium was detected by the characteristic “chickenwire”-like E-
cadherin staining. Scales bars represent 20uM. Sections represent lung regions in 
figure 5.0.5 
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5.1.3 Expression of the BMP pathway in healthy descending 
airways 
BMP pathway expression in healthy adult airways remains poorly defined despite 
extensive research on developing lungs and the emerging role of BMP signalling in 
lung diseases. To address this question, we set out to map the BMP pathway in 
healthy adult lung epithelium. The descending lung epithelium in the left cranial 
porcine bronchus was used (Figure 5.0.5). Protein and RNA were extracted from 
sequential sections along the length of the left cranial bronchus and the expression 
of various BMP ligands, receptors, SMADs and pathway inhibitors were examined. 
The sequential sections were characterised as trachea, conduction airways 
(section2-5) and distal bronchioles (6-9) for the purpose of this study. 
The expression of BMP-2, BMP-4 and BMP-7 mRNA were examined by qPCR, 
based on existing knowledge that these ligands are involved in lung morphogenesis 
and are expressed in the bronchial epithelium during inflammatory, fibrotic and 
malignant lung diseases.  There was a significant difference in the expression of all 
three ligands between the tracheal epithelium and distal epithelium. BMP-2 
expression was significantly (p<0.05) higher in the distal bronchioles and similarly, 
BMP-4 expression was significantly increased in conducting airways (p< 0.05) 
compared to the trachea. Conversely, BMP-7 mRNA expression was reduced in the 
distal bronchioles compared to the trachea (p<0.005) (Figure 5.0.8 A).  
SMAD-6 and SMAD-7, the inhibitory SMAD proteins were expressed at a higher 
level in the trachea compared to the distal epithelium (p<0.005 and p<0.05, 
respectively). SMAD-4 also known as co-SMAD, is expressed throughout the 
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bronchial epithelium with elevated mRNA levels present in the trachea compared 
to the distal bronchioles (p<0.05) (Figure 5.0.8 B). 
When BMP receptors mRNA expression was investigated in the descending 
epithelium of the left cranial lobe, there was no evident difference in BMPRIa 
expression. However, a significant decrease in BMPRIa receptor expression 
emerged between tracheal epithelium and distal bronchial epithelium (p<0.05) 
(Figure 5.0.8 C). 
The levels of gremlin and another common BMP-antagonist called noggin were 
examined using q-PCR in the descending lung epithelium of the left cranial lobe. 
The results indicated a significant negative gradient in both BMP antagonist mRNA 
expression between the tracheal epithelium and the distal bronchial epithelium 
(p<0.0005) (Figure 5.0.8 D). There was also a significant decrease in gremlin and 
noggin signal expression between the trachea and the conducting airways 
(p<0.0005). 
These results indicate that not only is the BMP pathway expressed in the healthy 
adult epithelium but that significant expression gradients of  BMP ligands and 
antagonists exist throughout the airways.  
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  Figure 5.0.8 Quantitative PCR of BMP signalling components in the 
descending lung epithelium 
Representative graphical analysis of q-PCR analysis of BMP ligands, SMADs, 
BMP receptors and BMP antagonists in the descending lung epithelium of the left 
cranial porcine bronchus. (A) The expression of BMP-2,-4 and -7 mRNA was 
significantly higher in the most distal region of the left cranial lobe. (B) SMAD-4 
mRNA was present throughout the airways with reduced expression in the distal 
bronchioles. Inhibitory SMADs, SMAD-6 and SMAD-7 mRNA was significantly 
reduced in the epithelium of distal bronchioles compared to the trachea. (C) There 
was no BMPRIa gradient present in the airways. BMPRIb was significantly reduced 
in the distal epithelium compared to the trachea. (D) There were significantly 
elevated levels of BMP inhibitors present in the proximal airways epithelium 
compared to distal regions. n=3, * =  p < 0.05, ** p < 0.005, Trachea = section1, 
CA, Conducting airways = sections 2,3,4,5 DB, distal bronchioles = sections 6,7,8,9 
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5.1.4 Expression of the BMP signalling proteins in healthy 
descending airways 
Following characterisation of the BMP signalling pathway at the mRNA levels, the 
level of expression of BMP pathway signalling proteins were examined by western 
blot. 
BMPRIa protein was expressed throughout the descending airways and no gradient 
in protein expression was detected (Figure 5.0.9 A). Investigation of SMAD-4 
protein expression throughout the descending airways revealed a significant 
decrease in expression between the tracheal epithelium and the distal bronchioles 
(Figure 5.0.9 B).  Unfortunately, there were no pig-specific antibodies available for 
the BMP ligands, BMPRIb, SMAD-6 or SMAD-7.  
pSMAD 1/5/8 was expressed homogenously throughout the descending airways 
(Figure 5.0.9 C). Previous results here showed that SMAD-4 protein and mRNA 
expression was reduced in the distal bronchioles which indicated the presence of 
non-canonical BMP signalling, Thus, pERK 1/2 was examined by western blot. 
pERK 1/2 was expressed in the descending lung epithelium of the left cranial 
bronchus and no significant gradient in protein expression was evident (Figure 5.0.9 
D). 
 These results provide further evidence that the BMP pathway is active during adult 
airway homeostasis.  
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Figure 5.0.9 Expression of BMP signalling proteins in the descending left 
cranial porcine bronchus 
Representative graphs of western blot analysis of BMPRIa, SMAD-4, pSMAD and 
pERK expression in the descending left cranial porcine bronchus. (A) No BMPRIa 
gradient existed in the descending bronchial epithelium. (B) SMAD-4 was 
differentially expressed between the trachea and the distal bronchioles (p<0.05) (C) 
No difference in pSMAD 1/5/8 expression was detected (D) No difference in pERK 
1/2 was detected in the descending bronchial epithelium, n=3, * = p < 0.05, ** p < 
0.005, Trachea = section1. CA, Conducting airways = sections 2,3,4,5. DB, distal 
bronchioles = sections 6,7,8,9 
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5.1.5 Establishing a porcine tracheal explant model in vitro 
By mapping the BMP pathway using quantitative PCR and western blotting, a BMP 
signalling gradient was detected in the descending airways. BMP-2 and BMP-4 
ligands were expressed at an elevated level in the distal bronchial epithelium 
compared to the trachea. In what appeared to be an inverse relationship, the BMP 
antagonists gremlin and noggin were expressed more abundantly in the tracheal 
epithelium and proximal airways compared to distal epithelial regions in the adult 
lung, (Figure 5.0.10). We hypothesised that this gradient was involved in 
maintaining epithelial homeostasis. To investigate this in adult porcine tracheal 
epithelium, an in vitro porcine tracheal explant model was designed. 
The tracheal tissue of the pig was sectioned longitudinally along the trachealis. This 
is the band of smooth muscle that bridges the gap between both sides of the 
cartilaginous tracheal circumference. Following wash steps, the explants were 
grown in culture at air liquid interface (Figure 5.0.11).  
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Figure 5.0.10 A BMP signalling gradient was detected in the descending 
porcine airways 
Quantitative PCR and western blotting analysis revealed a gradient in BMP 
signalling in the descending airways. BMP ligands were higher in the proximal 
airways compared to the distal regions of the lungs. Conversely, extracellular BMP 
antagonists gremlin and noggin were higher in the tracheal epithelium compared to 
the distal bronchial epithelium. Trachea=section 1, conducting airways = section 
2,3,4,5, distal bronchioles = sections 6,7,8,9 
Conducting airways 
section 2-5 
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section 6-9 
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Porcine tracheal explant 
12-well culture plate with medium 
Agar plug (10mm high approx.) 
Figure 5.0.11 Establishing an in vitro porcine tracheal explant model  
Longitudinal sections of trachea were sectioned and washed and dissected to 
small explant sections. These sections were placed on agar plugs in 12-well 
culture plates and grown for 2-3 days.  
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5.1.6 Examination of porcine tracheal explant architecture 
Following establishment of explant culture conditions, the tracheal tissue was 
maintained at 37 °C for 48 hrs. Histological analysis by H&E and PAS staining and 
E-cadherin immunofluorescence was carried out to assess the architecture of the 
explant and to ensure the epithelial layers remained intact following the culture 
process.  
The tracheal explants were fixed in formalin and embedded in wax after 48 hrs in 
culture. Subsequent H&E and PAS staining revealed that the epithelium was intact. 
The pseudo-stratified epithelium, a submucosal glands and lamina propria were 
evident following staining. The gland stained dark purple in the PAS stain due to 
presence of mucus and polysaccharides (Figure 5.0.12 A). Following E-cadherin 
immunofluorescence, the intact epithelium was clearly visible. The pseudostratified 
epithelium can identified by the tall E-cadherin positive epithelial cells situated on 
top of the small cuboidal basal cells (Figure 5.0.12 B). The lamina propria does not 
stain for E-cadherin protein and there was evidence of E-cadherin positive 
submucosal gland in the lower magnification image of the tracheal explant. 
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Figure 5.0.12 Histological analysis of porcine tracheal explants 
(A) H&E and PAS histological staining revealed the pseudostratified epithelium, 
submucosal glands, lamina propria and underlying connective tissue of the porcine 
tracheal explant remain intact following 24 hr culture in vitro. There was no damage 
to the sections during culture and processing. (B) E-cadherin immunofluorescence 
of the tracheal explants showed the chickenwire pattern of the intact epithelium. 
Epi = epithelium, SubM = submucosal glands, LP = lamina propria, Lu = lumen. 
Sclae bars represent 20uM, 20uM and 50uM respectively. 
DAPI combined 
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5.1.7 Evaluation of viability of porcine tracheal explants 
To assess for epithelial cell viability, uptake of the fluorescent nucleic acid 
intercalator 7AAD was examined.. The epithelial and submucosal layers of the 
tracheal explant were micro-dissected from the explant and prepared for enzyme 
digestion. The cells were then passed through a 70uM filter prior to incubation with 
the dye. FACS analysis revealed that approximately 85% of the tracheal explant 
cells remained viable following 48 hrs in culture (n=6) (Figure 5.0.13). 
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Figure 5.0.13 Porcine tracheal explants remained viable after 48 hrs in 
culture 
(A) Representative FACS data of porcine tracheal explant viability following 
48 hrs in culture. 82.2% of the cells remained viable, as 17.8% were 
fluorescent due to uptake of the intercalated 7AAD stain  (B) Graph depicting 
percentage cell survival following 48 hrs in culture (n=6). 
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5.1.8 BMP pathway activation following exogenous BMP-4 
stimulation of porcine tracheal explants 
Given that the epithelium of the tracheal explants were intact and the epithelial cells 
were viable following 48 hrs in culture, we wanted to confirm that the tissue was 
responsive to exogenous BMP ligand stimulation. The tracheal explants were 
grown in serum free conditions and treated with 100ng/ml BMP-4. The medium 
containing BMP-4 ligand was added into the chamber surrounding the agar plug 
and thus, any BMP-4 induced signalling was due to the activation of BMP receptors 
by growth factors present in the serum. This was chosen as the best method for 
BMP pathway activation in our culture model based on existing evidence that BMP 
receptors are present on the basal surface of polarised epithelial cells (Saitoh et al. 
2013). 
 Following 24 hr stimulation with exogenous BMP-4 ligand, RNA was harvested 
and reverse-transcription-PCR was carried out. An increase in ID-1 expression was 
evident (Figure 5.0.14 A). pSMAD 1/5/8 was expressed endogenously in the 
tracheal explant, as detected by western blot. Exogenous treatment with BMP-4 
induced an increase in pSMAD 1/5/8 expression in the tracheal explant. 
Densitometry analysis of the western blots revealed a significant increase in 
pSMAD 1/5/8 protein expression (p<0.05, n=3) (Figure 5.0.14 B).  
Taken together these results indicate that the porcine tracheal explant system 
recapitulated a healthy porcine epithelium in vivo. The explants maintained their 
epithelial cell phenotype, were viable in the culture system and were responsive to 
BMP-4 ligand treatment during in vitro culturing.  
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Figure 5.0.14 Porcine tracheal explants were responsive to exogenous BMP-4 
treatment 
Serum-free explants were supplied with medium containing 100ng/ml BMP-4 for 
24 hrs. This medium was placed in the chamber surrounding the agar plug and 
bathed the basal surface of the explant. The epithelium of the explant was 
dissected away from the connective tissue and harvested for RNA and whole cell 
protein. (A) rt-PCR indicated an increase in Id-1 expression. A 10% serum 
containing control was included. (B) Analysis by Western blot and subsequent 
densitometry showed a significant increase in pSMAD 1/5/8 expression n=3, 
p<0.05 
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5.1.9 Expression of epithelial cell markers and transcription 
factors of the distal lung epithelium in porcine tracheal explants 
following 24 hr treatment with BMP-4 
Given that BMP-4 is involved in distal epithelial cell expansion in lung 
morphogenesis and that BMP-4 mRNA was higher in distal lung epithelium in 
healthy porcine airways, we investigated whether BMP-4 exposure would result in 
expression of markers of distal cell phenotypes in the tracheal tissue.  
Following 24 hr stimulation with 100 ng/ml BMP-4, RNA was harvested from the 
tracheal explants and rt-PCR was carried out with a range of primers designed for 
pig epithelial cell markers. There was a significant increase in mRNA expression 
of SFTPC, a marker of the distal epithelial alveolar cell and ITGA-6, a marker for 
basal cells in the lung epithelium (p<0.05) (Figure 5.0.15).  There was no significant 
difference in the expression of EpCAM, K18, FOXA1 or AQP5 – markers of both 
bronchial and distal lung epithelium. 
 The expression levels of transcription factors responsible for distal epithelium 
differentiation SOX-9, ID-2 and GATA-6 were examined by rt-PCR. SOX-9, ID-2 
and GATA-6 were expressed at a low level in the tracheal tissue explants. A 
significant increase in both SOX-9 and ID-2 expression occurred in the tracheal 
explants following treatment with BMP-4 (p<0.05) (Figure 5.0.16). A serum 
control was included in all experiments to rule out the induction of any BMP 
pathway activation by growth factors ubiquitously present in the serum.   
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Figure 5.0.15 Expression of epithelial cell markers in porcine tracheal explants 
following BMP-4 stimulation 
There was a significant increase in mRNA expression of the basal cell surface 
marker ITGA6 and type II alveolar cell marker SFTPC in the tracheal explants 
following 24 hr incubation with 100 ng/ml BMP-4. An increase in EpCAM, K18 
and FoxA1 mRNA was evident, although not significant. There was no change in 
AQP-5 mRNA expression. n=3, * = p< 0.05 
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Figure 5.0.16 Expression of transcription factors of the distal epithelium in 
porcine tracheal explants following BMP-4 stimulation 
(A)Elevated mRNA expression of SOX-9 was detected following BMP-4 treated. 
(B) Elevated mRNA expression of ID-2 was detected following BMP-4 treatment 
(C) No significant difference in GATA-6 mRNA expression was detected following 
BMP-4 treatment. n=3, *=p<0.005 
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5.2 Discussion 
It is believed that signalling pathways involved in lung morphogenesis are 
reactivated in the airways during repair and recovery after injury. These signalling 
pathways are also activated in lung diseases, such as cancer and inflammatory lung 
diseases. Furthermore, gradients of morphogens, such as BMP4, are critical in 
forming the lung architecture as well as directing the spatial distribution of 
epithelial cells types throughout the airways during embryogenesis (Bellusci et al. 
1996; Weaver et al. 1999). The concept of BMP signalling gradients in adult lungs 
remains unaddressed. Without understanding growth factor expression patterns in 
healthy adult airways, the framework provided by developmental and disease 
studies will continue to act as a weak translational model for human disease and the 
design of therapeutics. The map generated in this study highlights BMP signalling 
as an important mediator of normal epithelial homeostasis in adult airways. BMP 
signalling components were expressed endogeneously in the descending lung 
epithelium of porcine airways and a BMP ligand-antagonist gradient was detected. 
We have identified a potential role for BMP-4 mediated signalling in the 
maintenance of distal epithelial cell populations and adult airway homeostasis. 
The porcine lung was chosen as the best available, clinically-relevant model of adult 
airways. Porcine lungs are steadily becoming a widely accepted model of adult 
human airways (Benahmed et al. 2014; Harrison et al. 2014; Judge et al. 2014; 
Rogers et al. 2008). On an economic level, no respiratory tissue is required in food 
production so the lungs are readily available from the local abattoir and circumvent 
the need for ethical approval. Large animal models are also translationally relevant. 
When comparing the lung anatomical features of humans and small vertebrates, 
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there are a large number of discrepancies. Gross differences in lung size and lobe 
numbers and more subtle differences such as the club cell distribution in the mouse 
trachea and the lack of terminal bronchioles in mice make the respiratory system of 
large animals such as the pig a more attractive and relevant model (Fox et al. 2006).  
Initially we investigated the changing architecture of the descending porcine 
epithelium throughout the airways. By using a map generated previously in the 
O’Dea lab, we carried out an extensive histological analysis of the large porcine 
airways and demonstrated the gradual transition of tall pseudostratified columnar 
epithelium of the trachea and upper airways to the simple ciliated epithelium in the 
smaller bronchioles. By combining this study with histological analysis of the 
descending left cranial bronchus we generated an extensive map of the changing 
epithelium in porcine airways (Figure 5.0.2, 5.6, 5.7). The use of the PAS stain 
allowed for visualisation of submucosal glands and goblet cells in the descending 
airways. Goblet cells were more infrequent in the descending airways of porcine 
lungs, as expected. The presence of basal cells lining the basement membrane were 
evident in the E-cadherin stained sections. This data also showed that no basement 
membrane deposition or epithelial disruption had occurred in the porcine airways. 
This study allowed for the optimisation of techniques required for additional studies 
in the project and provided an extensive characterisation of the gross anatomy of 
descending porcine epithelium. To the best of our knowledge, a similar histological 
characterisation of the descending porcine lung epithelium has not been completed. 
We hypothesised that BMP signalling was active in the healthy adult porcine 
airways. The existence of a BMP signalling gradient in fully developed lungs has 
not been explored. A previous study of porcine tissue showed that the BMP-4 gene 
was highly conserved between humans and pigs and that BMP-4 transcript was 
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present in the lung tissue of pigs at day 7, day 14, day 28 and also in a 1.5 yr old 
sow (Li et al. 2010). In the pig ovary it was found that a functional BMP signalling 
network exists (Brankin et al. 2005). These results indicate that BMP signalling 
does play some role in adult homeostasis in the body. Data from mouse and human 
asthmatic studies highlighted a tentative role for BMP signalling in adult airway 
homeostasis. Elevated expression of all three BMP receptors, BMPRIa, BMPRIb 
and BMPRII in the late stage of mouse lung development and in the post-natal 
epithelium further supported this hypothesis (Alejandre-Alcázar et al. 2007; 
Kariyawasam et al. 2008; Rosendahl et al. 2002). In this study, we demonstrated 
that BMPRIa and BMPRIb expression was maintained in the adult porcine 
epithelium (Figure 5.0.10). A reduction of BMPRIb RNA expression was detected 
in the distal epithelium. As BMP signalling requires a single type-1 BMP receptor 
to propagate the downstream SMAD signalling cascade the maintained expression 
of BMPRIa in the distal epithelium supported the concept of active BMP signalling 
in the airways, as evidenced by pSMAD 1/5/8 expression. This active signalling 
was further supported by the presence of BMPRIa protein throughout the airways, 
as detected by western blot (Figure 5.0.9). Interestingly a lower level of BMPRIa 
protein was detected in the distal airways compared to the trachea which could 
indicate that BMP signalling is more active in the proximal regions of the airways. 
BMPRIb and BMPRII protein expression were not examined in the distal airways 
due to a lack of specific antibodies. In summary the expression of BMP receptors 
in the adult porcine lung epithelium indicate that the airways are responsive to BMP 
signalling.  
The lung epithelium is the first point of contact with all inhaled pathogens, toxins, 
allergens and noxious gases and there is a constant low level of epithelial turnover. 
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Damaged, aged or injured cells need to be replaced to maintain airway homeostasis, 
ensure epithelial integrity is maintained and lung health is not compromised. (Brune 
et al. 2015; Crosby and Waters 2010). Repopulation of damaged regions of the 
epithelial sheath occurs through activation of regional progenitor populations and 
proliferation of existing undamaged cells in the airways. We hypothesise that the 
active pSMAD 1/5/8 signalling evident in the porcine lung epithelium is involved 
in regulating epithelial turnover and proliferation events. There was no gradient in 
total pSMAD 1/5/8 expression along the proximal-distal axis (Figure 5.0.9). We 
hypothesise that active pSMAD 1/5/8 expression is induced by BMP ligands such 
as BMP-2, BMP-4 and BMP-7, which were also observed throughout the airways. 
We speculate that the inverse patterns of BMP-2,-4 and -7 expression in the 
descending lung epithelium may account for the uniform pSMAD 1/5/8 expression 
throughout the airways. 
 Non canonical BMP signalling occurs via Rho-like small GTPases, 
phosphatidylinositol-3-kinase/AKT and other MAP kinase pathways. These Rho-
GDP induce downstream signalling cascades and induce phosphorylation of 
ERK/MEK. As a mediator of BMP signalling and other signalling cascades we 
investigated the presence of pERK-1 and pERK-2 in the descending lung 
epithelium. We found that phosphorylated ERK-1 and 2 (pERK1/2) were present 
in the descending porcine epithelium which indicated that a non-SMAD pathway 
was active in the airways. We hypothesise BMP ligand expression is responsible, 
at least in part, for this signalling however the lack of a gradient in expression is 
indicative of the presence of alternative growth factors. 
In summary, these findings indicate that BMP signalling is active in healthy 
descending porcine airways. The activity of SMAD-dependent and –independent 
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signalling pathways highlights a role for BMP signalling in normal epithelial 
turnover and maintaining epithelial homeostasis.  
Inhibitors of the BMP pathway are involved in controlling signalling events during 
lung morphogenesis. Our study found that a significant gradient in both BMP 
antagonists was present in the descending airways of healthy porcine lungs (Figure 
5.0.8). We hypothesise that the gradient in antagonist expression could be 
associated with BMP regulation of normal epithelial cell turnover and the 
differentiation processes governing airway homeostasis. Furthermore we 
hypothesise that the elevated expression of BMP antagonists in the proximal 
airways may be linked to regulation of distal epithelial populations. Reduced 
expression of BMP-2,-4 ligands in the trachea supported this hypothesis. Although 
there was a high level of gremlin and noggin in the trachea, a basal level of pSMAD 
1/5/8 expression was detected by western blot. This also supports the hypothesis 
that these inhibitors were regulating the BMP pathway – as opposed to preventing 
pathway activation completely. Furthermore, in the tracheal explant study, we 
speculate that the introduction of ectopic BMP-4 ligand overcame the control 
exerted on the pathway via endogenous gremlin and noggin expression and thus 
accounted for the observed increased in pSMAD 1/5/8 expression (Figure 5.0.14).  
The expression of iSMADs displayed a similar pattern as the extracellular 
antagonists when investigated by quantitative PCR. The expression of SMAD-7 in 
the porcine airways may be associated with TGF- β expression. Both SMAD-6 and 
SMAD-7 mRNA expression was higher in the tracheal epithelium compared to 
distal bronchial epithelium (Figure 5.0.8). The gradient along the proximal-distal 
axis supports the hypothesis that elevated BMP signalling is associated with 
maintaining distal epithelial cell populations. The role of SMAD-6 in maintaining 
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correct cell phenotype and homeostasis of the heart and has previously been 
demonstrated in mouse. Studies mutating Madh6, the gene that codes for SMAD-6 
protein, show that SMAD-6 plays an important role in adult cardiac homeostasis. 
The viable adult mutants displayed hyperplasia of mesenchymal cells, aortic 
ossification and hypertension(Galvin et al. 2000).  
In summary, these results indicate the importance of regulating the BMP signalling 
pathway in healthy adult airways. We hypothesise that the regulation of BMP 
signalling in the adult lung epithelium by iSMADs and other antagonists is an 
important process in adult airway homeostasis and could be involved in maintaining 
correct distal epithelial cell distribution. Antagonising BMP signalling has been 
shown to be vital for muscle, bone and adipose tissue homeostasis and our results 
indicate that BMP signalling regulation is also involved in lung homeostasis 
(Krause 2014) 
We identified a gradient in BMP-2 and BMP-7 ligand mRNA expression along the 
respiratory axis of the porcine lung (Figure 5.0.8). The presence of BMP ligand 
mRNA in healthy porcine epithelium is supported by evidence that BMP-2 -4 and 
-7 ligands are also expressed in healthy human airway epithelium (Kariyawasam et 
al. 2008). No distinct role for BMP-2 in lung morphogenesis or lung epithelial cell 
differentiation has been discovered, however BMP-2 expression is elevated during 
inflammation by IL-1 and TNF-a (Fukui et al. 2003).  BMP-2 also possesses the 
ability to induce EMT in human airway epithelial cells during epithelial restitution 
(McCormack et al. 2013). Thus, we hypothesise that there is a basal level of BMP-
2 ligand expression may be present in the airways and that following airway injury 
and the induction of pro-inflammatory cytokines, BMP-2 expression is elevated 
above a threshold and leads to the induction of EMT and the restoration of epithelial 
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integrity. BMP-7 is also elevated in the bronchial epithelium following the airway 
insult and it has been shown that BMP-7 co-localised with the Major Basic Protein 
subunit of infiltrating eosinophils in human asthmatic airways (Kariyawasam et al. 
2008). Similar to Kariyawasam et al., 2008 we hypothesise that BMP-7 is involved 
in airway repair and that the expression of BMP-7 in the healthy bronchial 
epithelium can be activated on demand following airway damage. These ligands 
could also be contributing to the basal activation of pSMAD 1/5/8 in the airway 
epithelium and contributing to control of epithelial cell proliferation. 
In summary, we speculate that BMP-2 and BMP-7 expression is involved in 
epithelial homeostasis and the maintenance of basal BMP signalling expression 
which can be elevated following epithelial injury to facilitate epithelial repair and 
restoration of homeostatic conditions. We propose a potential diverging role for 
BMP-2 and BMP-7 as outlined in previous work with the DLKP cell lines whereby 
BMP-7 may be involved in anti-inflammatory processes in the airways.  
BMP-4 is important for determining epithelial cell fate along the proximal-distal 
respiratory axis during development. By generating two independent 
overexpression systems of Xenopus Noggin (Xnoggin) and a dominant negative 
BMPRIb under the control of the Sp-C promoter, inhibition of BMP signalling in 
mice caused expansion of proximal cells in distal regions of the transgenic lung. 
Distal epithelial cell populations were completely ablated (Weaver et al. 1999). 
Similar proximal cell expansion was seen in the distal lung epithelium of mice 
possessing a Sp-C/Gremlin overexpression gene (Lu et al. 2001). In summary, these 
results indicated that cells exposed to high levels of BMP-4 develop a distal 
epithelial cell fate while those exposed to little or no BMP-4 adopt a proximal 
epithelial phenotype. A similar BMP-4 expression gradient was detected in the 
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healthy porcine airways (Figure 5.0.8). We hypothesised that the BMP-4 gradient 
is involved in maintaining distal epithelial cell population in healthy adult airways. 
This hypothesis was supported by the observation of high levels of gremlin and 
noggin expression in the tracheal epithelium.  
Following treatment of the tracheal explant with exogenous BMP-4, we found that 
the expression of the distal epithelial markers ITGA6 and SFTPC were increased 
(Figure 5.0.16).  Furthermore, the expression of transcription factors ID-2 and 
SOX-9 was elevated. These transcription factors are involved in cell differentiation 
and distal epithelial bud branching during lung development (Rockich et al. 2013). 
Our results indicate that BMP-4 treatment of the tracheal explants induced a more 
distal-like epithelial cell phenotype via the induction of distal transcription factor 
expression. 
ITGA6 is a marker for basal cells which possess stem cell qualities and SFTPC is 
the common marker of alveolar type II cells (Barkauskas et al. 2013; Rock et al. 
2009). Lineage tracing and clonal assay experiments have previously shown that 
epithelial cell populations expressing either of these markers have the potential to 
self-renew and differentiate (Barkauskas et al. 2013; Rock et al. 2009). A mouse 
model of airway injury highlighted the significance of BMP signalling in epithelial 
cell renewal. It was found that following club cell ablation by naphthelene 
exposure, the expression of a GFP construct under the control of a BMP-responsive 
element was localised around NEBs and in the terminal bronchioles. These regions 
are populated by airway progenitors cells which are responsible for controlling cell 
proliferation and differentiation during development and airway repair 
(Sountoulidis et al. 2012).  Both of these markers were elevated in tracheal 
epithelial explants following BMP-4 treatment. Taken together these results 
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indicate that BMP-4 induced signalling could be important for controlling epithelial 
cell differentiation in addition to promoting a distal epithelial cell phenotype in the 
tracheal epithelial cells. 
Previous experiments using ID-2 luciferase reporter constructs in C2C12 cells 
identified a BMP-responsive region in the ID-2 promoter. The 267-bp region 
contained two bipartite units – one containing the canonical BMP-responsive 
sequence (GGCGCC and GTCT) and one containing a variant of the SMAD-
responsive element (GGCGCC and GGCG/CCGC). (Nakahiro et al. 2010). 
Furthermore, ID-2 is expressed in the developing lung bud and is known as a marker 
for distal endoderm progenitors. Linage tracing experiments have also shown that 
ID-2 + cells in the distal tip of the lung epithelium give rise to both club cell, 
neuroendocrine cell and distal (alveolar type I and II) cell populations (Liu and 
Hogan 2002; Rawlins et al. 2009). In our experiments, BMP-4 treatment caused a 
significant increase in ID-2 expression in the epithelium of porcine tracheal 
explants (Figure 5.0.16). We hypothesise that in the porcine epithelium, this BMP-
responsive element in the ID-2 promoter is activated following BMP-4 treatment. 
The direct cellular effect of ID-2 expression in the explant remains undefined but 
we speculate that it is involved in promoting a distal epithelial cell phenotype and 
regulating proliferation events. We speculate that the expression of the transcription 
factor ID-2 could be responsible for the induction of SFTPC expression in the 
porcine tracheal explants. SFTPC-expressing cells are present in the distal 
epithelium and are capable of self-renewal and differentiation as previously 
mentioned (Figure 5.0.15).  
ID-1 genes are involved in regulating cell cycle progression and inhibiting cell 
proliferation via upregulation of p16, a cyclin-dependent kinase inhibitor, and E2A 
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transcription factors E12/47 also known as TCF3. For cell cycle progression, the 
E2F and pRB protein complex is phosphorylated by cyclin-D. This phosphorylation 
event facilitates cell cycle progression from G-phase to the S-phase (Giacinti and 
Giordano 2006). p16, as a cyclin dependent kinase inhibitor can block the 
phosphorylation event of pRB by Cyclin-D and inhibit cell cycle progression 
(Ruzinova and Benezra 2003; Sikder et al. 2003; Stone et al. 1995).  Suppression 
of cell proliferation by ID-1 has been documented in human fibroblasts and 
mammary epithelial cells. This group used  mouse-mammary-viral transfection of 
sense and anti-sense ID-1 vector systems in SPc2 cells (Desprez et al. 1995). 
Conversely, ID-2 has been found to stimulate cell cycle progression by inhibiting 
the anti-proliferative effects of pRB in human osteosarcoma and glioma cell lines 
(Iavarone et al. 1994; Lasorella, Iavarone, and Israel 1996; Lasorella, Uo, and 
Iavarone 2001; Sikder et al. 2003). In our porcine tracheal explant model, an 
increase in ID-1 expression was detected following BMP-4 treatment. Our 
experiments showed that ID-2 was also elevated in our study of porcine tracheal 
explants. The confounds the hypothesis that ID-1 could be causing decreased cell 
proliferation in the porcine tissue. While the relationship between ID proteins and 
cell cycle progression remains undefined in our culture model, we hypothesise that 
BMP induces ID expression in an attempt to regulate epithelial cell proliferation 
during adult airway homeostasis.  
SOX-9 is a transcription factor expressed at the distal bronchial epithelium and is 
involved in regulating branching morphogenesis and proliferation profiles of distal 
cell progenitors in the developing airways. Both SOX-9 ectopic expression in 
proximal airways and in distal epithelium inhibited cell proliferation highlighting 
that a finely tuned balance of SOX-9 signalling is required for correct control of 
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cell proliferation. In our experiments, BMP-4 treatment of porcine tracheal explants 
caused an increase in SOX-9 mRNA expression in the tracheal explants. We 
speculate that SOX-9 could be involved in controlling cell proliferation in the BMP-
4 treated tracheal explants, perhaps antagonising the pro-proliferative effect of ID-
2 signalling (Kowanetz et al. 2004). 
 Gain- and loss- of function studies found that SOX-9 is involved in regulating the 
organisation of cytoskeletal proteins and extracellular matrix proteins of mouse 
epithelial cells such as F-actin and acetylate tubulin, COL2A1 and laminin 
respectively (Rockich et al. 2013). Rockisch et al.,  highlighted the role of SOX-9 
in epithelial movement in the mouse lung and demonstrated reduced cell migration 
and wound closure following abrogation of SOX-9. During embryogeneis, SOX-9 
is also involved in EMT during neural crest delamination and interacts with BMP 
to orchestrate correct gut-tube morphogenesis (Liu et al. 2013). The process of 
EMT is also an important phenomenon for correct lung formation, airway repair 
and disease (Shannon and Hyatt 2004). BMP-4 induces epithelial cell movement in 
human bronchial epithelial cells and also during epithelial restitution following 
injury (McCormack et al. 2013; Molloy et al. 2008). We have also highlighted the 
role of BMP-4 in EMT in DLKP cell lines in this study. It is possible that EMT is 
induced in these tracheal explant cells following exogenous BMP-4 treatment and 
that SOX-9 expression is subsequently elevated and contributes to altered epithelial 
cell phenotype. A similar link between SOX-9 and the EMT process exists in 
endocardial endothelial cells whereby SOX-9 promotes EMT after delamination 
(Akiyama et al. 2004). The essential role of SOX-9 and the organisation of 
extracellular matrix proteins is also seen in an embryonic-lethal model of cardial-
SOX-9 knockdown (Lincoln et al. 2007). 
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In summary, the induction of elevated SFTPC, ITGA-6, ID-2, ID-1 and SOX-9 
expression in the porcine tracheal explants following BMP-4 treatment indicated 
that BMP-4 mediated signalling is important for determining distal epithelial cell 
fate. Furthermore, the results highlight the potential role of BMP signalling in 
regulating cell proliferation. 
While porcine explants allowed further investigation of the role of BMP signalling 
the airways, future experiments should utilise primary culture of airway epithelial 
cells. Development of air-liquid interface cultures would provide a robust platform 
for studying the role of BMP signalling during airway homeostasis. Using targeted 
inhibition of BMP signalling by siRNA, the role of BMP pathway activation in 
epithelial cell proliferation and differentiation could be elucidated. Furthermore, 
determination of the expression of pro-inflammatory cytokines following targeted 
injury of the epithelium and the effect of BMP ligands/inhibitors on cytokine 
release would provide further insight into the role of BMP signalling in airway 
repair and inflammation. 
Our work focused primarily on characterising canonical BMP signalling in the 
descending airways. The presence of pERK 1/2 in the descending airways 
highlighted that non-canonical BMP pathways were active in the airways. Future 
experiments should characterise non-canonical BMP signalling and other growth 
factor signalling in the descending airways. This could highlight different signalling 
gradients responsible for maintaining homeostasis in the lung epithelium. 
It is important for future work investigating the BMP pathway in the airways to 
identify the specific cell populations involved in BMP signalling and to investigate 
if there is any modulation in BMP signal expression following damage and during 
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repair of the airways. For example, double immunostaining of histological sections 
with epithelial cell markers would allow characterisation of the cells responsible for 
BMP pathway activation.  
 
Our study has shown that the BMP signalling pathway is active during adult lung 
homeostasis in a large animal model. We have mapped the expression of BMP 
ligands, SMAD signalling molecules and antagonists of the BMP pathway 
throughout the descending lung epithelium of a large animal model. By 
demonstrating the existence of BMP signalling gradients in the healthy epithelium 
we can speculate about the function of BMP pathway activation in healthy adult 
airways. In addition, we developed an ex vivo porcine tracheal explant model to 
further investigate the function of the ligand-antagonist axis which was evident in 
the descending lung epithelium. Following BMP-4 stimulation, tracheal explant 
upregulated various transcription factors involved in the control of epithelial cell 
proliferation and distal epithelial cell phenotype. While BMP signalling is now 
widely recognised as an important mediator of lung morphogenesis and epithelial 
repair following injury, our results indicate that basal BMP signalling is involved 
in maintaining epithelial homeostasis in adult airways.  
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Chapter 6 
Mapping the BMP signalling 
pathway in healthy, asthmatic and 
recovering rhesus macaques 
airways  
 
6.1  Introduction 
Both the architecture of the lungs and the epithelial cells types that line the airways 
change throughout the descending respiratory tract to reflect specialised functions 
therein. The trachea and bronchi are lined with ciliated and secretory cells in the 
form of a pseudostratified epithelium in order to facilitate the mucociliary escalator 
and the clearance of inhaled pathogens. At the terminal end of the bronchioles, a 
single layer of airway epithelial cells (AEC) type I and II line the alveolar sacs. 
These cells facilitate the bi-directional movement of gases between the airways and 
the blood (Chang et al. 2008). The establishment of these distinct niches during 
lung morphogenesis is tightly controlled by signalling molecules, growth factors 
and morphogens such as FGF, Wnt and BMP. These signalling factors 
communicate across the Epithelial-Mesenchymal-Trophic Unit (EMTU) which is 
made up of opposing layers of epithelial and mesenchymal cells encompassing a 
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network of basement membrane, fibroblasts, nerves and endothelial cells (Evans et 
al. 1999). 
 In adult lungs, the EMTU is constantly challenged by irritants, pathogens and 
disease-causing agents. It is believed that the signalling factors governing lung 
morphogenesis are re-activated following an injury. This causes the lung epithelium 
to initiate proliferation and differentiation pathways to correctly restore epithelial 
integrity. However, in situations of chronic injury or prolonged inflammation, the 
epithelium will likely undergo incorrect repair such as abnormal epithelial cell 
differentiation and remodelling events. While lung morphogenesis, normal repair 
and abnormal disease processes have been extensively studied, the underlying 
signalling processes governing lung phenotypic changes, remodelling, 
inflammation and restitution of epithelial homeostasis remain unclear (Beers and 
Morrisey 2011; Warburton 2012).   
We have established that BMP pathway is active in porcine lungs and that a BMP 
signalling gradient exists in healthy porcine airways. In addition, we have provided 
evidence that BMP-4 can induce tracheal epithelial cells to adopt a distal epithelial 
cell phenotype. The aim of this work was to investigate the role of BMP signalling 
in the healthy airways of non-human primates. In addition, BMP signalling in 
airways undergoing inflammatory lung disease and airways provided with a 
recovery period following inflammatory disease would be examined. We 
hypothesise that a BMP signalling gradient exists in healthy adult airways similar 
to that present during lung development and homeostatic porcine airways, and that 
this gradient may be altered during inflammatory airway disease and regeneration. 
In order to address these aims, we used an established model of allergic airway 
disease in rhesus macaques. As outlined previously these monkeys displayed 
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increased levels of HDMA-specific IgE in the serum, elevated numbers of 
eosinophils in the BAL and higher CD25 expression on circulating T lymphocytes 
(Schelegle et al. 2001). In addition, monkeys exposed to HDMA and O3 displayed 
rapid shallow breathing and a cough during aerosol challenge. Following necropsy, 
these monkeys displayed thickened basement membrane zone in the airways in 
addition to increased eosinophil accumulation in the conducting airways and mucus 
cell hyperplasia (Schelegle, Miller, et al. 2003; Van Winkle et al. 2004). We 
examined BMP signalling in the left cranial bronchus of the monkeys, similar to 
our study of healthy porcine airways.  
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6.1.1 The rhesus macaque model of allergic airway disease and 
recovery 
Rhesus macaque models of asthma and recovery were developed previously (Figure 
6.0.1 A). All monkeys in the study were male. Group 1 monkeys were exposed to 
filtered air for six months and served as healthy controls. Group 2 monkeys were 
sensitised to the HDMA Dermatophagoides farniae and housed in specialised air 
chambers supplied with cyclic doses of aerosolised Der f. HDMA and O3 for five 
months (Figure 6.0.1 B). These monkeys developed asthma and were sent to 
necropsy at six months old. A recovery model, Group 4, was also established 
whereby monkeys were exposed to cyclic doses of Der f. HDMA and O3 for five 
months followed by six months of filtered air, including one dose of aerosolised 
Der f. HDMA per month. These monkeys were sacrificed at twelve months old. 
Control animals, Group 3, were housed in filtered air for twelve months. 
Sequential airway generations of the left cranial lobe were dissected and 
characterised as trachea, conducting airways and distal bronchioles for the purpose 
of this study (Figure 6.0.1 C). Tissue from the trachea of 6 month old monkeys was 
no longer available and so could not be included in this study. We chose to examine 
expression of the BMP receptor, BMPRIa, as an indicator of potential cell 
responsiveness to BMP ligands. We used an antibody that recognises 
phosphorylated SMADs 1, 5 and 8 to detect nuclear localised SMADs as an 
indicator of active BMP signalling. We also examined expression of proliferating 
cell nuclear antigen (PCNA) as an indicator of regeneration in the airway 
epithelium. Immunofluorescence was carried out and stereologic quantification was 
performed using a Morphometrix software platform developed in UC Davis.  
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Figure 6.0.1 Experimental outline 
(A) Animals were chosen for the study based on a negative intradermal skin 
sensitivity test to Dermatophaoides farinae, a common house dust mite allergen 
(HDMA). Male rhesus macaques were included in the study. At 14 days old D. 
farinae in alum was injected subcutaneously in addition to an intramuscular 
injection of heat-killed Bortetella pertussis. At 28 days old, a repeated dose of D. 
farniae was given in alum. When the rhesus macaques were 30 days old they were 
moved to specially regulated air chambers. The asthma model cohort received 11 
repeated doses of ozone and aerosolized HDMA and were sent to necropsy at 6 
months old, as outlined in B. In the recovery model, the monkeys received the same 
cyclic exposure. After the 11
th
 cycle, filtered air (FA) was supplied to the chambers 
for an additional 6 months. These monkeys underwent necropsy when they were 
twelve months old. *HDMA + O
3
 was given for 2 hours on a monthly basis to 
maintain sensitivity. (B) Aerosolized ozone was supplied for five days (grey fill), 
with aerosolized HMDA (strike-through) on days three to five. Filtered air was 
subsequently supplied for nine days. This regimen was repeated 11 times. Treatment 
lasted for 5 months. (C) The left cranial lobe was harvested and the main stem 
bronchus was dissected into consecutive sections for paraffin wax embedding. For 
the purpose of this study, airway levels 3 and 5 are classified as the conducting 
airways with a ciliated pseudostratified columnar epithelium. Airway level 7 
sections are classified as distal bronchioles. The epithelial wall is made of simple 
ciliated columnar epithelium. 
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6.1.2 Expression of PCNA. BMPRIa and pSMAD 1/5/8 
expression in healthy six month old rhesus macaques 
Immunofluorescence was carried out to examine PCNA, BMPRIa and pSMAD 
1/5/8 expression in lung tissue sections from airway epithelium of healthy six 
month old (Figure 6.0.1). The volume of positively labelled epithelial cells per unit 
basal lamina was counted following randomised sampling of airway sections. 
Expression of PCNA was observed in the nuclei of epithelial cells throughout the 
airways of these animals. Following quantification, no significant difference in the 
level of PCNA expression was detected throughout the airways (Figure 6.0.2). This 
demonstrated that a low level of proliferation was present in the healthy descending 
airways, as expected. The expression of BMPRIa was observed in all epithelial 
regions examined and no significant difference in the level of membrane-bound 
BMPRIa expression was evident in the conducting airways and distal bronchioles 
in six month old rhesus macaques (Figure 6.0.3)  
Finally, the expression of nuclear-localised pSMAD 1/5/8 was investigated in 
healthy juvenile monkey airways and no significant difference was present between 
conducting airways and distal bronchioles (Figure 6.0.4). Nuclear pSMAD 1/5/8 
indicated that active BMP signalling was present in these healthy airways.  
  
BMP signalling in primate airways 
  
 
258 
 
 
  
Figure 6.0.2 PCNA expression in healthy six month old rhesus macaque 
airways 
Representative micrographs of PCNA immunofluorescence in healthy rhesus 
macaque airways. (A) Immunofluorescence of the descending airways showed that 
PCNA expression was present in the nuclei of epithelial cells in the conducting 
airways and distal bronchioles (B) Stereologic quantification of immunofluorescent 
images stained for PCNA did not reveal a significant difference in PCNA 
expression throughout the airways. CA, conducting airways, DB, distal 
bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells per unit of 
basal lamina. Scale bars represent 50uM, n=3. 
PCNA DAPI combined 
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Figure 6.0.3 BMRPIa expression in healthy six month old rhesus macaque 
airways 
Representative micrographs of BMPRIa immunofluorescence in healthy rhesus 
macaque airways. (A) Immunofluorescence of the descending airways showed that  
BMPRIa expression was present in the cytoplasm and at the membrane of epithelial 
cells in the conducting airways and distal bronchioles (B) Stereologic quantification 
of immunofluorescent images stained for BMPRIa did not reveal a significant 
difference in BMPRIa expression throughout the airways. CA, conducting airways, 
DB, distal bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells 
per unit of basal lamina Scale bars represent 50uM, n=3. 
BMPRIa DAPI combined 
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Figure 6.0.4 pSMAD 1/5/8 expression in healthy six month old rhesus macaque 
airways 
Representative micrographs of pSMAD 1/5/8 immunofluorescence in healthy 
rhesus macaque airways. (A) Immunofluorescence of the descending airways 
showed that pSMAD 1/5/8 expression was present in the nuclei of epithelial cells 
in the  conducting airways and distal bronchioles (B) Stereologic quantification of 
immunofluorescent images stained for pSMAD 1/5/8 did not reveal a significant 
difference in expression throughout the airways. CA, conducting airways, DB, 
distal bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells per 
unit of basal lamina. Scale bars represent 50uM, n=3. 
pSMAD 1/5/8 DAPI combined 
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6.1.3 Expression of PCNA, BMPRIa and pSMAD 1/5/8 
expression in healthy twelve month old rhesus macaques 
The expression of PCNA, BMPRIa and pSMAD 1/5/8 were also examined in 
healthy twelve month old rhesus macaques. These monkeys had been housed in 
filtered air chambers for twelve months (Figure 6.0.1). Tracheal tissue was 
available for these monkeys which allowed for increased investigation of signalling 
gradients throughout the airways.  
PCNA expression was examined throughout the airways and similar to six month 
old rhesus macaques, a low level of nuclear expression was evident in the 
descending epithelium (Figure 6.0.5). Following quantification of the positively 
labelled epithelial cells, no significant difference in expression was present between 
trachea, conducting airways and distal bronchioles. BMPRIa expression levels were 
examined in the descending airways by immunofluorescence. Membrane localised 
BMPRIa staining was present throughout the airways (Figure 6.0.6). This indicates 
that the descending epithelium is responsive to BMP ligands. Stereology did not 
reveal any difference in BMPRIa expression throughout the airways.  
pSMAD 1/5/8 expression was examined in the twelve month old healthy monkey 
airways. Similar to six month old monkeys, nuclear pSMAD 1/5/8 expression was 
present in the descending epithelium, indicating active BMP signalling (Figure 
6.0.7). pSMAD 1/5/8 expression was significantly higher in the tracheal epithelium 
compared to both conducting airways and distal bronchioles.  
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Figure 6.0.5 PCNA expression in healthy twelve month old rhesus macaque 
airways 
Representative micrographs of PCNA immunofluorescence in healthy rhesus 
macaque airways. (A) Immunofluorescence of the descending airways showed that 
PCNA expression is present in the nuclei of epithelial cells of the trachea, 
conducting airways and distal bronchioles (B) Stereologic quantification of 
immunofluorescent images stained for PCNA did not reveal a significant difference 
in PCNA expression throughout the airways. CA, conducting airways, DB, distal 
bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells per unit of 
basal lamina Scale bars represent 50uM, n=3 
PCNA DAPI combined 
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Figure 6.0.6 BMPRIa expression in healthy twelve month old rhesus macaque 
airways 
Representative micrographs of BMPRIa immunofluorescence in healthy rhesus 
macaque airways. (A) Immunofluorescence of the descending airways showed that 
BMPRIa expression is present in the cytoplasm and at the membrane of epithelial 
cells in the trachea, conducting airways and distal bronchioles (B) Stereologic 
quantification of immunofluorescent images stained for BMPRIa did not reveal a 
significant difference in protein expression throughout the airways. CA, conducting 
airways, DB, distal bronchioles, Vs TxRed/bl = volume of positively stained 
epithelial cells per unit of basal lamina Scale bars represent 50uM, n=3. 
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Figure 6.0.7 pSMAD 1/5/8 expression in healthy twelve month old rhesus 
macaque airways 
Representative micrographs of pSMAD 1/5/8 immunofluorescence in healthy 
rhesus macaque airways. (A) Immunofluorescence of the descending airways 
showed that  pSMAD 1/5/8 expression is present in the nuclei of epithelial cells in 
the trachea, conducting airways and distal bronchioles (B) Stereologic 
quantification of immunofluorescent images stained for pSMAD 1/5/8 reveals a 
significant decrease in protein expression between trachea and conducting airways 
and distal bronchioles. CA, conducting airways, DB, distal bronchioles, Vs 
TxRed/bl = volume of positively stained epithelial cells per unit of basal lamina 
Scale bars represent 50uM, **p<0.005, n=3 
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6.1.4 Expression of PCNA, BMPRIa and pSMAD 1/5/8 
expression in asthmatic rhesus macaques  
Following the induction of allergic airway disease in the rhesus macaques as 
previously described (Schelegle, Walby, et al. 2003), we investigated changes in 
the expression of BMP signalling components in the descending airways. We 
hypothesised that BMP pathway expression would be altered in asthmatic monkey 
airways, compared to healthy controls.  
No significant difference in PCNA expression was found throughout the 
descending airways of asthmatic monkey airways compared to healthy monkeys 
(Figure 6.0.8). Similarly, no significant difference in BMPRIa expression was 
found by stereologic quantification (Figure 6.0.9). Interestingly, some evidence of 
nuclear BMPRIa expression was present in asthmatic monkey airways. This result 
is explored further in section 6.1.6 . When pSMAD 1/5/8 immunofluorescence was 
carried out and quantified, a significant decrease in nuclear expression was found 
in the epithelium of asthmatic conducting airways compared to healthy controls 
(Figure 6.0.10).  
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Figure 6.0.8 PCNA expression in healthy and asthmatic rhesus macaques 
Representative micrographs of PCNA immunofluorescence in healthy and 
asthmatic rhesus macaque airways. (A) Immunofluorescence of the descending 
airways showed that PCNA expression was present in the nuclei of healthy 
epithelial cells in the conducting airways and distal bronchioles. There appeared to 
be a reduction in PCNA protein expression in asthmatic airways (B) Stereologic 
quantification of immunofluorescent images stained for PCNA did not reveal a 
significant difference in protein expression throughout the airways between healthy 
and asthmatic monkeys. CA, conducting airways, DB, distal bronchioles, Vs 
TxRed/bl = volume of positively stained epithelial cells per unit of basal lamina. 
Scale bars represent 50uM, n=3. 
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Figure 6.0.9 BMRPIa expression in healthy and asthmatic rhesus macaques 
Representative micrographs of BMPRIa immunofluorescence in healthy and 
asthmatic rhesus macaque airways. (A) Immunofluorescence of the descending 
airways showed that BMPRIa was expressed in the cytoplasm and at the cell 
membrane of epithelial cells in the conducting airways and distal bronchioles. 
There appeared to be a reduction in BMPRIa protein expression in asthmatic 
airways (B) Stereologic quantification of immunofluorescent images stained for 
BMPRIa did not reveal a significant difference in protein expression throughout the 
airways between healthy and asthmatic monkeys. CA, conducting airways, DB, 
distal bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells per 
unit of basal lamina Scale bars represent 50uM, n=3. 
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Figure 6.0.10 pSMAD 1/5/8 expression in healthy and asthmatic rhesus 
macaques 
Representative micrographs of pSMAD 1/5/8 immunofluorescence in healthy and 
asthmatic rhesus macaque airways. (A) Immunofluorescence of the descending 
airways showed that pSMAD 1/5/8 was expressed in the nuclei of epithelial cells 
in the conducting airways and distal bronchioles. There appeared to be a reduction 
in pSMAD 1/5/8 protein expression in asthmatic airways (B) Stereologic 
quantification of immunofluorescent images stained for pSMAD 1/5/8 revealed a 
significant decrease in protein expression between healthy and asthmatic monkeys 
in the conducting airways. CA, conducting airways, DB, distal bronchioles, Vs 
TxRed/bl = volume of positively stained epithelial cells per unit of basal lamina 
Scale bars represent 50uM, **p<0.005, n=3. 
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6.1.5 Immunofluorescence and stereological analysis of PCNA, 
BMPRIa and pSMAD 1/5/8 expression in recovering rhesus 
macaques  
Following cyclic exposure to HDMA/O3 over a six month period, a group of 
animals were subsequently housed in chambers supplied with filtered air for an 
additional six months in order to investigate the extent to which recovery, if any, 
could occur following a chronic lung injury, as previously reported (Evans et al. 
2004). Immunofluorescence showed a significant increase in nuclear PCNA 
expression (p=0.0013)  in the conducting airways of recovering monkeys compared 
to healthy twelve month old controls (Figure 6.0.11). Similarly, an increase in 
membrane bound BMPRIa and nuclear pSMAD 1/5/8 expression was evident in 
the epithelium of conducting airway in recovering monkeys (Figure 6.0.12 - .13) 
(p=0.0037 and 0.045 respectively). 
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Figure 6.0.11 PCNA expression in healthy and recovering rhesus macaque 
airways 
Representative micrographs of PCNA immunofluorescence in healthy and 
recovering rhesus macaque airways. (A) Immunofluorescence of the descending 
airways showed that nuclear PCNA expression was present in the epithelium of 
both healthy and recovering airways (B) Stereologic quantification of 
immunofluorescent images stained for PCNA showed that there was a significant 
increase in PCNA expression in the conducting airways between healthy and 
recovering monkeys. CA, conducting airways, DB, distal bronchioles, Vs TxRed/bl 
= volume of positively stained epithelial cells per unit of basal lamina. Scale bars 
represent 50uM, **p<0.005, n=3. 
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  Figure 6.0.12 BMPRIa expression in healthy and recovering rhesus macaque 
airways 
Representative micrographs of BMPRIa immunofluorescence in healthy and 
recovering rhesus macaque airways. (A) Immunofluorescence showed that 
BMPRIa was expressed in the cytoplasm and at the cell membrane of epithelial 
cells in both healthy and recovering airways (B) Stereologic quantification of 
immunofluorescent images stained for BMPRIa showed that there was a significant 
increase in BMPRIa expression in the conducting airways between healthy and 
recovering monkeys. CA, conducting airways, DB, distal bronchioles, Vs TxRed/bl 
= volume of positively stained epithelial cells per unit of basal lamina. Scale bars 
represent 50uM, **p<0.005, n=3. 
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  Figure 6.0.13 pSMAD 1/5/8 expression in healthy and recovering rhesus 
macaque airways 
Representative micrographs of pSMAD 1/5/8 immunofluorescence in healthy and 
recovering rhesus macaque airways. (A) Immunofluorescence of the descending 
airways showed that nuclear pSMAD 1/5/8 expression was present in the 
epithelium of both healthy and recovering airways (B) Stereologic quantification of 
immunofluorescent images stained for pSMAD 1/5/8 showed that there was a 
significant increase in nuclear protein expression in the conducting airways 
between healthy and recovering monkeys. . CA, conducting airways, DB, distal 
bronchioles, Vs TxRed/bl = volume of positively stained epithelial cells per unit of 
basal lamina. Scale bars represent 50uM, **p<0.005, n=3. 
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6.1.6 Immunofluorescence analysis of nuclear translocation of 
BMPRIa in the epithelium of asthmatic monkeys 
The epithelium of asthmatic monkeys displayed increased expression of nuclear 
BMPRIa. Healthy monkey airways expressed membrane bound BMPRIa. Nuclear 
BMPRIa expression was present in asthmatic airways (Figure 6.0.14 A).  
To investigate this expression further, pixel density analysis was carried out using 
Olympus cellSens Dimension 1.9 software. Analysis of nuclear staining patterns in 
control and asthmatic epithelial sections highlight elevated nuclear BMPRIa 
expression in asthmatic airways, as evidence by the overlapping DAPI and TxRed 
expression patterns (Figure 6.0.14 B). In the control airways, it was clear that 
BMPRIa/TxRed staining is excluded from the nucleus.  
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Figure 6.0.14 BMPRIa nuclear translocation in six month old asthmatic 
monkey airways 
Representative micrographs of BMPRIa immunofluorescence of six month old 
healthy and asthmatic monkeys. (A) Immunostaining showed membrane localised 
BMPRIa staining in the epithelium of healthy six month old rhesus macaque 
airways. Following six months exposure to HDMA + O3 there was evidence of 
nuclear translocation of BMPRIa, as indicated by the white arrows. (B) Image 
analysis using Olympus cellSens Dimension 1.9 software illustrated the pixel 
density of BMPRIa labelled with Alexa568 TxRed and DAPI staining. There was 
BMPRIa protein expression in the nuclei of epithelial cells in the asthmatic 
monkeys as evidenced by overlapping DAPI and TxRed staining.  
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Figure 6.0.15 Secondary antibody controls 
Representative immunofluorescence images of antibody controls on the descending 
airways of rhesus macaques. Secondary antibody controls were incubated with TBS 
in place of the omitted primary antibody. The anti-rabbit Alexa568-conjugated 
secondary antibody was then added. (A) Immunofluorescent images of controls in 
six month healthy and asthmatic rhesus macaques. (B) Immunofluorescent images 
from 12 month old healthy and recovering rhesus macaques. All scale bars represent 
50uM. 
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6.2 Discussion 
Lung development relies on a complex interplay between different signalling 
pathways. It is understood that growth factor gradients, such as BMP4, are critical 
in forming the lung architecture as well as directing the spatial distribution of 
epithelial cells types throughout the airways  (Bellusci et al. 1996; Weaver et al. 
1999). These pathways are believed to be reactivated in injured and diseased adult 
lungs to orchestrate epithelial repair and to restore healthy airway homeostasis. Our 
group and others have shown that BMP signalling is activated during repair in 
rodent models of airway injury using ovalbumin, nitronaphthalene and bleomycin 
exposure (Masterson et al. 2011; Rosendahl et al. 2002). Furthermore, BMP 
signalling is activated in lung stem cell niches following injury, highlighting the 
importance of the BMP pathway in epithelial cell differentiation and proliferation 
(Sountoulidis et al. 2012). However, to date, the concept of signalling gradients 
along the respiratory axis has not been investigated in healthy adult lungs. We have 
identified a BMP signalling gradient in rhesus macaque airways and demonstrated 
a reduction in BMP pathway activation in asthma. In addition, we showed that BMP 
pathway activity was elevated during active recovery in the airways and highlighted 
a potential mechanistic relationship between inflammation and BMP signalling. 
In our study, the presence of nuclear pSMAD 1/5/8 in the conducting airways and 
distal bronchioles of healthy six and twelve month old monkeys demonstrated 
constitutive activation of BMP signalling in these regions. Similar results have been 
reported by us and others in rat and human airway epithelium, although pSMAD 
1/5/8 was reported absent from the bronchial epithelium of PBS-treated mouse 
lungs (Rosendahl et al. 2002; Sountoulidis et al. 2012). In the present study, we also 
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detected a significant gradient in nuclear pSMAD 1/5/8 expression in the distal 
airways of healthy twelve month old non-human primates. This suggests that BMP 
signalling could be involved in the maintenance of homeostasis throughout the 
airways, but plays a more active role in the trachea compared with lower airways. 
Interestingly, membrane bound BMPRIa expression did not vary significantly 
throughout the airway epithelium. This indicates that positive regulators of BMP 
signalling, such as BMP ligands themselves, may be more active in the tracheal 
epithelium, or that negative regulators, such as noggin and gremlin, may be more 
active in the lower airways. The levels of nuclear PCNA in the healthy airways did 
not vary significantly, consistent with health and homeostasis.  
As presented earlier in this thesis, we found that BMPRIa and pSMAD 1/5/8 were 
also expressed in the lung epithelium of healthy porcine airways but no expression 
gradients were detected. In porcine airways we analysed total pSMAD 1/5/8 
expression in the lung epithelium whereas in primate airways we examined the level 
of nuclear pSMAD 1/5/8 expression specifically. This could account for the lack of 
a pSMAD 1/5/8 gradient in the pig lungs. We speculate that pSMAD 1/5/8 
expression is linked to epithelial turnover and proliferation events in the porcine 
airways as the induction of pSMAD 1/5/8 expression by BMP-4 treatment caused 
upregulation of ID-1 and ID-2 in tracheal explants, known regulators of cell cycle 
progression. In the primate airways, elevated levels of pSMAD 1/5/8 in the trachea 
could also be linked to epithelial cell proliferation and differentiation. We have 
shown that BMP-4 can induce a distal epithelial cell phenotype in porcine tracheal 
cells thus, we hypothesise that the elevated pSMAD 1/5/8 in the healthy primate 
tracheal epithelium may be induced by different BMP ligands, namely BMP-2 or 
BMP-7.  
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In summary, our results indicate a role for BMP signalling in airway homeostasis. 
Given that BMP signalling governs cell cycle progression in vitro and orchestrates 
correct epithelial cell differentiation during lung morphogenesis, we speculate that 
BMP signalling is involved in epithelial cell turnover in healthy airways and 
mediating epithelial homeostasis (Masterson et al. 2011; Molloy et al. 2008; 
Weaver et al. 1999).  
Repeat exposure to HDMA/O3 was used to induce allergic airway disease in the 6 
month treatment group of rhesus macaques. Previous studies of these monkeys 
demonstrated both immune and structural responses in the airways (Schelegle, 
Miller, et al. 2003). The animals displayed elevated eosinophil accumulation in both 
proximal and distal airways and increased eosinophil presence in bronchoalveolar 
fluid. Furthermore, the lungs displayed extensive remodelling which directly 
affected the functionality of the airways. Conducting airways and terminal 
bronchioles exhibited elevated mucous cell mass and a negative correlation 
between baseline airway resistance and the ratio of conducting airways to lung 
parenchyma was evident (Schelegle, Miller, et al. 2003). This suggested that the 
cyclic exposure model causing allergic airway disease potentially alters the 
rudimental growth factor and morphogen patterns that orchestrate correct 
respiratory tract repair and epithelial cell distribution. By examining the expression 
profile of BMP components along the airways, we have shown that the normal BMP 
pathway signals are indeed perturbed as a result of HDMA/O3 exposure. A 
significant decrease in nuclear pSMAD 1/5/8 in the lung epithelium of conducting 
airways was evident. Furthermore, although the results proved not to be statistically 
significant, a decreasing trend of BMPRIa expression could be seen in epithelium 
of the both the conducting airways and distal bronchioles.  
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Interestingly, in addition to reduced pSMAD 1/5/8 expression, nuclear localisation 
of BMPRIa was evident in the conducting airway epithelium of the six month 
asthma group (Figure 6.0.16). Infiltrating eosinophils were previously shown to be 
significantly elevated in the conducting airways and distal bronchioles of these 
monkeys and we hypothesised a link between these inflammatory cells and the 
BMP pathway. Many studies have shown that eosinophils and specifically their 
secondary derived proteins play a central role in airway remodelling, perpetuating 
airway hyper-responsiveness in asthma and inflammatory airway diseases but the 
signalling pathways governing these events remain poorly understood (Costello et 
al. 2009; Gleich and Adolphson 1993a, 1993b; Humbles et al. 2004). Previous 
results in our lab carried out by Dr. Emer Molloy, have shown that transient 
BMPRIa trafficking can be induced by eosinophil derived cationic proteins. When 
MAECs were treated with eosinophil derived cationic proteins BMPRIa was 
transiently trafficked from the membrane to the nucleus. This indicates a potential 
mechanism whereby the eosinophil-derived proteins may influence BMP signalling 
by altering the localisation of BMPRIa. Moreover, if reduced pSMAD 1/5/8 
signalling is a consequence of this modulation, this could explain the significant 
reduction in levels of nuclear pSMAD 1/5/8 in the conducting airways in the six 
month asthma group. This possibility is further supported by Kariyawasam et al., 
who demonstrated that eosinophils are the predominate producer of BMP-7 in the 
lung epithelium of asthmatic airways (Kariyawasam et al. 2008). Co-localisation of 
BMP-7 with MBP-positive eosinophils was observed in these asthmatic airways. 
As BMP-7 is known to act as an anti-inflammatory ligand in other organs, the 
authors speculated that the increase in ligand expression could be an attempt to 
regulate inflammation as part of the reparative processes in the airways 
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(Kariyawasam et al. 2008; Maric et al. 2003). Previous work presented here 
indicated that BMP-7 could also be linked to inducing MET to control fibrosis, as 
shown in the DLKP cell line. In addition, an in vitro study using the neuroblast 
IMR32 cell line reported a similar down-regulation of BMPRIa RNA expression 
following a 4hr exposure to eosinophil-derived MBP. Co-incubation of the cells 
with BMP-7 and MBP decreased the induction of ID-1, an established downstream 
target of the BMP pathway (Costello et al. 2009).  
Taken together with our results, we hypothesise that the attenuated expression 
levels of BMP signalling present in this non-human primate model of asthma are 
due to eosinophil-induced nuclear translocation of membrane-bound BMPRIa. 
Subsequent inhibition of downstream BMP signalling pathways interferes with 
appropriate epithelial repair processes mediated by BMP and its signalling partners 
such as FGF-7 (Desai and Cardoso 2002). This could contribute to a chronic disease 
state promoting incorrect epithelial turnover, an inflammatory phenotype and 
epithelial remodelling, all of which are well-established hallmarks of asthma.  
While BMP receptor processing and trafficking between the nucleus and the 
membrane are common in receptor synthesis and normal signal transduction, 
incorrect receptor trafficking can contribute to disease as evidenced by BMPRII 
mutations in pulmonary hypertension (Lane et al. 2000). Trafficking of receptors 
from the membrane and nuclear accumulation of FGF, EGF, NGF, IL-5 and Notch 
receptors have all been previously described (Di Guglielmo et al. 2003; Jans et al. 
1997; Lo and Hung 2006; Stachowiak et al. 1996; Struhl and Adachi 1998; 
Zwaagstra, Guimond, and O’Connor-McCourt 2000). As reviewed by Carpenter 
(2003) there are a number of possible routes into the nucleus.  Following ligand 
binding at the membrane, receptors enter the endosome where some are degraded 
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and others are re-cycled to the membrane or into the nucleus. Using a putative 
Golgi-ER pathway and the NLS to facilitate traversing across the nuclear envelope, 
the receptors can be translocated to the nucleus (Jans and Hassan 1998). Ligand-
independent nuclear accumulation has also been documented for TGF-β and EGFR 
(Carpenter 2003; Dittmann, Mayer, and Rodemann 2005; Lo and Hung 2006; 
Zwaagstra et al. 2000).  
The mechanism through which eosinophil cationic protein induce BMPRIa 
trafficking has not yet been elucidated. Despite multiple studies examining receptor 
trafficking and endosomal translocation in TGF- β and other TRK signal 
transduction pathways, BMP signalling trafficking remains largely enigmatic. 
Ligand-mediated BMPRIa trafficking has been previously reported in primary 
human lymphoblastoid cell lines (de la Peña et al. 2005).  Differential receptor 
internalisation pathways were explored in HEK and C2C12 cells and results showed 
that the activation of SMAD-dependent and –independent pathways by BMP 
ligands could be attributed to specific routes of endocytosis (Hartung et al. 2006). 
Furthermore, nuclear BMPRIa expression has also been reported when it co- 
localised with the splicing factor SAP49 in the inner leaflet of the nuclear 
membrane (Nishanian and Waldman 2004). We hypothesise that BMPRIa receptor 
translocation in that primate epithelial cells could be caused by eosinophil-induced 
ligand production by the epithelial cells or underlying fibroblasts to internalise the 
receptor. This could occur by the induction of BMP-2 which possesses a potential 
NLS and has been shown to bind directly to BMPRIa ((Nickel et al. 2001, E.L 
Molloy, PhD). Alternatively, a ligand independent pathway could be occurring 
which is mediated through the kinase activity of BMPRIa. Our results demonstrate 
that reduced membrane receptor expression could lead to reduced downstream 
BMP signalling in primate airways 
  
 
282 
 
BMP signalling by preventing phosphorylation of the R-SMAD receptor complex 
and subsequent translocation of pSMAD 1/5/8 into the nucleus. However, a specific 
role for BMPRIa in the nucleus has yet to be shown.  
The regenerating airway model used here provided further evidence for the 
involvement of BMP signalling in inflammatory airway disease and repair 
processes. The increased incidence of nuclear PCNA is consistent with repair 
processes in the conducting airways following a period of chronic injury and 
inflammation. Increased expression of membrane-localised BMPRIa in these 
regions indicates a role for BMP signalling in the repair/regeneration processes. In 
other mouse and human asthma models, similar increases in BMP signalling 
evidenced by nuclear pSMAD1/5/8 were observed in bronchial epithelium 
challenged with OVA or an aeroallergen, respectively  (Kariyawasam et al. 2008; 
Rosendahl et al. 2002).  Previous studies of this rhesus macaque model showed that 
these monkeys displayed modest signs of repair and airway regeneration. Perlecan 
was re-introduced at the basement membrane and there was evidence for the re-
establishment of correct mucous cell expression in the proximal airways (Evans et 
al. 2010). We speculate that this recovering phenotype of the airways is further 
promoted by increased BMPRIa expression at the membrane, promoting elevated 
ligand-induced nuclear translocation of pSMAD 1/5/8 protein. This causes the 
epithelial cells to enter a state of active repair and proliferation in an attempt to 
restore an appropriate homeostatic environment in the airways. This occurs perhaps 
through the expression of ID genes and elevated production of BMP-7 ligand in an 
attempt to counteract the anti-mitogenic properties of TGF-β to regulate cell 
proliferation, remodelling and epithelial differentiation (Moses, Yang, and 
Pietenpol 1991; Tirado-rodriguez et al. 2014).  
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We speculate that the higher BMPRIa membrane staining present in the recovery 
monkeys is a result of reduced eosinophil infiltration in the airways. This is 
supported by the reduced eosinophil presence in the BAL fluid of the recovery 
monkeys compared to the asthmatic monkey and previous human asthmatic airway 
studies that show attenuated cellular inflammation following the removal of airway 
insult (Kariyawasam et al. 2007). Lowered levels of eosinophilic granule proteins 
could decrease the nuclear translocation of BMPRIa and thus account for the 
elevated membrane--localised BMPRIa expression and nuclear pSMAD 1/5/8 
signalling present in the cells. As a result, an important feedback mechanism in the 
lung epithelium may exist whereby the removal of airway insult reduces eosinophil 
infiltration and eosinophil-induced downregulation of BMP signalling. This 
mechanistic hypothesis is supported by recent studies showing for the first time a 
definitive anti-inflammatory function of BMP signalling in the stomach and airway 
epithelium (Li et al. 2014; Takabayashi et al. 2014). The enhanced BMP pathway 
activity could induce the putative anti-inflammatory function of BMPs, preventing 
further inflammation and damage to the epithelium and facilitating the restoration 
of correct epithelial cell turnover and repair (Figure 6.0.16).  
We have shown that BMPRIa localisation is altered in asthmatic airways. We 
speculate that eosinophils – and particularly the cationic effector proteins of 
eosinophils - could be responsible for the altered receptor expression. The 
mechanisms involved in BMP receptor trafficking, the effect of nuclear localised 
BMPRIa and the definitive role of eosinophilic effector proteins in this process 
remain poorly understood. Future experiments should address this potential 
mechanistic relationship between eosinophils and BMP signalling. 
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To conclude, this study using this non-human primate model of allergic airway 
disease indicate that not only are developmental pathways re-activated during 
inflammatory airway disease involving epithelial injury, but that basal expression 
of the BMP signalling pathway is important for maintaining healthy airways.  
 
 
BMP signalling in primate airways 
  
 
285 
 
 
 
 
  
Figure 6.0.16 Hypothesis of eosinophil-induced transient trafficking of 
BMPRIa 
Healthy airway epithelial cells express BMPRIa at the membrane and normal 
homeostatic BMP signalling occurs via downstream activation of pSMAD 1/5/8. 
Following airway insult and the induction of an inflammatory response in the 
airway epithelium, infiltrating eosinophils are recruited to the site which illicit their 
response by releasing cationic proteins. Either by binding BMPRIa directly or 
inducing BMP ligands, eosinophilic cationic proteins potentially induce BMPRIa 
nuclear-translocation and the BMP signalling pathway is disrupted. Reduced BMP 
signalling occurs which in turn affects cell proliferation and epithelium remodelling 
events. Removal of the pathogen facilitates the restoration of membrane bound 
BMPRIa signalling and activation of normal BMP signalling events. This 
encourages active epithelial repair and restoration of epithelial integrity. 
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Chapter 7  
Final Conclusions 
7.1 Conclusion 
Bone morphogenetic signalling is involved in correct lung morphogenesis and 
establishing correct epithelial cell distribution along the developing airways. We 
have shown that BMP signalling remains active in healthy adult airways. Using 
porcine bronchial tissue, we demonstrated that BMP ligands, BMP antagonists and 
intracellular SMAD molecules are expressed in homeostatic lung epithelium. We 
detected a BMP signalling gradient in the airways and illustrated that this BMP-4 
expression gradient may be responsible for maintaining distal epithelial cell 
distribution in the airways. In addition, we have demonstrated active BMP 
signalling is present in healthy rhesus monkey airways. These results provide 
evidence that basal BMP pathway signalling is maintained in healthy adult airways. 
The work also highlights a potential role for active BMP signalling in homeostatic 
airways.  
In order to investigate BMP signalling in adult lung diseases we used an established 
model of allergic airway disease in rhesus macaques. BMP signalling was reduced 
in asthma and subsequently elevated during active recovery of the lung epithelium. 
We highlighted a potential mechanistic relationship between inflammation and 
BMP in the airways. Using a lung cancer cell model, we investigated the role of 
BMP signalling in EMT-mediated phenotypic switching. Firstly, by stimulating 
subpopulations of a heterogeneous lung cancer cell line with BMP-4 or gremlin, we 
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showed that BMP signalling was capable of inducing phenotypic switching 
between the clones. Moreover, using an E-cadherin reporter plasmid we 
demonstrated the differences in phenotype along the cadherin axis and highlighted 
that differences in E-cadherin gene processing between the clones result in a more 
invasive and mesenchymal cell phenotype. This work implicates BMP signalling 
with increased tumour invasiveness and the induction of EMT in cancer cells.    
Overall these data highlight the presence and importance of BMP signalling 
gradients in healthy adult airways and further implicate BMP signalling in the 
pathogenesis of inflammatory and malignant airway diseases.  
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7.2 Future directions 
We have shown that BMP signalling is active in the descending lung epithelium of 
both porcine and non-human primate airways. While porcine explants allowed 
further investigation of the role of BMP signalling the airways, future experiments 
should utilise primary culture of airway epithelial cells. Development of air-liquid 
interface cultures would provide a robust platform for studying the role of BMP 
signalling during airway homeostasis. Using targeted inhibition of BMP signalling 
by siRNA, the role of BMP pathway activation in epithelial cell proliferation and 
differentiation could be elucidated. Furthermore, determination of the expression 
of pro-inflammatory cytokines following targeted injury of the epithelium and the 
effect of BMP ligands/inhibitors on cytokine release would provide further insight 
into the role of BMP signalling in airway repair and inflammation. 
Our work focused primarily on characterising canonical BMP signalling in the 
descending airways. The presence of pERK 1/2 in the descending airways 
highlighted that non-canonical BMP pathways were active in the airways. Future 
experiments should characterise non-canonical BMP signalling and other growth 
factor signalling in the descending airways. This could highlight different signalling 
gradients responsible for maintaining homeostasis in the lung epithelium. 
It is important for future work investigating the BMP pathway in the airways to 
identify the specific cell populations involved in BMP signalling and to investigate 
if there is any modulation in BMP signal expression following damage and during 
repair of the airways. For example, double immunostaining of histological sections 
with epithelial cell markers would allow characterisation of the cells responsible for 
BMP pathway activation.  
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We have shown that BMPRIa localisation is altered in asthmatic airways. We 
speculate that eosinophils – and particularly the cationic effector proteins of 
eosinophils - could be responsible for the altered receptor expression. The 
mechanisms involved in BMP receptor trafficking, the effect of nuclear localised 
BMPRIa and the definitive role of eosinophilic effector proteins in this process 
remain poorly understood. Future experiments should address this potential 
mechanistic relationship between eosinophils and BMP signalling. 
We have shown that the DLKP cell lines are a dynamic model for studying tumour 
heterogeneity and phenotypic switching. Our results demonstrated the differences 
in E-cadherin gene processing, growth patterns and expression of cell adhesion 
proteins between the DLKP clones. Further characterisation of these clones would 
be beneficial and provide further insights into the re-programming events that have 
occurred to give rise to the different cell phenotypes. This would provide important 
information regarding potential therapeutic targets for cancer treatments. 
Investigating the effect of the E-cadherin reporter plasmids in DLKP-I clones would 
be very useful. These cells express N-cadherin, similar to DLKP-M but lack E-
cadherin. They represent an EMP population between DLKP-SQ and DLKP-M on 
the EMT axis. Transfection of DLKP-I cells would further elucidate where on the 
cadherin axis this “intermediate” population exists. Future experiments should 
address the potential cleavage events and downregulation of the E-cadherin protein 
which occurs in DLKP-M cells following E-cadherin overexpression.  
In this study, we investigated the effect of BMP-4 and gremlin on DLKP cell 
populations. Further experiments should utilise BMP-2 and BMP-7 to investigate 
the effect of these ligands on motility and EMT. In addition the role of TGF-β has 
Final conclusions& future directions 
  
 
291 
 
not been explore in DLKP cells lines. Firstly, the level of expression of endogenous 
TGF-β ligands and receptors would be investigated in DLKP cell lines. In addition, 
targeted inhibition of TGF-β / BMP signalling using siRNA or neutralising 
antibodies would provide a greater insight into the role of BMP and TGF-β 
signalling in EMT. By silencing BMP signalling in DLKP-M cells, their 
mesenchymal metastatic properties may be reversed. These experiments could also 
elucidate the role of BMP signalling with proliferation in DLKP cell populations. 
Future experiments investigating BMP signalling and EMT should be carried out. 
Treatment experiments involving DLKP-M clones and BMP-4 could lead to 
important findings regarding growth factor induced EMT and fibrosis. The role of 
BMP signalling in vivo during tissue fibrosis would be of particular interest and 
could highlight BMP as a potential therapeutic target.  
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A 
 
 
 
 
B DLKP-SQ Em2 purified population  
 
 
 
 
DLKP-M Em2 purified population  
  
Figure 8.0.1. Generation of fluorescent DLKP-SQ and DLKP-M clones by 
Dr. Emer Molloy. (A) Expansion of the fluorescent clones was carried out by 
serial dilution for clonal expansion was carried out using the Corning ® Serial 
dilution protocol. Single Fluorescence cells were selected based on FACS 
fluorescence. (B) FACS analysis of purified DLKP-SQ Em2 and DLKP-M Em2 
populations displayed 83.26% and 93% YFP expression, respectively. This 
work was carried out by Dr. Emer Molloy (O’Dea lab). 
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Dr. Joanne Masterson 
designed the Eprom and Em2 plasmids - validated in 
Beas2b and mouse airway epithelial cells
Dr. Emer Molloy
1) transfected DLKP-SQ and DLKP-M with plasmids 
to create mixed populations of Eprom and Em2
2) generated stable clones using G418 selective culture
3) examined proliferation and migration of cells
4) examined actin, B-catenin, cytokeratin, PCNA 
expression in DLKP-SQ Eprom and Em2
Thérése Lynn
1) used the mixed populations of Eprom and Em2
clones prepared by Dr. Emer Molloy
2) generated stable clones using G418 selective culture
3) carried out downstream processing and examination 
of clones as presented in Chapter 4
Figure 8.0.2 Flow chart of DLKP work carried out in the O’Dea lab  
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Figure 8.0.3 Gene expression analysis in DLKP clones
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Figure 8..0.4 Gene expression analysis in DLKP-SQ and DLKP-M clones 
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Figure 8.0.5 Genes expressed higher in DLKP-M compared to DLKP-SQ 
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Figure 8.0.6 Genes expressed higher in DLKP-M compared to DLKP-SQ 
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Figure 8.0.7 Genes expressed higher in DLKP-M compared to 
DLKP-SQ 
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Figure 8.0.8 Genes expressed higher in DLKP-SQ compared to DLKP-M 
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Figure 8.0.9 Genes expressed higher in DLKP-SQ compared to 
DLKP-M 
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Figure 8.0.10 Genes expressed higher in DLKP-SQ compared to 
DLKP-SQ 
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Figure 8.0.11 Larger images of DLKP-SQ cells treated with BMP-4 
Continued from figure 3.0.4. At the same microscope exposure, increased 
nuclear localisation of SMAD-4 and pSMAD 1/5/8 was evident in DLKPSQ 
cells treated with 100 ng/ml BMP-4 for 24 hrs, as indicated by the white 
arrows.   
Appendix 
 
 
305 
 
control      + BMP-4 
  
S
M
A
D
-4
 
p
S
M
A
D
 1
/5
/8
 
Figure 8.0.12 Larger images of DLKP-M cells treated with BMP-4 
Continued from figure 3.0.6. At the same microscope exposure, increased 
nuclear localisation of SMAD-4 and pSMAD 1/5/8 was evident in DLKP-M 
cells treated with 100 ng/ml BMP-4 for 24 hrs, as indicated by the white 
arrows.   
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Figure 8.0.13 Larger images of DLKP-I cells treated with BMP-4 
Continued from figure 3.0.8. At the same microscope exposure, increased 
nuclear localisation of SMAD-4 and pSMAD 1/5/8 was evident in DLKP-I 
cells treated with 100 ng/ml BMP-4 for 24 hrs, as indicated by the white 
arrows.   
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